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Characterizing the roles of the putative Tor1p effector, Sfp1p, in 
growth and development of the fungal pathogen Candida albicans 
 
Amine El Osmani 
 
C. albicans is one of the most common fungal pathogens of humans. Important virulence-
determining traits include proper cell proliferation and the ability to develop into different 
cell types, including yeast, pseudohyphae and hyphae. Both of these processes are 
dependent on environmental cues such as availability and types of nutrients. It is thus 
important to understand how these cues are sensed and integrated with the machinery that 
control cell division and development. The TOR pathway plays an important role in 
mediating environmental conditions in many organisms, and accordingly, TOR kinase is 
required for cell division and the maintenance of hyphal growth in C. 
albicans (1). However, the mechanisms by which TOR regulates these processes in the 
pathogen are not clear. Here, we provide the first characterization of Sfp1p, an orthologue 
of a major downstream effector of TOR kinase in S. cerevisiae. Deletion of SFP1 in C. 
albicans resulted in a decrease in cell size, which could be reduced further in the presence 
of poor carbon source media. The sfp1D/sfp1D cells grew slowly, formed small colonies, 
and were more sensitive to rapamycin, suggesting that Sfp1p mediates a least part of Tor1p 
function in C. albicans. Transcription profiles of the deletion strain demonstrated down-
regulation of genes involved in ribosome biogenesis, translation, and amino acid synthesis, 
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consistent with a role in the TOR pathway. However, many hyphal-specific genes were 
upregulated, as well as some genes associated with the opaque cell fate, suggesting 
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1.1 C. albicans Overview 
Candida albicans is a multimorphic fungus present in 80% of mammals, including 
humans. It lives as a commensal in the gastrointestinal tract and on mucosal surfaces and 
its proliferation is under the tight control of the host’s immune system (2). Nevertheless, 
this opportunistic pathogen can invade and colonize host tissues in immuno-compromised 
individuals, including chemotherapy and HIV patients, or following antibiotic treatments 
that unbalance the gastrointestinal flora. The results can be minor superficial infections of 
the mucosa but can reach severe life-threatening systemic infections especially when the 
fungus enters the bloodstream (3). Several types of drugs are available to candidiasis 
patients but only a few are fungicidal. Most, including azoles like fluconazole, polyenes 
like amphoterecin B, and allylamines like terbinafine, target the biosynthesis of ergosterols, 
components of the fungal cytoplasmic membrane, proving to be fungistatic. Another type, 
flucytosine, is converted into subproducts that inhibit RNA transcription, RNA translation, 
and DNA replication, but has been associated with multiple side effects on the bone 
marrow, gastrointestinal tract, liver, and kidneys and it has also been challenged with high 
rates of resistance (4). Thus, Candida albicans is a worldwide leading cause for fungal 
infections (5) and the fourth most common cause for nosocomial infections in the US with 
mortality rates reaching 50% (6). Due to serious side effects and increasing drug resistance, 
new drug targets and therapeutic strategies are needed. To this end, we require a more 




1.2 Virulence-determining trait: Morphogenesis 
1.2.1 C. albicans cell types  
 Contributing to its pathogenesis, C. albicans demonstrates the ability to undergo 
phenotypic switching in response to environmental conditions like temperature, acidity, 
carbon source and nutrient availability (6, 7). Three main growth forms are distinguishable: 
the yeast, hyphal and pseudohyphal forms. Yeast cells grow as ellipsoid single cells with 
round-shaped buds that detach at the end of cytokinesis. Hyphae continuously grow in a 
long narrow tubular form with parallel walls and no constriction at the site of septation. 
Pseudohyphae consist of a thick chain of elongated yeast cells with clear constrictions at 
sites of septation but no detachment. A fourth growth form, the opaque state, corresponds 
to the mating competent form of yeast cells as opposed to the white state for mating 
incompetent cells. Opaque cells grow as oblong-shaped cells with a rough surface and on 
solid media as flat colonies, whereas white cells grow as smooth domed soft colonies with 
well defined sharp edges (6, 8). 
 Candida albicans’ ability to switch between morphologies in response to 
environmental cues is necessary for its virulence as blocking cells in a specific form results 
in a significant loss of virulence (9-11). Further, plasticity in form allows C. albicans to 
exist in different environments of the host. Filamentous forms facilitate tissue invasion and 
evasion from the host’s immune system; filaments allow the fungus to break out of 
macrophages, for example, and permit migration across endothelial layers and the blood-
brain barrier. Yeast forms, on the other hand, might be more advantageous for colonizing 
tissues and travel through the bloodstream (12-15). 
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1.2.2 Environmental regulation of morphogenesis  
 Morphogenesis in C. albicans is regulated by a diversity of environmental cues and 
associated signalling pathways (Fig. 1). For example, yeast growth is favored at low 
temperature and low pH while hyphal growth can be induced at a higher temperature of 
37C in combination with serum, high pH or alternative carbon sources (8). The yeast-to-
hyphal morphogenetic switch is well characterized. Its regulation involves many different 
environmental signalling pathways, including the mitogen activated protein kinase 
(MAPK) and the cyclic adenosine monophosphate (cAMP)/protein kinase A pathways 
(16), for example. The MAPK and the cAMP/PKA pathways (17) are activated by a 
common GTPase encoded by the RAS1 gene (18). In the MAP kinase pathway, Ras1p 
transduces a signal through a cascade of kinases including Cst20p, Ste11p, Hst7p, and 
Cek1p resulting in the activation of Cph1p, a transcription factor required for mating and 
hyphal growth on solid media (19). In the cAMP/PKA pathway, Ras1p activates the 
adenylyl cyclase Cdc35p (also known as Cyr1p) that catalyzes the conversion of adenosine 
triphosphate to 3’, 5’-cyclic adenosine monophosphate (cAMP). This leads to its 
accumulation and the activation of a cAMP dependent protein kinase (PKA), composed of 
a catalytic subunit (Tpk1p or Tpk2p) and a regulatory subunit (Bcy1p) (20, 21). The 
downstream targets of this pathway are various transcription factors including Efg1p (22), 
and Tec1p that are required for the regulation of hypha-specific genes. Another pathway 
that transduces environment signals is the pH response pathway consisting of Rim8p, and 
Rim20p that activate Rim101p, a transcription factor required for alkaline induced hyphal 
growth, and the matrix embedding pathway. The latter in turn activates Czf1p, another 
transcriptional regulator of hyphal growth (5). Ultimately the pathways control the physical 
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switch to hyphal growth as well as co-expression of hyphal-specific genes (HSG’s), many 
of which are virulence factors (23). 
 
1.3 Virulence-determining trait: Cell proliferation  
1.3.1 Cell cycle and G1/S regulation in S. cerevisiae 
 Another aspect of the biology of C. albicans that is important for virulence is its 
ability to proliferate, which is under control of the cell cycle. In yeast like Saccharomyces 
cerevisiae, the cell cycle consists of an initial growth phase (G1) during which cells 
increase their content and volume in preparation for division. Once a critical cell size is 
attained, cells initiate budding and transition from the G1 phase to the S phase at a 
checkpoint referred to as Start. This is when cells become committed to budding and 
division. The S phase mainly consists of the duplication of the cell content including DNA 
replication in preparation for mitosis. A second growth phase (G2) allows the budding cell 
to increase in size and prepare for the transfer of the genetic material. A final stage referred 
to as the M phase for mitosis follows. It is preceded by a second checkpoint (G2/M) that 
ensures the proper replication of the genetic material and ends with the separation of the 
budding cell from the mother cell during cytokinesis, and entry of the new cells into G1 
phase or a “dormant” phase referred to as G0. The cell cycle is regulated at many different 
levels, but the major players are the cyclin-dependent kinases (CDKs) (16, 24). CDKs 
associate with phase-specific cyclins to phosphorylate several targets that allow transition 
between cell cycle stages. 
5 
 
 The G1/S transition is a crucial stage where many cell types either commit to 
division or exit the cell cycle to follow different developmental pathways (16). The G1/S 
regulatory circuitry is well defined in the model yeast S. cerevisiae. Here, the CDK Cdc28p 
associates with the G1 cyclin Cln3p and activates the SBF/MBF G1/S transcription factor 
complex, which is composed of ankyrin-repeat proteins specific to fungi (25, 26). SBF is 
composed of the DNA activating factor Swi6p in association with the DNA binding factor 
Swi4p (SBF), and mediates G1/S early events such as cyclin expression, budding, and cell 
wall deposition. MBF is composed of Swi6p in combination with the DNA binding element 
Mbp1p, which mediates DNA replication. SBF is activated through Cdc28p/Cln3p-
mediated inactivation of Whi5p, an SBF repressor and considered the pRb functional 
equivalent (25, 26). The mechanisms underlying Cdc28p/Cln3p-dependent activation of 
MBF is unclear, but MBF is a transcriptional repressor of its targets outside G1 phase, with 
the assistance of a co-repressor Nrm1p, thus restricting MBF target gene expression to G1 
phase (27). SBF and MBF bind SCB (Swi4/6 cell cycle binding box) and MCB (Mlu1 cell 
cycle box) elements, respectively, (28). Their targets include other transcription factors and 
additional G1 cyclins such as CLN1 and CLN2 (29), for example. 
 The G1/S machinery and Start are coordinated with cell growth through external 
and internal cues. These cues dictate the critical size cells need to reach to progress through 
Start to the S phase. Smaller cells are the result of quicker progression through G1/S 
relative to growth or slower growth relative to division (30, 31). These cues include nutrient 
conditions (like carbon source type and amino acid availability) (24) and internal rates like 




1.3.2 Cell cycle regulation in C. albicans: G1/S transition 
 In C. albicans, the cell cycle is not as well defined but a framework for the G1/S 
circuitry is emerging based on sequence comparisons, cell-cycle stage-specific DNA 
expression profiles and limited functional analyses (35-37). For example, C. albicans 
contains orthologues of the CDK Cd28p (38, 39) and G1 cyclins CCN1 (previously known 
as CLN1) (40), CLN3 (previously known as CLN2) (38), and HGC1 (41). Yeast cells 
lacking CCN1 grew more slowly, implying a cell cycle function (42), but absence of HGC1 
had no effect on yeast growth (41). In contrast, CLN3 was essential for growth as cells 
lacking this factor arrested in G1 phase (43, 44). C. albicans also contains orthologues of 
the G1/S transcription complex factors Swi6p, Swi4p and Mbp1p. Cell size defects and 
expression profiles of cells lacking Swi4p and Swi6p suggested that these factors may 
constitute a single G1/S transcriptional complex that is important for the G1/S transition in 
C. albicans yeast cells (35, 37). Thus, some important players in the putative G1/S circuit 
have been identified in C. albicans but a detailed knowledge of the regulatory network is 
lacking. Moreover, the putative G1/S regulatory circuit in C. albicans shows some clear 
differences compared to the situation in S. cerevisiae. For example, C. albicans lacks an 








1.4 The G1/S transition and its relationship with morphogenesis  
 Intriguingly, the G1/S transition in C. albicans demonstrates an important and 
novel link with hyphal development in C. albicans. For example, it was found that the 
deletion of CCN1 results in the inability to maintain hyphal growth under certain conditions 
(42). A subsequent study found that Ccn1p associates with Cdc28p to target the septin 
cytoskeleton protein Cdc11p required for hyphal development (45). Despite not having a 
yeast cell cycle function, the cyclin Hgc1p was found to be required for hyphal growth, 
where it interacts with the CDK Cdc28p to promote hyphal morphogenesis and prevent 
cell separation by sequestering some polarity proteins from the site of cytokinesis (41). In 
addition the same study provided evidence that HGC1 expression was linked to the signal 
transduction pathway cAMP/PKA. Further, yeast cells lacking Cln3p were found to switch 
to hyphal and pseudohyphal growth following an extended G1 phase delay (43, 44), and 
cells lacking Swi4p or Swi6p also grew in a more filamentous manner (35, 37). Finally, 
absence of orthologues of factors that regulate the SCF ubiquitin ligase complex in S. 
cerevisiae and in turn influence G1 phase progression, including Grr1p and Cdc4p, also 
results in filamentation in C. albicans (46-49). Thus, G1 phase appears to be linked to 







1.5 Environmental sensing and cell cycle progression: the TOR pathway 
1.5.1 TORC complex  
 In order to ensure successful growth and division, cells must be able to sense their 
environment as well as transduce the signals to the cell division apparatus. Several 
signalling pathways function in this regard, one of which is the TOR pathway. Target of 
rapamycin or TOR (50) was discovered through work with the drug rapamycin, an 
antibiotic produced by the bacterium Streptomyces hygroscopicus that has novel antifungal 
properties as well as valuable immunosuppressive and antiproliferative activities (51). A 
mutation that confers resistance to this drug in S. cerevisiae led to the identification of 
Tor1p, a phosphatidylinositol kinase-related kinase (PIKK) (50). Rapamycin inhibits this 
kinase by forming a complex with a peptidylprolyl isomerase (rotamase), the FK506-
binding protein (FKBP12). The complex then binds directly to Tor1p and blocks its 
activity. While rapamycin also inhibits FKBP12 enzymatic activity, it is the association 
with the Tor1p kinases that is behind its antifungal and immunosuppressive properties 
since preventing the complex from binding to the kinase confers resistance to rapamycin 
(52). The gene product is a large 280 kDa protein that is functionally conserved from yeast 
to humans. Structurally it consists of an essential serine/threonine kinase domain at its 
carboxy-terminal and N-terminal to the kinase domain is the FKBP12-rapamycin binding 
(FRB) domain. These domains are demarcated by a FAT domain, N-terminal to the FRB, 
and a FATC domain, C-terminal to the kinase domain. Both are not very well understood 
but they are exclusively found coupled in all PIKKs, suggesting an important interaction 
between them. The N-terminal is composed of up to 20 tandem HEAT repeats, each 
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consisting of an antiparallel α-helical motif and suspected to play a role in protein-protein 
interactions and anchoring the kinase to the plasma membrane (53, 54). 
 Treatment of cells with rapamycin was found to result in a response similar to the 
nutrient-deprivation response (55), including G1 cell cycle arrest, protein synthesis 
inhibition, accumulation of glycogen, and autophagy (56, 57). This has prompted many 
investigations of TOR's involvement in the nutrient-sensing pathway, leading to its position 
as a central controller of growth in response to nutrients (58, 59). The pathway is also 
involved in the response to other environmental conditions like temperature, energy and 
stress levels, as well as growth factors and pheromones (54) making it the main transducer 
of growth regulating environmental signals (60). Most of the factors involved in this 
pathway have been primarily characterized in the model yeast Saccharomyces cerevisiae, 
but the majority of them were found to have counterparts in other fungi, flies, worms, plants 
and mammals (61). Most eukaryotes have a single copy of the TOR kinase, but the budding 
yeast has two homologous copies, ScTOR1 and ScTOR2. These homologues form two 
distinct protein complexes, TORC1 and TORC2, which mediate different aspects of the 
growth response. The former regulates the temporal aspects (feeding cues to the cell cycle) 
while the latter controls its spatial aspects (regulating actin polarization). TORC2, is 
insensitive to rapamycin and exclusively made of the association of the ScTor2p kinase 
with ScLst8p, ScAvo1p, ScAvo2p, ScAvo3p, ScBit61p and ScBit2p (62). The rapamycin 
sensitive complex TORC1 is formed by the association of either ScTor1p or ScTor2p with 
ScLst8p, ScKog1p, and ScTco89p. The functions of these components are not fully 




1.5.2 TORC effectors  
 In Saccharomyces cerevisiae, TORC1 transduces environmental signals to factors 
regulating transcription, translation and ribosome biogenesis (Fig. 2). One of its direct 
targets is ScTap42p, a regulatory protein that associates with ScSit4p, a PP2A (protein 
phosphatase 2A)-related serine/threonine phosphatase involved in the G1/S transition of 
the cell cycle (63, 64). Under normal conditions, ScTap42p is phosphorylated, inactive, 
and tightly bound to TORC1 at the plasma membrane (65). When TORC1 is inactivated 
(by nutrient depletion or rapamycin treatment), ScTap42p is released and a number of 
stress-regulated, nitrogen catabolite repressed, and retrograde signalling genes are 
activated. An example is the transcription activator of nitrogen catabolite repressed genes, 
ScGln3p, which relocates from the cytoplasm to the nucleus when ScTap42p is activated 
(66-68). A less understood example is ScMaf1p, a negative regulator of RNA polymerase 
III that is dephosphorylated by PP2A resulting in its translocation from the cytoplasm to 
the nucleus (69, 70). Thus, ScTap42p is playing a role in the regulation of its associated 
phosphatase in response to TORC1 activity.  
 An ScTap42p-independent effector of TORC1 is ScSch9p, a protein kinase 
involved in the transcriptional activation of osmostress responsive genes and the regulation 
of progression through G1. ScSCH9 was first identified in a screen for gene deletions that 
result in significant cell size effects. Cells deleted for ScSCH9 showed one of the smallest 
cell size phenotypes observed in S. cerevisiae accompanied by a growth defect (71, 72). It 
is a direct substrate of TORC1, and when phosphorylated results in the induction of 
ribosome biogenesis (RIBI) and ribosomal protein (RP) genes (73, 74). Huber et al. (2011) 
demonstrated that the transcriptional repressors ScSTB3, ScDOT6, and ScTOD6 are direct 
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targets of ScSch9p and their combined deletion results in nearly a complete loss of RIBI 
and RP gene repression when ScSch9p is inhibited (74). The combined deletion also partly 
restored the ScSCH9 deletion cell size and growth defect. ScSch9p was also recently found 
to play a role in the nutrient sensing cAMP-PKA pathway, regulating the localization of 
PKA’s regulatory subunits, ScBcy1p (74-76).  
 
1.5.3 The nutrient-sensing Split Zinc Finger protein Sfp1p is also a target of Tor1p  
 Another established effector of the TOR pathway is ScSfp1p, a split zinc finger 
protein discovered by Blumberg & Silver in 1991. Sfp1p was found to be required for 
normal yeast growth as it caused a block in the nuclear targeting of nucleolar proteins when 
present in high copy numbers (77). It was later found to be involved in the regulation of 
the G2/M transition and the DNA damage response (78). In comparison to an isogenic wild 
type strain, the deletion of ScSFP1 in S. cerevisiae resulted in a smaller cell size, an 
increase in doubling time of 100 minutes, the accumulation of cells in G1, and failure to 
arrest at G2/M under DNA damaging conditions. This led to the conclusion that ScSfp1p 
plays a negative regulatory role at the G2/M transition. Subsequently, ScSfp1p was 
proposed to be a novel repressor of the G1/S transition that acts upstream of the G1/S 
transcriptional regulators SBF and MBF (71). Similar to deletion of ScSCH9, deletion of 
ScSFP1 resulted in the smallest cell sizes observed accompanied by a significant increase 
in doubling time. Induction of ScSFP1 resulted in the expression of nucleotide 
biosynthesis, aminoacyl tRNA synthetases, ribosome biogenesis, rRNA, transcription, 
translation initiation and elongation genes indicating a role in regulation of growth (79). In 
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addition, absence of ScSfp1p caused a decrease in the expression of a reporter gene with 
the RRPE and PAC promoter elements, indicating that transcription from promoter regions 
containing these elements is Scfp1p-dependent. Mutational analysis revealed that the PAC 
element serves as a repressor, the RRPE as an activator, and that the two C-terminal zinc 
fingers of the ScSfp1p protein are essential for its function (79). More recently, a direct 
interaction between ScSfp1p and Tor1p was demonstrated by immunoprecipitation. A Rab 
escort protein, ScMrs6p was found to be required for the nuclear localization of ScSfp1p 
and might be involved in the regulation of TORC1-dependent ScSch9p activity. In 
addition, a negative feedback mechanism was reported whereby ScSfp1p’s transcriptional 
role leads to a reduction in the TORC1 ScSch9p activity (80, 81). 
 
1.5.4 The TOR pathway and C. albicans  
 In C. albicans, a TOR pathway exists but is not fully characterized. One copy of 
the TOR gene exists with 60% sequence homology to both S. cerevisiae copies. Most of 
the TORC1 and TORC2 components have homologues in C. albicans, including SIT4, 
GLN3, MAF1, and SCH9, for example, but others such as ScBIT61 and ScBIT2 (52) are 
missing. Of the factors that have been investigated, several show conservation in function 
but, intriguingly, also influence filamentation (61, 63, 82, 83). For example, Sit4p plays a 
role in cell growth, hyphal development and virulence, and through microarray expression 
analysis was shown to be involved in cell wall biosynthesis and the osmotic stress response 
(63). Sit4p interacts with Mds3p, another member of the C. albicans TOR pathway 
involved in morphogenesis (83). Similarly, Gln3p functions downstream of the TOR 
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pathway and is required for filamentation on specific nitrogen sources like urea and 
ammonium (82, 84). Further, Liu et al. (2010) found that the deletion of SCH9 resulted in 
a phenotype similar to the one observed in S. cerevisiae, where cells were reduced in size, 
and delayed in growth (85). In addition, absence of CaSch9p resulted in increased 
sensitivity of cells to several compounds including rapamycin, affected filamentation on 
select medium, and attenuated virulence in a mouse model of systemic candidiasis (85). In 
alignment with these findings, transcription profiles of C. albicans cells treated with 
sublethal doses of rapamycin demonstrated modulation of genes associated with nitrogen 
starvation, ribosome biogenesis, and hyphal-specific cell wall adhesions (86). Finally, 
recent work showed that down-regulation of the TOR pathway was required for 
maintaining hyphal growth, as this resulted in downregulation of the MAPK Hog1p and 
subsequent induction of the transcription factor Brg1p. Brg1p in turn outcompetes a 
repressor of hyphal growth for binding to hyphal specific genes (87). 
 Thus, aspects of the TOR pathway are emerging in C. albicans, but a detailed 
picture of all of the components and their mechanisms of action in regulating growth as 
well as development is lacking.  
 
1.6 Objectives: 
 In order to obtain a better understanding of how Tor1p functions in regulating 
growth and development in C. albicans, and to gain important insights into how 
environmental cues such as nutrients are sensed and communicated to the cell division 
apparatus, we characterized an orthologue of Sfp1p, a transcription factor lying 
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downstream of the TOR and PKA nutrient sensing pathways in S. cerevisiae. We 
demonstrate that C. albicans Sfp1p has some conservation in function in regulating growth 
and cell size, possibly through influencing ribosomal biogenesis, but may also play a role 




2.0 MATERIAL & METHODS 
 
2.1 Media and growth conditions 
Cells were grown in rich medium (YPD) (1.0% yeast extract, 2.0% peptone, and 
2.0% dextrose) or complete minimal medium (MM) (0.67% yeast nitrogen base without 
amino acids, 2.0% dextrose, 0.15% complete amino acid mix). The complete amino acid 
mix consisted of 4.9% adenine; 2.5% uracil; 4.9% tryptophan; 2.5% histidine; 2.5% 
arginine; 2.5% methionine; 3.7% tyrosine; 3.7% isoleucine; 18.4% valine; 3.7% lysine; 
6.2% phenylalanine; 12.4% glutamic acid; 24.7% threonine; 7.4% leucine. Appropriate 
amino acids were left out when selecting for URA3+, HIS1+ and/or ARG4+ prototrophs. 
For solid medium, 2.0% agar was added. To investigate the effect of different carbon 
sources, glucose in MM was replaced with 2.0% galactose, raffinose or glycerol. Strains 
carrying SFP1 under control of the MET3 promoter (88) were grown in MM without 
methionine (-MC) or with 2.5 mM methionine and 0.5 mM cysteine (+MC) to induce or 
repress expression, respectively. Spider medium consisted of 2.0% nutrient broth, 2.0% 
mannitol, and 0.4% K2PO4, pH to 7.2 with NaOH (89). Synthetic low-ammonium dextrose 
(SLAD) medium (90) consisted of a 0.17% yeast nitrogen base without amino acids and 
(NH4)2SO4, 2.0% dextrose, and 50 µM (NH4)2SO4. Rapamycin was added to YPD or MM 
medium from a 100 µM stock in ethanol. A similar volume of EtOH was added to control 
cells. For growth assays, overnight cultures of cells were diluted to an Optical Density at 
600 nm (OD600nm) of 0.1 and incubated at 30 C for the indicated times. Hyphal growth 
was induced by the addition of 10% Fetal Bovine Serum (FBS) to YPD or MM medium 
and incubating at 37 °C for 2 hours. For microarray analysis, cells were inoculated in 5 ml 
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fresh MM media then serially diluted 5 times in 10 ml fresh MM media from 102 to 106 in 
order to obtain an overnight 30 C culture of cells at an OD600nm of < 0.01, and collected 
the next day at an OD600nm of 0.8. This was done to account for the difference in the growth 
rate of the sfp1∆::URA3/sfp1∆::HIS1 mutant and the isogenic control (SFP1/SFP1; URA3; 
HIS1). Growth curves were constructed by inoculating cells in 3ml fresh MM and YPD for 
overnight incubation at 30 C. Cultures were diluted next day from a stationary phase 
OD600nm to an OD600nm of 0.1 in 10ml fresh MM or YPD media and incubated at 30 C for 
10 to 12 hours. Measurements were taken every two hours starting with T0 (at the start of 
incubation) and up to T10 or T12 (after 10 h or 12 h of incubation time). Values from 2 to 4 
independent cultures were averaged and normalized to a T0 OD600nm of 0.1. The doubling 
rate of each strain was estimated from the final averaged growth curve. The sfp1∆/sfp1∆ 
growth curve was also constructed with haemocytometer cell counts in order to account 
for potential cell size effects on the 600nm optical density measurements. 
 
2.2 Strain construction 
Strains, oligonucleotides and plasmids are listed in Tables 1-3, respectively. In 
order to delete SFP1, constructs made by PCR fusion (91, 92) were utilized. 
Oligonucelotides HH20F, HH20R and HH22F, HH22R amplified approximately 800 bp 
fragments from genomic DNA (gDNA) lying, respectively, upstream and downstream of 
the SFP1 open reading frame. The PCR amplification conditions of both fragments 
consisted of 3 min at 94 ºC; 25 cycles of 30 sec at 94 ºC, 30 sec at 52 ºC, and 1 min at 68 
ºC, followed by 7 min at 68 ºC. Oligonucleotides HH30F and HH30R were used to amplify 
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URA3 from pBSCaURA3 at the following conditions: 94 ºC for 3 min, 25 cycles of 30 sec 
at 94 ºC, 30 sec at 45 ºC, 1.5 min at 68 ºC, followed by 7 min at 68 ºC. The three PCR 
products were then combined in a 1:2:1 ratio (50 ng: 150 ng: 50 ng) with oligonucleotides 
HH20F and HH22R to create the final fusion construct. The PCR conditions included 2 
min at 95 ºC, 10 cycles of 10 sec at 95 ºC, 30 sec at 46 ºC, 3 min at 68 ºC, 15 cycles of 10 
sec at 95 ºC, 30 sec at 46 ºC, and 3 min at 69 ºC, followed by 7 min at 69 ºC. The product 
was purified and transformed into strain BWP17, resulting in strain HHCa20, or SN148, 
resulting in strain AM1401. The second copy of SPF1 was replaced with HIS1 using the 
same 5’ and 3’ end fragments. The middle fragment was amplified at the same PCR 
conditions using oligonucleotides HH30F and HH30R and plasmid pBSCaHIS1. The 
HIS1-containing construct was transformed into strains HHCa20 and AM1401 to replace 
the second wild type copy of SFP1, resulting in strains HHCa28 and AM1415 respectively. 
In order to create a strain carrying a single copy of SFP1 under control of the MET3 
promoter (88) oligonucleotides AOM1F and AOM1R were used to amplify an 824 bp 
fragment from gDNA, located 857 bp upstream of the SFP1 start codon. PCR conditions 
consisted of 94 ºC for 3 min, 30 cycles of 94 ºC for 30 sec, 50 ºC for 30 sec, 68 ºC for 1 
min, followed by 68 ºC for 7 min. Oligonucleotides AOM3F and AOM3R amplified a 799 
bp fragment from gDNA that included the SFP1 start codon and downstream sequence. 
The PCR conditions included 94 ºC for 3 min, 30 cycles of 94 ºC for 30 sec, 38 ºC for 30 
sec, 68 ºC for 1min, followed by 68 ºC for 7 min. Oligonucleotides AOM2F and AOM2R 
were then used to amplify a HIS1-MET3 fragment from pFA-HIS1-Met3p. PCR conditions 
included 94 ºC for 3 min; 30 cycles of 94 ºC for 30 sec, 50 ºC for 30 sec, 68ºC for 3 min, 
followed by 68 ºC for 7 min. A final fusion PCR construct was created from the three 
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products at a ratio of 1:2:1 of the 5’, middle, and 3’ fragments (50 ng : 150 ng: 50 ng) using 
oligonucleotides AOM1F and AOM3R. PCR conditions included 94 ºC for 3 min; 10 
cycles of 94 ºC for 30 sec, 45 ºC for 30 sec, 68 ºC for 5 min, 15 cycles of 95 ºC for 30 sec, 
45 ºC for 30 sec, 69 ºC for 5 min, followed by and finally 69 ºC for 7 min. The construct 
was transformed into strain AM1401, resulting in strains AM1511 and AM1512. 
In order to tag SFP1 with HA, oligonucleotides AOL1F and AOL1R amplified a 
HA-HIS1 cassette from plasmid pFA-HA-CaHIS1 using the following conditions: 94 ºC 
for 4 min, 30 cycles of 94 ºC for 1 min, 45 ºC for 1 min, 68 ºC for 2 min, followed by 68 
ºC for 7 min. The product was transformed into strain HHCa20, resulting in strain 
AM1213. In order to tag SFP1 with GFP, oligonucleotides AOL3F and AOL3R amplified 
a GFP-ARG4 from plasmids pFA-GFP-CaARG4 using the following conditions: 94 ºC for 
4 min, 30 cycles of 94 ºC for 1 min, 46 ºC for 1 min, 68 ºC for 3 min, followed by 68 ºC 
for 7 min. The product was transformed into strain HHCa20, resulting in AM1312 and 




Transformations were done according to Rose et al. (1990) with modifications (93). 
Briefly, 4 to 10 μg of the purified PCR product was mixed with 300 μl of an overnight cell 
culture grown in rich media to an OD600nm of ≥12.0, pelleted, washed and resuspended in 
100 μl one-step-buffer (25 μl boiled salmon sperm DNA; 0.015 g DTT; 800 μl sterile 50% 
PEG 4000; 200 μl sterile 1M LiAc) then incubated overnight at 30ºC and heat-shocked 
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next day at 43 ºC for 1 hour before plating on solid selective media. After incubating at 30 
ºC for 2 days, screening of colonies was done by PCR, southern blotting, and western 
blotting (for HA-tagged strains). 
 
2.4 Genomic DNA extraction  
To extract gDNA, 5 ml of an overnight culture of cells were treated for 2 h at 37 
°C with 100 U lyticase (10 U/µl) in 1 ml Sorbitol buffer (1 M sorbitol, 0.1 M EDTA pH 
8.0) and 8 mM DTT. The lysate was then centrifuged at 13,500 rpm for 1 min and the 
supernatant removed. The pellet was resuspended in 200 µl of 50 mM Tris pH 8.0, 20 mM 
EDTA pH 8.0. After resuspension SDS was added to a final concentration of 1%, and the 
sample was incubated at 65 °C for 30 min. 100 µl of a 5 M KAc solution was then added 
to the sample, which was then incubated on ice for 60 min, and centrifuged at 13,500 rpm 
for 10 min. The supernatant was transferred to a new tube and gDNA precipitated by adding 
an equal volume of isopropanol. The pellet was washed with 70% ethanol then resuspended 
in 150 µl buffer of 10 mM TRIS pH 8.0. RNA was removed from the sample by adding 2 
µl of 10 mg/ml RNase A (Fermentas) and incubated at 37 °C for 30 min. Samples were 
quantified using the Hoefer DQ300 nanospectrometer and stored at 4 °C before use. 
 
2.5 PCR screening of strains  
PCR screening of strains utilized the method of Ling et al. (1995) (94). Briefly, 
colonies growing on selective media were transferred by streaking onto fresh selective 
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solid media for three rounds. Single colonies were then lysed enzymatically by carrying 
with a sterile pipette tip and mixing with 10 µl of a Zymolyase solution (2.5 mg/ml of 
Zymoylaze (MP Biomedicals, LLC), 1.2 M sorbitol, 0.1 M NaPO4). Incubation at 43 °C 
for 60 min allowed for the enzymatic reaction to take place and 50 µl PCR reactions were 
then performed with 2 µl of the resulting lysed cells solution, 15 M of oligonucleotides, 
100 mM of dNTPs (Fermentas), and Expand Long Template Polymerase with Buffer 3. 
For the double deletion of SFP1, strain HHCa28 (sfp1∆::URA3/sfp1∆::HIS1), 
prepared in the BWP17 wild type background, was screened using three sets of 
oligonucleotides along with its isogenic control, HHCa1 and the wild type strain BWP17. 
The first set of oligonucleotides, SFP1FS1 and SFP1FR1, flank the SFP1 locus and would 
amplify a wild type fragment of 3.3 kb, a sfp1∆::URA3 fragment of 3.1 kb, and a 
sfp1∆::HIS1 fragment of 3.0 kb. The second oligonucleotide set used SFP1FS1 with a 
URA3 embedded oligo, URA3R1 to amplify a 2.1 kb sfp1∆::URA3 fragment. Similarly, 
the third set consisted of SFP1FS1 and HIS1R1, a HIS1 embedded oligo. The third set 
amplified a 1.4 kb sfp1∆::HIS1 fragment. All three sets were used in 50 µl PCR reactions 
at the following conditions: 94 °C for 3 min; 30 cycles 94 °C for 30 sec, 40 °C for 30 sec, 
68 °C for 2 min; followed by 68 °C for 7 min, and a hold at 4 °C. The double deletion of 
SFP1 prepared from the wild type SN148 background and resulting in strains AM1401 
(sfp1∆::URA3/SFP1) and AM1415 (sfp1∆::URA3/sfp1∆::HIS1) were also screened using 
the SFP1 locus flanking oligos, SFP1FS1 and SFP1RS1. A 3.3 kb wild type SFP1 fragment 
a 3.1 kb sfp1∆::URA3 fragment, and a 3.0 kb sfp1∆::HIS1 fragment were amplified at the 
following PCR conditions: 94 °C for 3 min; 30 cycles 94 °C for 30 sec, 40 °C for 30 sec, 
68 °C for 3.5 min; followed by 68 °C for 7 min. The AM1401 strain was also confirmed 
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using oligos SFP1FS1 and URA3R1 amplifying a 2.1 kb sfp1∆::URA3 fragment at the 
following conditions: 94 °C for 3 min; 30 cycles 94 °C for 30 sec, 40 °C for 30 sec, 68 °C 
for 3 min; followed by 68 °C for 7 min. AM1415 was also confirmed using the same set of 
oligos SFP1FS1 and URA3R1 for a 2.1 kb sfp1::URA3 fragment and another set SFP1FS1 
and HIS1R1 for a 1.4 kb sfp1::HIS1 fragment at the following conditions: 94 °C for 3 min; 
30 cycles 94 °C for 30 sec, 39 °C for 30 sec, 68 °C for 2.5 min; followed by 68 °C for 7 
min. 
The HIS1-MET3p-SFP1/sfp1Δ::URA3 strains (AM1511 and AM1512) were 
screened using two sets of oligonucleotides along with wild type BWP17 strain. The first 
set of oligonucleotides, HH20F and CaMETr, amplify a HIS1-MET3p fragment of 3.7 kb, 
and no wild type fragment. This set was used in 50 µl PCR reactions at the following 
conditions: 95 °C for 1 min; 25 cycles 95 °C for 30 sec, 45 °C for 30 sec, 72 °C for 4 min; 
followed by 72 °C for 7 min. The second set, HH20F and CaHIS1R amplified a 1.58 kb 
fragment of the HIS1 marker. Reactions (50 µl) were performed at the following 
conditions: 95 °C for 1 min; 25 cycles 95 °C for 30 sec, 49 °C for 30 sec, 72 °C for 2 min; 
followed by 72 °C for 7 min. 
The AM1213 strain (SFP1-HA-HIS1/sfp1∆::URA3) was confirmed using 
oligonucleotides SFP1FS1 and SFP1RS1 to amplify a 3.3 kb wild type fragment, a 4.8 kb 
SFP1-HA-HIS1 fragment, and a 3.1 kb sfp1∆::URA3 fragment. PCR conditions were the 
following: 94 °C for 3 min; 25 cycles at 94 °C for 30 sec, 40 °C for 30 sec, 68 °C for 6 
min; followed by 68 °C for 7 min, and a hold at 4 °C. Similarly strains AM1312 and 
AM1317 (SFP1-GFP-ARG4/sfp1∆::URA3) were confirmed using the same oligo pair at 
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the same PCR conditions to amplify the same wild type and sfp1∆::URA3 fragments in 
addition to a 6.0 Kb SFP1-GFP-ARG4 fragment. 
 
2.6 Southern blotting 
To confirm the genotype of the sfp1∆::HIS1/ sfp1∆::URA3 strains (HHCa28 and 
AM1415), Southern blotting was also utilized, using the DIG system (Roche Diagnostics). 
A 754 bp probe homologous to the 3’ flank of SFP1 was amplified by PCR using 
oligonucleotides HH22F and HH22R. 500 ng of the PCR product was labelled by boiling 
for 10 min to denature, cooling on ice for 5 min, then centrifuging and adding 10 µl of 10x 
hexanucleotide mix, 10 µl of 10x dNTP -DIG labelling reaction, and 25 U of Klenow in a 
total reaction volume of 100 µl. The reaction was incubated overnight at 37 °C and stopped 
the next day by adding 4 µl of 0.5 M EDTA. The labelled probe was precipitated by adding 
1 µl of 20 mg/ml glycogen, 7.92 µl of 5 M LiCl, and 3 volumes 95% EtOH, then mixing 
and cooling at -20 C overnight. The probe was pelleted by centrifugation at 4 °C, 13,500 
rpm for 10 min, washed with 150 µl 70% EtOH, and resuspended in 50 µl TE buffer.  
Genomic DNA from the sfp1∆::HIS1/sfp1∆::URA3 strains AM1415, HHCa28, the 
SFP1/SFP1; URA3; HIS1 isogenic control, HHCa1, and the wild type strains BWP17 and 
SN148, were digested with 40 U of DraI (NEW ENGLAND BioLabs) by mixing 4 g 
gDNA with 10 µl of 10x BSA (10 mg/ml), 10 µl of 10x Buffer 4, and water and incubating 
overnight at 37ºC. DraI cuts the SFP1 locus to result in a 4191 bp fragment for the wild 
type SFP1 gene, a 2968 bp fragment for sfp1∆::URA3, and a 1944 bp fragment for 
sfp1∆::HIS1. Digests were then precipitated overnight at -20 ºC with 4 µl 5 M NaCl and 
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400 µl 95% EtOH. Samples were collected by centrifuging at 13,500 rpm for 10 min at 4 
ºC, washed with 70% EtOH, air-dried for 15 min, and resuspended in 20 µl TE buffer. 
Digested gDNA was then loaded on a 1% agarose gel containing 0.4 mg/ml Ethidium 
Bromide along with 10 µl of the DIG-labelled molecular weight marker and separated 
overnight at 25 V. The gel was washed twice for 15 min in denaturing solution (1.5 M 
NaCl; 0.5 M NaOH), rinsed with water, and washed twice for 15 min in neutralizing 
solution (3 M NaCl; 0.5 M Tris-HCl pH 8.0). The samples were then transferred overnight 
to a positively charged nylon membrane (Boehringer Mannheim) in 20x SSC (3 M NaCl; 
300 mM Na3C6H5O7 pH 7.0). The following day, the membrane was rinsed in 2x SSC, UV 
crosslinked in the Stratalinker (Stratagene) and stored at 4 ºC. 
The membrane was then prehybridized by rotating for 1 h at 65 ºC in 12 ml of 
preheated prehybridization solution (5x SSC, 1% blocking agent; 0.1% Sarkosyl (Sodium 
Lauryl Sarcosinate); 0.02% Sodium Dodecyl Sulfate (SDS)). Next, 50 ng of the probe was 
boiled, snap-cooled on ice, and added to 10 ml of the 65 ºC preheated prehybridization 
solution, which was then added to the membrane. Hybridization was performed overnight 
at 65 ºC. The following day, the membrane was washed twice for 5 min with 50 ml room 
temperature 2x Wash Solution (2x SSC; 0.1% SDS), twice for 15 min with 50 ml 65 ºC 
preheated 0.1x Wash Solution (0.1x SS; 0.1% SDS), then equilibrated in Solution 1 (0.1 
M Maleic Acid; 0.15 M NaCl) for 3 min. The membrane was then blocked for 1 h at room 
temperature in 100 ml of 1x Blocking Solution (Roche). Anti-DIG-alkaline phosphatase 
coupled antibody was diluted 1/10 000 in 50 ml Solution 1, added to the membrane, and 
incubated for 30 min with shaking. The membrane was then washed twice for 15 min at 
room temperature (300 µl Tween 20 in 100 ml Solution 1), equilibrated for 5 min in 
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Solution 3 (0.1 M NaCl; 0.1 M Tris pH 9.5), then transferred to a hybridization bag and 
incubated with 2 ml of Solution 3 containing 102x diluted CSPD (chloro-5-substituted 
adamantyl-1,2-dioxetane phosphate) for 5 min at room temperature. The membrane was 
sealed, incubated for 15 min at 37 ºC, and then exposed to an X-ray film for 15 min. 
 
2.7 Microscopy 
Cell microscopy was performed on a Leica DM6000B microscope (Leica 
Microsystems Canada Inc, Richmond Hill, ON, Canada) equipped with a Hamamatsu Orca 
ER digital camera (Hamamatsu Photonics, Hamamatsu City, Japan) using 63x and 100x 
objectives and DAPI (460 nm) filter sets. Images were captured with OpenLab software 
(Improvision Inc, PerkinElmer). Staining of nuclei was done by pelleting cells, washing 
twice with double distilled sterile water, and fixing with 70% EtOH. Pellets were then 
rinsed with double distilled sterile water and DNA was stained with 4'-6'-diamidino-2-
phenylindole (DAPI) by incubating cells for 15 min in 100 μl of a 1 μg/ml DAPI solution. 
Cells were then rinsed twice with double distilled sterile water before visualization. Cell 
size measurement was done manually from microscope images taken under the 63x lens. 
A minimum of 100 yeast cells and 50 hyphal cells were measured and Microsoft Excel was 
used to analyse the data, calculate the mean, standard deviation, variance and standard error 
of the mean values. Additional statistical analyses including the normality test, the 
parametric student’s t-test, and the non-parametric Mann-Whitney test was performed 




2.8 RNA extraction 
For microarray analysis, SFP1/SFP1 (HHCa1) and sfp1∆/sfp1∆ (HHCa28) cells 
were serially diluted after inoculation 2 to 6 fold in 10 ml minimal media targeting an 
OD600nm of 0.001 in 10 ml MM. After overnight incubation at 30 C, 3 ml and 5 ml, 
respectively, of the strains at an OD600nm of 0.8 were collected, washed, with sterile water, 
and frozen at -80 ºC. RNA was then extracted and purified using the MasterPure yeast 
RNA purification kit (Epicentre Biotechnologies). Alternatively, the hot phenol method 
(95) was utilized for Northern blots, since it resulted in higher yields. Cells were inoculated 
overnight in 10 ml minimal medium and diluted next day from a stationary phase to an 
OD600nm of 0.1 in 100 ml of fresh culture media to be collected by centrifugation for 5 min 
at 3500 rpm in a 50 ml conical at an OD600nm of 0.8. 
Cells were resuspended in 10 ml SAB buffer Ph 5.0 (50 mM NaCH3COO; 10 mM 
EDTA; 0.1% Diethylpyrocarbonate (DEPC)) and lysed by vortexing for 10 min at 65 ºC 
with 3 g of acid washed glass beads, 1 ml of 10% SDS, and 10 ml of a 65 ºC-preheated 1:1 
SAB-Phenol solution. Samples were cooled down to room temperature, then centrifuged 
for 10 min at 3,000 rpm. The lower phase was discarded and replaced with another 10 ml 
65ºC-preheated 1:1 SAB-Phenol solution to vortex for another 10 min. This was repeated 
a total of 2 to 3 times to minimise DNA contamination and maximise purity. The upper 
phase was then transferred to a new tube and mixed by vortexing for 2 min with 10 ml 
chloropane, then centrifuging for 4 min at 3,000 rpm. The upper phase was transferred to 
a clean conical and vortexed with 10 ml of a 24:1 chloroform-isoamylalcohol solution, then 
centrifuged for 4 min at 3,000 rpm. The upper phase was transferred again and RNA 
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precipitated by adding 1 ml of 3 M NaCH3COO and 30 ml of 95% EtOH. After incubating 
overnight at -20ºC, the extracted RNA was collected by centrifuging at 3,500 rpm for 15 
min, washed with 70% EtOH, resuspended in 100 μl DEPC treated water, and stored at -
80 ºC. 
 
2.9 Microarray Expression Analysis 
In order to determine the transcription profiles of cells lacking Sfp1p, total RNA 
from strains HHCa1 and HHCa28 was reverse transcribed and directly labelled with dCTP-
Cy5 or dCTP-Cy3 (96, 97). Briefly, 40 μg of total RNA was mixed with 1.5 μl 100 pmol/μl 
AncT mRNA primer and incubated at 70 ºC for 10 min followed by another 10 min 
incubation at room temperature. The samples were then mixed with 3 μl 6.67 mM dGTP, 
dATP, dTTP mix; 1 μl 2 mM dCTP; 4 μl 0.1 M DTT; 8 μl 5x First Strand Buffer and 2 μl 
SuperScript II reverse transcriptase. In addition 2 μl of 1 mM Cy3 was added to the Cy3 
sample, and 1 μl of 1 mM Cy5 with 1 μl DEPC H2O to the Cy5 sample. RNA was then 
reverse transcribed at 42 ºC for 2 h, after which an additional 1 μl of reverse transcriptase 
was added to each sample and reverse transcription extended for an additional 1 h. Next, 1 
μl of 10 mg/ml RNase A and 1μl (0.05 U) of RNase H were added to each tube and 
incubated at 37 ºC for 30 min. The reaction samples were then topped up to 50 μl with 
DEPC H2O and purified using Qiagen columns. 
 C. albicans microarray gene chips were obtained from the National Research 
Council - Biotechnology Research Institute (NRC-BRI) in Montreal, Quebec. Chips were 
prehybridized for 1 h in a moist chamber at 42 ºC with 50 μl of prehybridization solution 
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(400 μl DIG EASY HYB buffer; 20 μl 10 mg/ml yeast tRNA; 20 μl 10 mg/ml salmon 
sperm DNA) that was previously incubated at 95 ºC for 3 min. The cDNA samples were 
concentrated to a 3 μl volume, combined, and topped to 30 μl with the same buffer. After 
heating at 95 ºC for 3 min, the sample was kept in a 42 C bath until use. The chips were 
washed in preheated distilled water, dried by centrifuging for 2 min at 2000 rpm, and 
hybridized overnight with the 30 μl of sample at 42 ºC. The chips were then washed once 
for 10 min in 42 ºC 1x SSC, 0.2% SDS after removal of the cover slips, twice for 10 min 
at 37 ºC in 0.1x SSC, 0.2% SDS, then once for 5 min in 0.1x SSC at room temperature. 
The chips were subsequently rinsed six times in 0.1x SSC before drying. Arrays were 
scanned using a GenePix 4000B scanner (Axon Instruments) and the data was analysed 
with GeneSpring v.9.0 software (Silicon Genetics, Redwood City, CA). Significantly 
modulated genes were identified based on a 1.5 fold cut-off and a t-test with p < 0.05.  
 
2.10 Northern blotting 
Northern blotting probes were designed to be fragments of the exonic gene 
sequence amplifiable by PCR using the Expand Long Template PCR System (Roche). The 
50μl reaction mix was composed of 50 to 100 ng of gDNA (extracted as described in the 
southern blotting section) mixed with 1x buffer 3 (Roche), 400 μM dNTP, 0.6 μM of each 
of the forward and reverse gene specific oligonucleotides (Table 2), 0.75 μl of the enzyme 
mix, and topped with water. 
In order to investigate the expression levels of developmental genes in the absence 
of SFP1, probes for an opaque specific gene, CDR3 and a white specific gene, WH11 were 
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designed. A 341 bp fragment from the 5’end of the CDR3 locus was amplified by PCR 
using oligos HHCDR3F and HHCDR3R (98) at the following conditions: 94 °C for 3 min; 
30 cycles of 94 °C for 30 sec, 38 °C for 30 sec, 68 °C for 1 min; followed by 68 °C for 7 
min, and a hold at 4 °C. The full CDR3 sequence was also used as a probe in a 1.35 kb 
fragment restriction digested with HindIII from plasmid p425-GPD-CDR3 obtained from 
Dr. Martine Raymond. The plasmid was transformed into E. coli competent cells by mixing 
1 μl of the 10 ng/μl plasmid preparation to 50 μl of the competent cells and leaving on ice 
for 30 min. The cells were then heat-shocked at 42 °C for 2min and cooled on ice for 5 min 
before incubating at 37 °C in 900 μl of 2YT media for 1 hour. Cells were then plated on 
2YT plates with ampicillin (100 μg/ml) and incubated overnight at 37 °C. Colonies 
growing on these plates were transferred to fresh liquid 2YT media with 100 μg/ml 
ampicillin and incubated overnight at 37 °C before DNA extraction by mini-prep. 
Restriction digests with 2 μl of HindIII (New England Biolab) and 3 μg of the plasmid 
preparation were done in 30 μl reactions by mixing with 0.3 μl of 100 x BSA, 3 μl of Buffer 
#2, and topping with sterile water. Digests were performed overnight at 37 °C. The WH11 
probe was prepared by PCR amplification of a 200 bp long fragment using oligos 
HHWH11F and HHWH11R at the following conditions: 94 °C for 3 min; 30 cycles of 94 
°C for 30 sec, 38 °C for 30 sec, 68 °C for 1 min; followed by 68 °C for 7 min, and a hold 
at 4 °C. 
In order to separate RNA fragments, 20 μg of the extracted and purified RNA was 
mixed with 3.5 μl 10x MOPS (pH 7.2; 0.4 M MOPS 0.1 M NaAcetate; 10 mM EDTA), 
3.5 μl formaldehyde, 10 μl formamide, and topped to 20 μl with DEPC-treated water. RNA 
samples were denatured by heating to 65 ºC for 15min then 2 μl loading buffer (1 mM 
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EDTA; 50% Glycerol; 0.02% Bromophenol blue) and 2 μl 10% Ethidium Bromide were 
added and the samples loaded on a RNA agarose gel (1% Agarose; 1% MOPS; 20% 
Formaldehyde; prepared in DEPC treated water). RNA fragments were separated by 
electrophoresis in 1x MOPS at 100 V for 3 h then washed with distilled water 4x 15 min, 
verified under a UV transilluminator and transferred overnight to a Zeta-Probe membrane 
in 10x SSC buffer (pH 7.0; 1.5 M NaCl; 150 mM NaCitrate). 
The membrane was prehybridized in 20 ml 500 mM NaPO4 pH 7.2; 1 mM EDTA; 
7% SDS; 1% BSA; 0.01% salmon sperm DNA by rotating for 4 h in a hybridization oven 
at 65 ºC. The purified PCR product probe was then diluted to a concentration of 50 ng in 
45 μl of RNase free TE buffer (10 mM Tris pH 8.0; 1 mM EDTA). It was then denatured 
by boiling for 5 min, snap cooled for 5 min, added to a reaction tube from the RediPrime 
II labelling system (GE healthcare Life Sciences), with 5 μl Redivue dCTP32 and incubated 
at 37 ºC for 45 min. The reaction was stopped with 2 μl 0.5M EDTA and the radioactive 
probe purified with a G-50 ProbeQuant micro column (GE healthcare Life Sciences). The 
probe was then boiled for 5 min, snap cooled on ice for another 5 min, then added to the 
prehybridization solution to hybridize overnight at 65 ºC. The membrane was then washed 
for 10 min in 20 ml 65 ºC preheated wash buffer 1 (40 mM NaPO4 pH 7.2; 5% SDS; 1 mM 
EDTA; 0.5% BSA), followed by a 20 min wash in 65 ºC preheated wash buffer 2 (40 mM 
NaPO4 pH 7.2; 1% SDS; 1 mM EDTA). The membrane was then exposed to a phosphor 





2.11 Quantitative RT-PCR 
RNA used for the real time RT-PCR was extracted using the hot phenol method and the 
MasterPure RNA extraction kit (Epicentre Biotechnologies) method as described. 
However in order to minimize DNA contamination, DNase I treatment with the Epicentre 
kit was extended to 45 min. 5 μg of the hot phenol extracted RNA was treated for 45 min 
at 37 °C as well with 5 U of the Fermentas DNase I enzyme and buffer. The DNase I-
treated RNA was reverse transcribed by adding 1.5 μl of the 500 μg/ml Oligo dT primer, 
and 1 μl of the 10 mM dNTP mix to 500 ng RNA and topping the reaction volume up to 
12 μl with DEPC-H2O. RNA was denatured by heating the reaction to 65 °C for 5 min 
then quickly cooled on ice and mixed with 4 μl of the 5x first strand buffer, and 2 μl of the 
0.1 M DTT provided with the SuperScrit II reverse transcriptase (Invitrogen Cat. 
#18064022). The reaction was heated to 42 °C for 2 min before adding 1 μl of the reverse 
transcriptase and incubating at 42 °C for 50 min. The enzymes were heat inactivated at 70 
°C for 15 min and RNA removed at 37 °C for 20 min after the addition of 1 μl of the 10 
mg/ml RNase A (Roche Cat. # 10109142001) and 0.5 μl of the 1 U/μl RNase H (Roche). 
As a reverse transcription contamination control (NoRT), a similar reaction was prepared 
for each RNA sample without adding the SuperScript II reverse transcriptase. 
Five serial dilutions (10x to 1000x) of the reverse transcribed RNA samples, and 
the NoRT controls were prepared in sterile H2O. 5 μl of each dilution was mixed with 12.5 
μl of the Maxima SYBR Green/ROX qPCR Master Mix (Fermentas) 0.3 μM of each 
primer, and completed to a 25 μl reaction volume with nuclease-free water. These reactions 
were prepared in a 96 well plate and loaded in the ABI Prism at the following settings : 
UDG pretreatment at 50 °C, for 2min; initial denaturation at 95 °C for 10 min; and 40 
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cycles of denaturation at 95 °C for 15 sec, annealing at 60 °C for 30 sec, and extension at 
72 °C for 30 sec. 
 
2.12 Western Blotting 
Cells were grown overnight in YPD media, diluted next day to an OD600nm of 0.1 in 5 ml 
of the same media and collected at an OD600nm of 1.0 by centrifugation for 5 min. Pellets 
were lysed by adding 20 μl of a RIPA (Radio Immuno Precipitation Assay) buffer (10 mM 
NaH2PO4; 0.1% SDS; 10 mM EDTA; 150 mM NaCl; 1% Triton; 1 mM AESBF; 2 μg/ml 
Leupeptin; 5 μg/ml Aprotinin), and 200 μl of acid washed glass beads (Sigma) then 
homogenized for 1 min in a Mini-BeadBeater-8 (BioSpec Products). The extract was 
collected after adding an additional 200 μl of the RIPA buffer, and centrifuged for 5 min 
at 4 °C, 13,500 rpm. The protein concentration of the extract was estimated with a Bradford 
assay, and 30 μg was prepared in 25 μl of a 1X sample buffer (50 mM Tris pH 6.8; 2% 
SDS; 10% Glycerol; 100 mM DTT; 0.01% Bromophenol Blue), boiled for 10 min, then 
loaded on a 10% SDS-PAGE mini gel with a 4% stacking top and separated 
electrophoretically at 75 V for 30 min, then 150 V for 1 h in running buffer (25 mM Tris, 
192 mM Glycine, 0.1% SDS). Proteins were transferred onto a PVDF membrane (pre-
treated with methanol for 10 min) overnight under a constant 30 V, at 4 °C in transfer 
buffer (pH 8.3; 25 mM Tris; 192 mM Glycine; 0.1% Methanol). The membrane was then 
dried for 5 min, blocked for 2 h in a 5% skimmed milk; 0.05% Tween 20 solution prepared 
in TBST buffer (pH7.6; 50 mM Tris; 150 mM NaCl; 0.05% Tween 20), washed 3x 15 min 
in TBST, incubated in primary solution for 1.5 h, washed 3x 15 min in TBST, incubated 
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in secondary for 1.5 h, washed 3x 15 min in TBST, then reacted with a 1 ml ECL solution, 





3.1 Candida albicans contains an SFP1 orthologue. 
In S. cerevisiae, Sfp1p was first identified as a factor that blocks nuclear transport 
at high copy numbers (77). It was later found to play a role in the DNA damage checkpoint 
(78) and negatively influence the G1/S and G2/M transitions (71, 78, 99). Sfp1p also acts 
a sensor of the environment as it mediates in part the effects of the environmental sensor 
kinase Tor1p (80, 81), as well as PKA (99, 100). In C. albicans, little is known about how 
environmental signals impinge on cell proliferation (101). A TOR1 orthologue was found 
to be essential for growth and play an important role in influencing hyphal development 
and morphogenesis (82-84, 86, 102-104). However, only a few downstream effectors of 
Tor1p in C. albicans have been characterized, including Sit4p (63, 83), Gln3p (84), Gat1p 
(82) and Sch9p (85), for example. In order to further our understanding of how cell 
proliferation is mediated by environmental cues, and gain insights on the mechanisms by 
which Tor1p may function in C. albicans, we explored the role of another potential Tor1p 
mediator, Sfp1p. Based on the sequence assembly 21 of the Candida albicans genome 
(http://www.candidagenome.org), there are two uncharacterized ORF’s annotated as SFP1. 
The first, orf19.872, has no significant similarity to the well characterized S. cerevisiae 
SFP1 (YLR403W), and is indicated as being a possibly spurious ORF. The second, 
orf19.5359, has a total sequence identity of 45% to its orthologue in S. cerevisiae 
(YLR403W), with 73% nucleotide sequence identity at the 3’end and 79% amino acid 




3.2 Absence of SFP1 reduces cell size and growth rate 
 In S. cerevisiae, the SFP1 null phenotype has been described as one of the most 
abnormally small “whi” mutants and shows an increase in yeast doubling rate (71). In order 
to characterize C. albicans SFP1, the alleles of orf19.5359 were sequentially replaced with 
URA3 and HIS1 markers (Fig. 3) in strains BWP17 and SN148, resulting in strains 
HHCa28 and AM1415 (sfp1Δ::HIS1/sfp1Δ::URA3), respectively. PCR and Southern blot 
screening confirmed the deletion of both alleles (Fig. 4). In order to ensure that any effects 
were due to absence of Sfp1p, a strain carrying a single copy of SFP1 under control of the 
MET3 promoter was constructed resulting in strain AM1511 (HIS1-MET3p-
SFP1/sfp1Δ::URA3), allowing for the induction or repression of SFP1 in the absence or 
presence of 2.5 mM methionine and 0.5 mM cysteine, respectively (88) (Fig. 5). As an 
isogenic control, strain BWP17 was transformed with pBSCaURA3 and pBSCaHIS1, 
resulting in strain HHCa1 (SFP1/SFP1, URA3+, HIS1+). 
When strains were grown on minimal complete medium for 2 days at 30 C, 
colonies lacking Sfp1p (HHCa28) were reduced in size compared to the control strain 
(HHCa1) (Fig. 6A). Reduced colony size was also observed on YPD medium, and when 
SFP1 was deleted in a different strain background (AM1415; data not shown). When 
MET3::SFP1/sfp1 (AM1511) cells were plated on repressing medium, they also showed 
a reduction in cells size, unlike on inducing medium (Fig. 6A), confirming that the effect 
was due to the absence of Sfp1p. Some heterogeneity in size was observed for 
MET3::SFP1/sfp1 colonies on repressing medium, but the size was always reduced 
relative to colonies on inducing medium. In contrast, the control strain (HHCa1) formed 
colonies of normal and similar size on repressing and inducing medium (Fig. 6A). When 
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overnight cultures of strains HHCa1 and HHCa28 were diluted into fresh liquid medium 
and incubated for 7 h, length (L) by width (W) measurements of cells lacking Sfp1p 
revealed a significant size reduction compared to control cells in either MM (Fig. 6B) or 
YPD medium (Table 4). After 24 h of incubation, differences in cell size were more 
prominent in both media, where sfp1/sfp1 cells were 23% or 29% reduced in MM and 
YPD, respectively, relative to control cells. Comparing length x width ratio distributions 
at 24 h, none of the cells lacking Sfp1p reached the largest cell size categories attained by 
44% of wild type cells (Fig. 6C). In contrast, 70% fell within the smallest cell size 
categories, compared to 25% of wild type cells (Fig. 6C). Thus, there is a clear shift towards 
a smaller size in the distribution of cells lacking Sfp1p. 
When yeast cell doubling rate was quantified using OD600nm measurements, cells 
lacking Sfp1p showed a significant increase relative to control strains. The isogenic control 
strain HHCa1 demonstrated a mean doubling rate of 110 min, while sfp1/sfp1 cells 
(HHCa28) doubled in 161 min (Fig. 7A), representing an increase of 46%. Strains made in 
a different background (AM1415) showed similar growth defects. To eliminate the effects 
of possible cell size differences on OD600nm measurements, cell numbers were scored using 
a haemocytometer at each time point. The results are consistent with OD600nm 
measurements, and confirm a reduction in doubling rate in the absence of Sfp1p (Fig. 7B). 
Thus, sfp1/sfp1 cells show a reduction in cell size and growth rate, suggesting that Sfp1p 





3.3 Sfp1p is not essential for mediating cell size in response to select poor carbon 
sources.  
 Jorgensen et al. (2004) reported cells of S. cerevisiae lacking SFP1 or SCH9 failed 
to adjust size in response to poor carbon sources; sfp1 cells were at the minimum size and 
did not reduce further when incubated in poor carbon source media, unlike control cells. In 
order to determine whether C. albicans Sfp1p was also critical for mediating nutrient 
modulation of cell size, sfp1/sfp1 cells were incubated in liquid MM containing either 
2% glucose, galactose, raffinose, or glycerol for 10 or 24 h, and fixed. Based on mean 
width-by-length ratios, wild type C. albicans yeast cells were reduced in size when 
incubated in the presence of galactose, glycerol and raffinose carbon sources relative to 
glucose (Fig. 8, Table 5), similar to that observed for S. cerevisiae cells. However, unlike 
the situation in S. cerevisiae, the mean length-by-width ratios of sfp1/sfp1 cells of C. 
albicans could still reduce in response to raffinose, galactose and glycerol, although the 
changes were less dramatic than those seen in control cells, and were more evident after 24 
h incubation (Fig. 8, Table 5). The final length x width ratios at 24 h were the same for 
wild-type and sfp1p/sfp1 cells incubated in raffinose, suggesting that this value may 
reflect the minimum cell size (Table S1). When growth rates were determined for the 
strains in different carbon source media, wild-type cells showed a reduction in glycerol. 
The rate was similar to cells lacking Sfp1p grown in glucose, raffinose or galactose (Fig. 
8C). However, the growth rate was reduced further in sfp1/sfp1 cells grown in the 
presence of glycerol (Fig. 8C). Collectively, these results suggest that sfp1/sfp1 cells are 
not at a minimum cell size, and that Sfp1p is not essential for mediating the effects of select 




3.4 C. albicans is hypersensitive to sublethal concentrations of rapamycin in the 
absence of Sfp1p. 
Sfp1p is an established effector of the TOR pathway and a direct target of the Tor1p 
kinase in S. cerevisiae (81). However, in C. albicans, few elements of the TOR pathway 
have been characterized (83, 85, 86, 104-107). In order to determine whether C. albicans 
Sfp1p participates in the TOR pathway, sfp1/sfp1 (HHCa28) and control (HHCa1) cells 
were incubated on solid medium containing 0 ng/ml or 10 ng/ml of rapamycin, which binds 
to Fkbp12p to form a complex with Tor1p and block its activity. Although high 
concentrations (≥100 ng/ml) of rapamycin are lethal (51, 52, 108), 10 ng/ml of the drug 
allows growth, indicating that Tor1p function is not completely blocked (51). When 
incubated on YPD plates for 2 to 3 days at 30 C in the presence of 10 ng/ml of rapamycin, 
strain HHCa1 showed a slight sensitivity to rapamycin at a dilution of 103 (Fig. 9). 
However, cells lacking Sfp1p (HHCa28) showed enhanced growth sensitivity, suggesting 
that reduced Tor1p activity is dependent on Sfp1p. Thus, C. albicans Sfp1p may be a 
downstream effector of the TOR signalling pathway.  
 
3.5 Sfp1p levels increase during cell cycle progression in C. albicans. 
In S. cerevisiae, Sfp1p is regulated at the transcriptional level in part through either 
increased expression or stability, as its levels vary with cell cycle stages, peaking at G2 
phase of the mitotic cell cycle (78). Spellman et al. (1998) through microarray analysis of 
cells synchronized by elutriation found that the SFP1 transcript accumulates at later stages 
38 
 
of the cell cycle corresponding to a peak at G2 (109). In order to investigate the regulation 
of C. albicans Sfp1p, we tagged it at the C-terminus in strain HHCa20 
(SFP1/sfp1Δ::URA3) with 3 copies of the hemagglutinin (HA) epitope, resulting in strain 
AM1213 (SFP1-HA-HIS1/sfp1Δ::URA3) (Fig. 10). In order to determine whether Sfp1p-
HA was functional, the growth rate was investigated, and found to be similar to that of 
control strain SN148 (Fig. 10C). Strain AM1213 was then incubated overnight in YPD 
medium at 30C to stationary phase, when most cells are in G1 phase and unbudded. After 
collecting samples at this time “0”, the remaining cells were diluted into fresh medium, 
collected at subsequent time intervals, and processed for Western blotting. A separate 
sample at each time point was also collected, fixed, sonicated and scored for the proportion 
of budding cells to determine the approximate degree of cell cycle progression. From time 
0 to 60 min, when the majority of cells were unbudded, the levels of Sfp1p were detectable 
but low (Fig. 11). At later time points, when more cells were budded and thus were 
progressing into the cell cycle, Sfp1p levels were enriched (Fig. 11). Sfp1p levels were 
lower at 120 vs. 90 min, despite the former having a higher proportion of budded cells, but 
the PSTAIRE (Cdc28p cyclin dependent kinase) loading control signal indicated unequal 
loading. Since it is difficult to obtain synchronized cells in C. albicans (36), it was not 
possible to determine the precise cell cycle stage in which Sfp1p levels peaked. However, 
the general pattern of expression is consistent with an increase during later stages of the 
cell cycle as seen in S. cerevisiae (78, 109). 
In S. cerevisiae, Sfp1p is also regulated at the posttranslational level via 
localization. Jorgensen et al. (2004) measured the variation in abundance and localization 
of the YFP (Yellow Fluorescent Protein) tagged Sfp1p, and found that the protein is located 
39 
 
in the nucleus under normal conditions but quickly exits to the cytoplasm in the presence 
of rapamycin or following starvation (99). Similar results were also reported by Marion et 
al. (2004) for a GFP-tagged Sfp1p protein under the control of its native promoter (100). 
Sfp1p levels are also regulated by proteasomal degradation since protein nuclear 
concentrations increase upon nutrient deprivation in the absence of the proteasome 
activator Blm10p (110). However rapamycin and carbon starvation did not affect total 
protein abundance and electrophoretic mobility of a MYC-tagged version of Sfp1p 
implying that environmental signals do not affect protein levels nor result in protein 
modifications (99). In order to gain more insight into the regulation of Sfp1p in C. albicans, 
the protein was tagged at its amino-terminus with GFP (Green Fluorescent Protein) in an 
SFP1/sfp1Δ strain (HHCa20), resulting in strains AM1312 and AM1317 (SFP1-GFP-
ARG4/sfp1Δ::URA3) (Fig. 10). The tagged protein was found to be functional since the 
growth rate of the SFP1-GFP/sfp1 strains was indistinguishable from that of the wild type 
strain (Fig. 10C). In order to determine the localization pattern, strains AM1312, AM1317, 
the parental strain HHCa20 and the wild type strains BWP17 and SN148 were incubated 
in minimal or YPD medium at 30 C to an OD600nm of 0.8, washed with sterile water, 
mounted on a slide, and examined immediately. No specific GFP signal was detected (Fig. 
12). However, this could be due to limitations of microscope sensitivity coupled with 
expression levels of the protein. 
Thus, Sfp1p in C. albicans shows some similarity to its orthologue in S. cerevisiae 
with respect to cell-cycle-dependent levels of expression. C. albicans Sfp1p appears to 




3.6 The absence of Sfp1p reduces the diameter of hyphal cells, and impairs 
filamentation under specific conditions 
Since Tor1p was shown to be important for hyphal development (82-84, 86, 102-
104), as well as its downstream effector Sch9p (85), we asked whether Sfp1p also 
influenced hyphal growth. Strains HHCa1 and HHCa28 were inoculated on several hyphal 
and pseudohyphal inducing media, including YPD supplemented with 10% fetal bovine 
serum (FBS), synthetic low-ammonium dextrose (SLAD), and Spider medium, and 
incubated at 37 C for several days. After 3 days in the presence of 10% FBS, colonies 
from control strain HHCa1 were wrinkled, indicating extensive filamentation. In contrast, 
sfp1/sfp1 colonies were smooth (Fig. 13). A similar result was observed after longer 
incubation (5 days), indicating that the absence of filaments in sfp1/sfp1 colonies was 
not simply due to a slower growth rate, and suggesting that Sfp1p is required for hyphal 
growth on serum-containing solid medium. On solid Spider medium, control and 
sfp1/sfp1 colonies showed a similar degree of filamentation (Fig. 13). However on solid 
SLAD medium, colonies lacking Sfp1p showed reduced filamentation compared to control 
colonies. Surprisingly, sfp1/sfp1 colonies were also no longer reduced in size on this 
medium (Fig. 13), indicating that some aspect of SLAD medium suppressed the growth 
defect.  
In order to determine whether Sfp1p influenced hyphal formation under liquid 
growth conditions, strains HHCa1 and HHCa28 were incubated in YPD medium at 37C 
supplemented with 10% serum for 1.5 h. Cells lacking Sfp1p (HHCa28) were able to form 
hyphae, but the filaments’ average length (9.27 µm ±0.45 µm) and width (1.41 µm ±0.05 
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µm) were smaller compared to those of control cells (length: 15.17 µm ±1.23 µm; width: 
1.74 µm ±0.05 µm) (Table 6). Differences in length may be due to the slower growth rate, 
or a failure in the ability to maintain hyphal growth. However, the concomitant reduction 
in hyphal diameters suggests that the hyphal cells are smaller in size, much like the yeast 
form, in the absence of Sfp1p. Thus Sfp1p is involved in the regulation of C. albicans yeast 
and hyphal growth as its absence results in size reduction of both and is required for 
filamentation under select conditions. While many investigations have identified factors 
important for hyphal growth, the hyphal feature that is analyzed is presence/absence of 
length/morphology of hyphal filaments (41, 42, 111). This is the first report of a reduction 
in hyphal width as well as length, and thus suggests that Sf1p plays an important role in 
influencing hyphal cell size and not just growth rate or morphology. 
 
3.7 Sfp1p modulates metabolism, ribosome biogenesis, cell cycle, and development 
genes. 
In S. cerevisiae, Sfp1p plays a major role in regulating the expression of ribosomal 
protein and ribosome biogenesis genes (71, 99). Direct binding of Sfp1p to the promoters 
of ribosomal protein genes has been reported (100) and conserved promoter elements were 
found to be common in ribosome biogenesis genes induced by this transcription factor 
indicating weak binding or the activation through co-factors (79, 99). In fact, Gertz et al., 
(2005) found, through ChIP analysis and the comparison of gene expression levels, that 
Stp2p is a potential co-factor of Sfp1p (112). In order to identify potential targets of C. 
albicans Sfp1p and further understand its functions, the transcription profiles of sfp1/ 
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sfp1 cells were obtained. Strains HHCa28 and HHCa1 were grown to an OD600nm of 0.8 
in minimal medium at 30 C, and collected. Total RNA was extracted, reverse transcribed, 
and directly labelled with Cyanine 5 or 3. Four different C. albicans gene chips were 
hybridized with independently prepared and labelled samples. Significantly modulated 
genes were selected based on a 1.5 fold expression cut-off coupled with a t-test function 
using p <0.05 confidence. In the absence of Sfp1p, 374 genes were found to be up-regulated 
and 370 were repressed (Table S2). Pie chart distributions of the total set of modulated 
genes were produced by manually sorting genes into single, select categories (Fig. 14). 
Based on this method 3.2% of the downregulated gene set was involved in ribosome 
biogenesis, 7.6% in the regulation of the cell cycle, and 2% in nucleus organization while 
percentages shift to 0.8%, 4%, and 0.5% in the list of upregulated genes, respectively (Fig. 
14). The data was also sorted according to biological processes using the GO Slim Mapper 
at CGD (http://www.candidagenomedatabase.org). Of the total number of modulated genes 
36.5% are involved in transport, 26.6% in the response to chemical stimulus, 23.7% in the 
response to stress, 20.4% in filamentous growth, 15.1% in the response to drug, 12.3% in 
the cell cycle, 8.3% in cell wall organization, 7.5% in signal transduction, 7% in translation 
and 3.8% in ribosome biogenesis (Fig. 15). Using the Fisher exact test and a cutoff value 
of p <0.05, we identified seven GO Slim Mapper categories for which the ratio of genes 
from our dataset was significantly different from the ratio of genes in the genome. These 
were ribosome biogenesis, transport, response to chemical stimulus and drug, cytokinesis, 
nucleus and cell wall organization (Table 7). While the identified 46 cell cycle genes 
modulated in the absence of Sfp1p did not represent a significant ratio, some of these genes 
were associated with the G1/S transition, suggesting an influence of Sfp1p on START. 
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These are MBP1, a putative component of the MBF G1/S transcription complex, GRR1, an 
orthologue of the F-box protein component of the SCF ubiquitin ligase complex, HCM1, 
an orthologue of the S. cerevisiae forkhead transcription factor that regulates S-phase 
specific expression of spindle and chromosome segregation-associated genes, RNR1, a 
ribonucleotide reductase, and HTA3, the putative histone H2A subunit. Comparing the 
ratios of upregulated and downregulated genes associated with the same category, we 
identified 13 categories with a 2% difference or more. A higher proportion of 
downregulated genes were found to be associated with ribosome biogenesis, translation, 
organelle organization, the response to chemical stimulus, stress, and drug, RNA, DNA 
and lipid metabolism, interspecies interaction and pathogenesis. A higher proportion of 
upregulated genes were associated with the signal transduction and protein modification 
processes (Fig. 15). These results are in agreement with findings in S. cerevisiae, where 
Sfp1p regulates the expression of multiple ribosome biogenesis and ribosomal protein 
genes in response to nutrient conditions (Jorgensen et al. 2002). In addition, as a direct 
target of TOR (80, 81) and the Ras/PKA pathway (99), Sfp1p is involved in the 
transduction of and response to multiple environmental signals. Thus, our results suggest 
that Sfp1p plays may play a similar role in C. albicans. The manual examination of our 
dataset revealed other potential effects of the absence of Sfp1p. Multiple cell wall 
ergosterol genes involved in the uptake, sensitivity, and resistance to certain drugs (113) 
were found to be modulated (ERG3, ERG5. ERG6, ERG10, ERG11, ERG13, ERG25, 
ERG252). Transport genes including the downregulation of 9 genes involved in the ER to 
Golgi transport and the upregulation of 18 vacuolar transport genes were also found. Thus, 
Sfp1p may also be involved in the cell wall organization and intracellular transport in C. 
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albicans, either directly through its transcription factor role or indirectly as a secondary 
effect to its ribosome biogenesis regulation role. In support of these findings, previous 
studies linked cell wall integrity (102) adhesion gene expression (86), and vesicular 
transport (114) to the TOR pathway in Candida albicans. 
Since Tor1p was shown to be important for hyphal development (82-84, 86, 102-
104) and its putative downstream effectors Sch9p (85) and Sfp1p also influenced hyphal 
formation under certain conditions, we predicted that hyphal-specifc genes may also be 
modulated in the absence of Sfp1p. Based on the GO Slim Mapper results, a few genes 
associated with hyphal growth were modulated in the absence of Sfp1p in C. albicans. The 
expression of 5 genes (MED20, SRB9, SLR1, RGA2, and PMR1) was upregulated while 3 
genes (ABG1, ALS1 and CDC42) were downregulated. Among these, MED20 and SRB9 
both encode subunits of the RNA polymerase II mediator complex and are involved in 
filamentous growth (115). SLR1 encodes a protein similar to the mammalian SR-like RNA 
splicing factor and is also involved in filamentous growth (116). PMR1, encoding a 
putative secretory pathway P-type ATPase, is required for hyphal oscillation on semisolid 
media (117). Abg1p, a vacuolar membrane protein, is required for normal hyphal branching 
(118) and Als1p is an adhesin expressed on the surface of hyphae (119). Interestingly, 
Cdc42p a Rho-type GTPase required for budding and hyphal growth was downregulated 
2.18 times, while its putative GTPase-activating protein, Rga2p, which represses hyphal 
development (120, 121), was upregulated 3.73 times. Thus, absence of Sfp1p influences 
expression of some hyphal specific and regulatory genes. 
Interestingly, genes involved in other developmental pathways, including mating, 
were modulated in the absence of Sfp1p. CDR3, encoding an opaque-specific multidrug 
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resistance transporter, was upregulated 3.16 times; OBPA, which encodes a mating locus 
oxysterol-binding protein, was upregulated 2.37 times; and KAR4, encoding an opaque-
specific transcription factor similar to a pheromone induced protein, was upregulated 1.51 
times. The modulation of opaque-developmental genes in the absence of Sfp1p was novel 
and unexpected, because these genes are normally only expressed when the Mating Type 
Locus (MTL) switches from the normal heterozygous to a homozygous state. This in turn 
requires chromosome 5 loss or mitotic recombination (122). To date, there is only one other 
report of a simple genetic change in a heterozygous MTL background resulting in induction 
of mating type genes (123). Since multiple studies have linked the TOR pathway to mating 
and meiosis in both the fission yeast S. pombe and the budding yeast, S. cerevisiae (1, 67, 
124-129), we were interested in confirming whether Sfp1p function was linked to the 
expression of mating-type genes. GO Slim Mapper categorization of our microarray data 
revealed that 22 significantly modulated genes fell under the conjugation and cell 
development categories. Particularly, STE11 and STE50, which are involved in the mating 
response in S. cerevisiae (130, 131) and CST20 encoding a protein kinase required for 
mating efficiency and virulence (132) were found to be upregulated in the absence of 
Sfp1p.  
In order to validate the microarray results, we used Northern blotting and qPCR. 
Cells of strains HHCa28, HHCa1, and CIB4 [YPB-ADHpt/CDR3] 
(cdr3::hisG/cdr3::hisG, YPB-ADHpt/CDR3) were grown to an OD600nm of 0.8 in minimal 
medium at 30 C, collected, and 20 g of RNA was loaded onto gels for Northern blotting. 
Probing for CDR3 did not reveal induction in sfp1/ sfp1 cells (Fig. 16). This may be due 
to the fact that it was only induced 3 fold, according to the microarray data. However, we 
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also did not detect CDR3 in opaque phase cells under our conditions. The only strain 
showing CDR3 was CIB4 [YPB-ADHpt/CDR3], which overexpressed the gene (Fig. 16A). 
We next attempted qPCR to test for induction of CDR3. The experiment was repeated three 
times but signal was detected in control samples with no template indicating contamination 
(data not shown). Furthermore, we investigated the differences in expression levels of 
WH11, a white-specific gene, in sfp1∆/sfp1∆ cells compared to the isogenic SFP1/SFP1 
control. WH11 transcript levels were found to be higher in the control cells but loading as 
measured by ACT1 levels was unequal (Fig. 16B). Thus the results are not conclusive. 
Intriguingly, however, in a separate investigation in collaboration with another 
member of the lab, C. albicans yeast cells were exposed to rapamycin at concentrations 
that completely block TOR function, and a master regulator of the opaque state, WOR2, 
was found to be highly upregulated via Northern blotting (Fig. 16C). Thus, TOR may 
negatively regulate opaque-specific genes and perhaps sexual development, but it is not 






The ability of C. albicans cells to sense and respond to their environment has crucial 
implications for growth, development, and virulence. The TOR pathway plays an important 
role in mediating environmental conditions in many organisms, and accordingly, TOR 
kinase is required for cell division and maintenance of hyphal growth in C. albicans (1, 83, 
86, 104). However, the mechanisms by which TOR regulates these processes in the 
pathogen are not clear. Here, we provide the first characterization of Sfp1p, an orthologue 
of a major downstream effector of TOR kinase in S. cerevisiae. Deletion of SFP1 in C. 
albicans resulted in a decrease in cell size, which could be reduced further in the presence 
of poor carbon source media. The sfp1/sfp1 cells grew slowly, formed small colonies, 
and were more sensitive to rapamycin, suggesting that Sfp1p mediates at least part of Tor1p 
function in C. albicans. Transcription profiles of the deletion strain demonstrated down-
regulation of genes involved in ribosome biogenesis, translation and amino acid synthesis, 
consistent with a role in the TOR pathway. However, many hyphal-specific genes were 
upregulated, as well as some genes associated with the opaque cell fate, suggesting 
additional and novel links with development. 
 
4.1 Sfp1p is important for the regulation of cell size and growth in C. albicans. 
Cell size is the result of a fine balance between growth and division, established in 
response to environmental conditions like nutrient status and internal factors like ribosome 
biogenesis (32, 33). In yeast such as S. cerevisiae, this balance is mainly coordinated at the 
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G1/S transition, where cells commit to division when a critical cell size is attained. Since 
sfp1 cells in S. cerevisiae were small and grew slowly, Sfp1p was proposed to function 
in cell size and growth regulation (71, 133). Here, we show that Sfp1p in C. albicans may 
play a similar role, since cells depleted of Sfp1p were reduced in size and growth rate 
relative to control cells. Similar to S. cerevisiae cells, C. albicans cells show nutrient 
modulation of the critical cell size threshold, since the size of wild type cells was reduced 
when incubated in poor carbon sources. However, the extent of involvement of Sfp1p in 
mediating this response in C. albicans is not clear, since sfp1/sfp1 cells were not “blind” 
to poor carbon source, and could reduce their size even further. In contrast, the size of 
sfp1 cells of S. cerevisiae was at a near minimum and barely reduced in response to poor 
carbon sources (99). Thus, additional factors may be involved in mediating nutrient effects 
on cell size in C. albicans, either in a redundant or more prominent manner. Absence of 
another downstream effector of Tor1p, Sch9p, also resulted in a small cell phenotype in C. 
albicans (85, 134), but individual sizes in response to poor carbon sources were not 
reported. However, sch9/sch9 colonies on medium containing galactose or glycerol as 
the sole carbon source did not show any growth defects (85), unlike sfp1/sfp1 cells. 
Thus, nutrient modulation of cell size in C. albicans is not mediated in an identical manner 
as in S. cerevisiae, and may only partly involve Sfp1p.  
 Our results suggest that Sfp1p’s role in regulating growth and cell size also extends 
to hyphal cells. When sfp1/sfp1 cells were incubated in liquid YPD containing 10% 
serum at 37C, hyphae could form but were reduced in length. While this may simply 
reflect a reduced growth rate, hyphal diameters also decreased, suggesting a global size 
defect. This result is novel as previous studies on growth regulation in C. albicans hyphae 
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have only reported effects on length (6) and the issue of hyphal size control has not been 
fully addressed. Despite the differences in cell geometry, our results suggest that at least 
some similar mechanisms may underlie size control in yeast and hyphal cells, and that this 
could involve Sfp1p function.  
 
4.2 Sfp1p may function in part through regulating ribosome biogenesis. 
In S. cerevisiae, Sfp1p is a transcriptional activator of ribosome biogenesis genes 
and functions via RRPE promoter elements (79, 135). It also activates ribosomal protein 
genes directly and indirectly through intermediate transcription factors like Fhl1p, Ifh1p, 
and Rap1p (71, 99). Our findings suggest that Sfp1p in C. albicans may also function in 
regulating ribosome biogenesis and protein gene expression. Go Slim Mapper analysis 
showed that “Ribosome biogenesis” genes represented one of the most enriched groups of 
modulated genes in C. albicans cells lacking Sfp1p. Although significant, the full 
complement of ribosome biogenesis and ribosomal protein genes were not modulated, 
unlike in sfp1 cells of S. cerevisiae (71, 99). The difference may reflect a more limited 
involvement of Sfp1p in these processes in C. albicans. Alternatively, this may be due to 
technical issues associated with our microarray experiments, including large variability 
between slides that resulted in several genes not meeting the significance criteria. Future 
work involving ChIP-chip approaches to identify Sfp1p targets will help. The modulated 
expression of several key G1/S-associated cell cycle genes in C. albicans cells lacking 
Sfp1p also supports a role for Sfp1p in ribosome biogenesis. In S. cerevisiae, inhibition of 
ribosome biogenesis results in Whi5p-mediated repression of the G1/S transcriptional 
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activator SBF (136), thus preventing passage through Start. However, the mechanisms by 
which Whi5p “senses” ribosome biogenesis are not clear. Further, overexpression of the 
CDK inhibitor Far1p in S. cerevisiae results in an upregulation of RNA and protein content 
in a manner that is dependent on Sfp1p function (137). Of the significantly-modulated 
genes in C. albicans cells lacking Sfp1p, 46 fell within the cell cycle category. This was 
not a significant enrichment relative to the total number of genes in the genome associated 
with this category (Fisher’s exact test), but this could be due to asynchrony of the cell 
populations, which would dilute the effect of gene expression patterns associated with any 
cell cycle delay. Although expression patterns of specific genes require confirmation via 
qPCR, it is noteworthy that some key G1/S–associated genes were modulated, including 
MBP1, GRR1, HCM1, RNR1 and HTA3. The influence of ribosome biogenesis on the G1/S 
transition has not been investigated in C. albicans, but if a similar relationship exists as 
that observed in S. cerevisiae, this data further suggests a potential role for Sfp1p in 
ribosome biogenesis.  
 
4.3 Sfp1p may be a component of the TOR pathway in C. albicans. 
 The hypersensitivity of C. albicans sfp1/ sfp1 cells to sub-lethal concentrations 
of rapamycin suggests that Sfp1p may be a potential target of the TOR pathway, as reported 
in S. cerevisiae (81). A similar approach was utilized to link several other factors to the 
TOR pathway in C. albicans, including Gln3p (82), Gat1p (82), Rhb1p (102, 106), Sch9p 
(73, 85, 134), and Hog1p (104, 138).  
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Additional lines of evidence supporting the involvement of Sfp1p in the TOR 
pathway in C. albicans stem from the transcription profiles of sfp1/sfp1 cells. For 
example, another study showed that C. albicans cells treated with sub-lethal doses of 
rapamycin down-regulate genes associated with ribosomal proteins, rRNA processing, 
translation initiation and elongation, and amino acid biosynthesis, and induce genes 
associated with nitrogen catabolite repression and amino acid starvation, for example (86). 
In C. albicans sfp1/sfp1 cells, similar groups of genes were modulated. Further, an 
orthologue of the Tor effector TAP42 was induced 1.75 fold, and one of the most highly-
repressed genes was SSK2, a MAPKKK regulator of the Hog1p pathway that was recently 
shown to be downstream of TOR signalling during hyphal development in C. albicans 
(104, 138, 139). The sfp1/sfp1 cells also showed modulation of genes associated with 
cell wall organization/synthesis and the cell wall integrity (CWI) pathway, including the 
protein kinase C PKC1 and Rho1p GTPase-activator SAC7, which are connected with the 
TOR pathway in S. cerevisiae (65, 140). A link between the TOR and CWI pathways in C. 
albicans is not yet clear, but Tor1p is connected to expression of cell-wall-containing 
adhesions in C. albicans (86).  
Intriguingly, the small colony size phenotype of sfp1/sfp1 cells was suppressed 
when cells were plated on solid SLAD, a nitrogen-limiting medium that induces 
filamentous growth in both S. cerevisiae and C. albicans (101, 141). The mechanisms 
underlying this suppression are not yet clear, but it is interesting to note that the TOR kinase 
activity is activated by rich nutrient media, but reduced in nutrient poor medium, including 
nitrogen-limiting conditions. Further, Sfp1p has a repressive effect against TORC-
dependent phosphorylation of Sch9p in S. cerevisiae; sfp1 cells have elevated TOR 
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activity and hyperphosphorylated Sch9p (81). It is not known if a similar circuit exists in 
C. albicans, but if so, it is possible that plating sfp1/sfp1 cells on SLAD reduces 
otherwise elevated TOR activity and Sch9p phosphorylation to a level that is more optimal 
for cell growth, leading to suppression of the growth defects. 
 
4.4 Sfp1p influences filament development in C. albicans  
Our results suggest that Sfp1p contributes to the developmental process of hyphal 
growth, but in a nutrient-dependent manner. On solid media, Sfp1p is important for 
filamentation on SLAD, a medium characterized by a low concentration of ammonium that 
induces the nitrogen limitation response (102, 106, 142-144). This in turn activates the 
cAMP/PKA and TOR pathways, leading to filamentous growth. Hsu et al., (2013) recently 
reported that a downstream target of the Tor1p pathway that regulates filamentation in 
response to nitrogen limitation is the CCAAT binding complex, a heteromeric 
transcriptional regulation complex that acts on the CCAAT motif in gene promoters (145). 
This complex links TOR signalling with the Mep2p-PKA-MAPK pathway. Disruption of 
the CCAAT binding complex prevents nitrogen limitation-induced filamentation, but 
induces multiple ribosome biogenesis, transcription, translation and RNA processing genes 
in the presence of rapamycin. Thus, it is possible that Sfp1p contributes to the mediation 
of the nitrogen limitation response in C. albicans, possibly through its putative connection 
to the TOR pathway.  
Serum and high temperature represent one of the strongest inducers of hyphal 
growth (101) in C. albicans, and are mediated in part via cAMP and TOR signalling (58, 
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146). Serum is proposed to initially activate the cAMP pathway, which leads to removal 
of a repressor from the promoters of hyphal-specific genes. Serum also results in a 
reduction in TOR signalling, which in turn down-regulates the MAPK Hog1p, leading to 
activation of the transcription factor BRG1. Brg1p in turn binds hyphal-specific gene 
promoters and prevents the repressor from re-binding (104). The effects of Tor1p on Hog1p 
are thought to be mediated by the Tor1p effector phosphatases Ptp2p and Ptp3p. However, 
the fact that sfp1/sfp1 cells are defective in hyphal formation on solid-serum-containing 
medium suggests that Sfp1p may also lie in this pathway. In this case, Sfp1p does not 
appear to be acting as a direct repressor of filamentation or mediate all of the effects of 
TOR down-regulation on hyphal development and hyphal-specific gene expression, as C. 
albicans cells treated with a non-lethal dose of rapamycin showed a much stronger and 
extensive induction of hyphal genes (86) compared to sfp1/sfp1 cells. Sch9p, another 
effector of Tor1p, is also required for serum-induced hyphal growth on solid medium (85), 
suggesting that Tor1p activity in response to serum may be mediated by several factors. 
In contrast, cells lacking Sfp1p were not defective in filamentation on Spider 
medium, which contains 2% mannitol as a carbon source. The filamentous response to this 
medium is mainly transduced by the cAMP/PKA pathway that involves Gpr1p, a plasma 
membrane G-protein receptor, and Gpa2p, a G-protein alpha subunit, and subsequent 
activation of the downstream Efg1p transcription factor (147, 148). The MAPK pathway 
is also in part responsible for filamentation on this medium (149). Although expression of 
GPA2 and the MAPK component CST20 were upregulated in the absence of Sfp1p (1.66 
and 1.78 fold respectively), the ability of sfp1/sfp1 cells to form normal filaments on 
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Spider medium suggests the existence of some redundancy or that Sfp1p is not playing a 
significant role in these pathways. 
Notably, transcription profiles of sfp1/sfp1 cells also demonstrated a twofold 
downregulation in CDC42 expression. Cdc42p activity is required for the concentrated 
delivery of vesicles to the hyphal tip and was recently shown to be required for the 
maintenance of hyphal growth (150). Further, expression of RGA2, a GAP for Cdc42p and 
negative regulator of hyphal growth, was induced 3.7 fold. It is however not clear how 
Sfp1p may influence these expression patterns-whether it is a direct role or if the 
modulation is a response to the down-regulation of ribosomal gene expression. However, 
if confirmed by qPCR and similar modulation is observed under certain hyphal-inducing 
conditions, this may also explain the defects in hyphal formation. 
 
4.5 Sfp1p and the TOR pathway may be linked to the developmental state of mating 
in C. albicans. 
In C. albicans, a morphogenetic switch of the white mating incompetent cells to 
the opaque mating competent form of growth is regulated by the mating type locus (MTL). 
In order for mating to proceed, the locus must switch from being heterozygous to 
homozygous or hemizygous, which requires the deletion of an allele or the loss of a copy 
of chromosome 5 during duplication (151). Our results thus suggest that Sfp1p and possibly 
Tor1p function may also influence the mating pathway. The expression of several members 
of the MAPK cascade including CST20, STE11 and STE50 was upregulated in the absence 
of Sfp1p. We also noted the induction of several opaque-specific and pheromone response 
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genes in cells lacking Sfp1p, including CDR3, OBPA, FIG1, CST20, STE11, STE50, KAR4, 
and the downregulation of one white specific gene (RME1). We were not able to validate 
induction of CDR3, for example, using qPCR or Northern blots, but this could be due to 
technical issues as we were also not able to detect expression of CDR3 in a positive control 
strain. These expression patterns were intriguing since the only other example of induction 
of mating responses/genes in a strain that is otherwise heterozygous at the MTL occurs in 
the absence of HBR1, a factor involved in the response to hemoglobin (123). Intriguingly, 
we found strong induction of the opaque-specific regulator WOR2 in cells treated with high 
doses of rapamycin. Since TOR is involved in regulating development in other systems 
(127, 128, 152), it is conceivable that the TOR pathway, possibly involving Sfp1p function, 
may influence the developmental mating pathway in C. albicans.  
 
4.6 Sfp1p and Sch9p show more divergence in function in C. albicans than in S. 
cerevisiae. 
A comparison of the sfp1/sfp1 phenotype with that of sch9/sch9 cells in C. 
albicans reveals some important insights on the functions of these factors. Sfp1p and Sch9p 
play parallel and redundant roles in S. cerevisiae (73, 99). In C. albicans, both influence 
the regulation of filamentous growth on solid YPD medium supplemented with 10% serum 
at 37°C, but are differentially required for filamentation on SLAD (85). Further, 
sfp1/sfp1 cells grew slowly on galactose and glycerol, while sch9/sch9 cells, at least 
on a colony level, did not appear to have growth defects (85). Thus, our results suggest that 
Sfp1p and Sch9p may have less redundant functions in C. albicans. They may act in 
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parallel branches of the TOR pathway, but with a different involvement in select nutrient-
sensing pathways. This highlights differences in the regulatory circuitry governing growth 




In summary, we have shown that Sfp1p of C. albicans is important for controlling 
growth and size of both yeast and hyphal cells, and influences hyphal development under 
specific conditions. We also provide evidence that Sfp1p may function in part through 
regulating ribosome biogenesis, and may lie downstream of the TOR pathway. However, 
we cannot rule out Sfp1p-independent effects and the possibility that it may lie in additional 
pathways. Future experiments are aimed at addressing this question. Finally, we provide 
preliminary evidence suggesting for the first time that the Tor pathway may also be linked 
to the developmental mating pathway in C. albicans. Our results reveal new insights on 
factors required for regulating growth, cell size and development in an important fungal 
pathogen of humans, C. albicans.  
 
4.8 Future work 
 To validate our findings future work will include the confirmation of Sfp1p targets 
through promoter analysis, co-immunoprecipitation, ChIP-chip analysis, and 
qPCR/Northern blotting of genes within the ribosome biogenesis, G1/S transition, 
filamentous growth, and mating response categories. Cell size measurements will be 
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further supported by FACS analysis and the extent of the divergence between Sfp1p and 
Sch9p’s roles will be evaluated by constructing and characterizing a double deletion strain 
lacking both genes. The involvement of Sfp1p in other signalling pathways can be studied 
by measuring the effects of constitutive activation and/or repression of these pathways on 






Figure 1: Signalling pathways regulating hyphal gene expression in C. albicans. Several 
pathways in C. albicans are influencing the expression of hypha-specific genes in response 
to multiple environmental conditions including temperature, pH, serum, high CO2 levels, 









Figure 2: TORC1 pathway effectors in S. cerevisiae. The TORC1 pathway responds to 
multiple signals including nutrient conditions, growth factors, stress, rapamycin and 
caffeine to regulate the activity of effector proteins involved in several cellular functions 
including ribosome biogenesis (RIBI) and ribosomal protein (RP) gene expression, 
repression of RNA Polymerase III, translation, and the expression of nitrogen catabolite 




Figure 3: PCR gene manipulation strategies. (A) Gene knock-out strategy used to replace 
gene coding region with a selectable marker amplified from a plasmid. (B) MET3 promoter 
insertion strategy for the conditional regulation of SFP1. (C) Epitope tagging strategy for 







Figure 4: Confirmation of the sfp1∆/sfp1∆ strains by PCR and Southern Blot. (A) The 
sfp1/sfp1 strains constructed in two different backgrounds (BWP17, and SN148) were 
confirmed by amplifying the SFP1 gene region using a combination of two flanking 
primers (flanking) and a combination of one flanking primer and one embedded in the 
selective marker (HIS1 or URA3). Fermentas GeneRuler 1kb DNA ladder standard sizes 
shown are 4 kb, 3.5 kb, 3 kb, 2.5 kb, 2 kb, 1.5 kb, 1 kb, 0.75 kb, 0.5 kb & 0.25 kb  (B) The 
same strains were also confirmed by probing for the SFP1 gene region with a DIG-labelled 
754 bp probe after digesting with DraI. Roche DIG-labeled, molecular weight marker II 










Figure 5: Confirmation of the MET3::SFP1-URA3/sfp1∆:;HIS1 (AM1511 & AM1512) 
strains by PCR. Map and gel of PCR screen, showing integration of a HIS1-MET3 -
containing construct at the 5’ end of SFP1 in strain AM1401 (SFP1/sfp1Δ::URA3). The 
HIS1-MET3 was confirmed in two PCR reactions as a complete 3.7 kb fragment and a 
partial 1.58 kb fragment corresponding to the HIS1 marker. Fermentas GeneRuler 1kb 
DNA ladder standard sizes are 10 kb, 8 kb, 6 kb, 5 kb, 4 kb, 3.5 kb, 3 kb, 2.5 kb, 2 kb, 1.5 




Figure 6: Cells and colonies depleted of Sfp1p show a reduction in size. (A) Cells of strain 
HHCa28 (sfp1::HIS1/sfp1:;URA3), the isogenic control HHCa1 (SFP1/SFP1, URA3+, 
HIS1+) and the conditional AM1511 (MET3::SFP1-URA3/sfp1∆::HIS1) were plated on 
SD+MC or SD-MC medium, and incubated at 30C for 48 h. (B) Cells of stains HHCa1 
and HHCa28 were incubated in minimal medium at 30C overnight, diluted to an OD600nm 
of 0.2 in fresh minimal medium and incubated for 7 or 24 h. Bar: 10 m. (C) Cell size 
measurements, represented by width x length values, of strains HHCa1 and HHCa28 grown 





Figure 7: Cells lacking Sfp1p are reduced in growth rate. (A) Cells of strain HHCa28 
(sfp1::HIS1/sfp1::URA3) and the isogenic control HHCa1 (SFP1/SFP1, URA3+, 
HIS1+) were incubated in SD or YPD medium at 30C overnight, and diluted to an OD600nm 
of 0.1 in fresh medium. Cells were incubated and the OD600nm was recorded every 2 h. 
Growth curves and error bars are based on the average optical density measurements from 
four independent cell cultures normalized to a starting OD600nm of 0.1. Growth rates are 
calculated for the segment between the T4 to T10 giving a doubling time of 1.8 h for the 
control versus 2.7 h for the mutant. (B) Number of cells were quantified for strains in (A), 




Figure 8: Cells lacking Sfp1p can still modulate cell size in response to select poor carbon 
sources. Cells of strains HHCa28 (sfp1::HIS1/sfp1::URA3) and the isogenic control 
HHCa1 (SFP1/SFP1, URA3+, HIS1+) were incubated in minimal medium containing 
either glucose, galactose, glycerol or raffinose overnight at 30C, diluted to an OD600nm of 
0.1 in fresh medium, and incubated for 10 or 24 h. (A) Cells at 10 h were fixed for imaging. 
Bar: 10 m. (B) Cells at 10 or 24 h were fixed and length x width measurements were 
recorded as an indication of cell size. (C) Growth of strains was investigated by recording 









Figure 9: Cells lacking Sfp1p are hypersensitive to sublethal concentrations of Rapamycin. 
Strains HHCa28, AM415 (sfp1::HIS1/sfp1::URA3) and isogenic control HHCa1 
(SFP1/SFP1, URA3+, HIS1+) were incubated overnight in YPD medium at 30C, diluted 
to an OD600nm of 1, serially diluted 5 times and spotted (2 µl) on solid media containing 









Figure 10: Construction and confirmation of Sfp1-HA and Sfp1p-GFP strains. (A) MAP 
and PCR screen showing SFP1-HA-HIS1/sfp1 (AM1213) and SFP1-GFP-ARG4/sfp1 
(AM1312; AM1317) strains alongside the parental SFP1/sfp1::URA3 strain (HHCa20). 
A 6.0 kb fragment corresponded to SFP1-GFP-ARG4, a 4.8 kb fragment for SFP1-HA-
HIS1, a 3.3 kb fragment for SFP1, and a 3.1 kb fragment for sfp1::URA3. (B) Western blot 
confirmation of two SFP1-HA-HIS1/sfp1 strains (AM1213; AM12114) alongside the 
parental SFP1/sfp1::URA3 strain (HHCa20) and an S. cerevisiae strain with a 45 KDa HA 
tagged protein, as negative and positive controls, respectively. (C) Growth rate of HA and 
GFP-tagged Sfp1p strains. Strains AM1213, AM12114, AM1312, AM1317, SN148 and 
HHCa20 were incubated in YPD medium overnight at 30C, diluted to an OD600nm of 0.1 
in fresh medium, and incubated for the indicated times, at which OD600nm was recorded. 
Graphs are the result of 4 separate experiments. Average standard errors are ±0.64 for 
SN148, ±1.16 for HHCa20, ±1.04 for AM1213, ±0.81 for AM12114, ±0.51 for AM1312 





Figure 11: Sfp1p-HA levels increase during cell cycle progression. (A) Strain AM1213 
(SFP1-HA-HIS1/sfp1-URA3) was incubated overnight in YPD medium at 30C, diluted 
to an OD600nm of 0.2 in 500 ml of fresh YPD. At the indicated times, 50 ml of culture were 
collected for protein extraction. A portion of cells were also fixed and stained with DAPI 
in order to determine the budding ratio. PSTAIRE (Cdc28p) was used as a loading control.  
 
 
Figure 12: Localization of Sfp1p-GFP. Strains AM1312 (SFP1-HA-HIS1/sfp1-URA3), 
AM1317 (SFP1-HA-HIS1/sfp1-URA3), and HHCa20 (SFP1-HA-HIS1/sfp1-URA3) 
were incubated overnight in YPD medium at 30C, diluted to an OD600nm of 0.2 in 500 ml 
of fresh YPD. Cells were collected (750 µl) at an OD600nm of 0.8, washed and prepared for 




Figure 13: The absence of Sfp1p results in a reduction in filamentation on select medium, 
and lack of nitrogen source suppresses the cell size defect of sfp1 cells. Strains HHCa28 
(sfp1::HIS1/sfp1::URA3) and HHCa1 (SFP1/SFP1, URA3+, HIS1+) were incubated in 
minimal media overnight, and diluted to an OD600nm of 0.01 before streaking on solid 
media. Plates were incubated at 37°C for 3 to 5 days for the 10% FBS plates, and 5 to 7 




Figure 14: Distribution of genes differentially modulated between the sfp1Δ/sfp1Δ strain 
and its SFP1/SFP1 isogenic control. Four independent gene microarray chips were 
analyzed to obtain 374 upregulated and 370 downregulated genes that were differentially 
modulated between the sfp1/sfp1 strain and its SFP1/SFP1 isogenic control while 
satisfying the 1.5x expression cutoff level and a t-test p value <0.05. Genes were manually 








Figure 15: GO Slim Mapper categories with 2% difference or more between upregulated 
and downregulated genes in the absence of Sfp1p. Significantly upregulated and 
downregulated genes from microarray analysis of the sfp1∆/sfp1∆ strain (HHCa28) were 
categorized by biological process using GO Slim Mapper. The percentages of upregulated 
and downregulated genes associated with each category were subtracted (upregulated-








Figure 16: Northern blot confirmation of the expression of opaque and white phase specific 
genes. (A) The CDR3 transcript, encoding an opaque specific gene, could not be detected 
in both the control SFP1/SFP1 (BWP17) and the mutant sfp1∆/sfp1∆ (HHCa28) strains 
unlike the YPB-ADH-CDR3 transformed strain overexpressing the CDR3 gene. The 
loading control gene ACT1 indicates unequal loading for the sfp1∆/sfp1∆ strain. (B) The 
WH11 transcript encoding a white phase specific gene could be detected in the BWP17 
(SFP1/SFP1) control strain but not in the sfp1∆/sfp1∆ (HHCa28) and opaque phase 
SFP1/SFP1 cells. The loading control gene ACT1 indicates unequal loading for the 
sfp1∆/sfp1∆ strain. (C) Rapamycin treatment results in the overexpression of WOR2, an 
opaque transcriptional regulator. Cells were diluted from an overnight stationary culture to 
an OD600nm of 0.1 in 300ml of YPD and grown to an OD600nm of 0.8 - 1.0 before adding 
100ng/ml. RNA was extracted from 100ml cell pellets at 0min before the addition of 





Table 1: Candida albicans strains used in this study 




Fonzi & Irwin, 1994 
SN148 arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ 
ura3Δ::imm434/ura3Δ::imm434 
iro1Δ::imm434/iro1Δ::imm434 
Noble & Johnson, 2005 
HHCa1 SFP1/SFP1 ura3Δ::im434/URA3 
his1Δ::hisG/HIS1 arg4Δ::hisG/arg4Δ::hisG 
This study 
HHCa20 SFP1/sfp1Δ::URA3 This study 
HHCa28 sfp1Δ::HIS1/sfp1Δ::URA3 This study 
AM1213 SFP1-HA-HIS1/sfp1Δ::URA3 This study 
AM130 SFP1-GFP-HIS1/SFP1 This study 
AM1312 SFP1-GFP-ARG4/sfp1Δ::URA3 This study 
AM1317 SFP1-GFP-ARG4/sfp1Δ::URA3 This study 
AM1401 SFP1/sfp1Δ::URA3 This study 
AM1415 sfp1Δ::HIS1/sfp1Δ::URA3 This study 
AM1511 HIS1-MET3p-SFP1/sfp1Δ::URA3 This study 
AM1512 HIS1-MET3p-SFP1/sfp1Δ::URA3 This study 
CIB4 [YPB-
ADHpt/CDR3] 





Table 2: Oligonucleotides used in this study. 
Oligonucleotides Sequence (5’ to 3’) 
CaURA3R TTC AAA TAA GCA TTC CAA CC 
CaHIS1R ACT GGG ATA TCA GCT GCA GG 
CaMETr TGG GGA GGG TAT TTA CTT TTA AAT 
SFP1FS1 CAG GTA GTG TAC TTG AGT AT 
SFP1RS1 ATT CTA CTC TGC CAA GCA AC 
HH20F ATA TGA AAT CAC CTC TTC TCA CTC CCA TTC 
HH20R AGG TTT CGA TAG AAC GTA AAT CGA GAT TAG 
HH30F CTA ATC TCG ATT TAC GTT CTA TCG AAA CCT TAT AGG 
GCG AAT TGG AGC TC 
HH30R AAG CTC GCT CTC GTC ATA CAC AAG TAT GGA GAC GGT 
ATC GAT AAG CTT GA 
HH22F TCC ATA CTT GTG TAT GAC GAG AGC GAG CTT 
HH22R TAT GTT GGT TTT GAT GGA AGA TCT TCT AGC 
HH23F AAG TTC AAA GTT CCT ACA TTG AAT GAT TTG 
HH23R ATT AGG GCT AGT GCT ATT GGA TAC AGG TTA 
HH24F TAA CCT GTA TCC AAT AGC ACT AGC CCT AAT GGT GCT 
GGC GCA GGT GCT TC 
HH24R GAA CAT GAT ATT GTG GAA TAG TTA GAA TCA TCA TCG 
ATG AAT TCG AGC TC 
HH25F TGA TTC TAA CTA TTC CAC AAT ATC ATG TTC 
HH25R CAA CAA CAA ACA AAT TCT ACG ATA TGA TAG 
AOL3F AAC CAT ATA GAT GTG AGG TAT GTG GTA GAG GAT ATA 
AGA ATC TCA ATG GAT TGA AAT ACC ATC GTG CTG GCG 
CAG GTG CTT C 
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AOL3R AGT TAT TCT TGC CAA TCA GAT GGT TAC AAC AAT GTA 
CTA GAC GCT TGA AGA AGA AGA CCA AGT AGG CAT 
CAA TTC GGT AGT CAT CGA TGA ATT CGA GCT C 
AOM1F GAG AAA GCG ATC CTT AAA GAA GCG CA 
AOM1R TCT CCA CTA GAT AGG GTG GCG GTT GT 
AOM2F ACA ACC GCC ACC CTA TCT AGT GGA GA 
GGA TCC TGG AGG TGG AGG ATG AGG 
AOM2R TTT TCA AAT ATC TTG GTA TTA AAC AT 
CAT GTT TTC TGG GGA GGG TAT TTA 
AOM3F ATG TTT AAT ACC AAG ATA TTT GAA AA 
AOM3R GAT CAT GTT GCT GAA GTA TCT GAT GG 
HHWOR2F CCT CTG TAC CAA CAC CAC CA 
HHWOR2R CCA GCA CCA CCA ACT ATT GA 
HHWH11F TCC GAC TTA GGT AGA AAA GA 
HHWH11R TTT GGA GTC ACC AAA AAT AG 
HHACT1F TGG CTA ACT TCA ATG TAT CTG 
HHACT1R CGT CGT CAC CGG CAA AA 
HHACT1q1F ACG GTG AAG TTG CTG CTT TAG TT 
HHACT1q1R CGT CGT CAC CGG CAA AA 
HHCDR3q1F GCT GTA CAA AAT GAA TTG CAT CGT 
HHCDR3q1R GCT TGG TTG GTA TCT GGT TCC T 
HHCDR3q2F TCT TGG TAT TAT CCT GTT GGG TTG T 
HHCDR3q2R GAT TAA CCA CAT CAA TAC ACC ACG AT 
HHCDR3F CCA AGA CAT CAC AAG CAG 





Table 3: Plasmids used in this study. 
Plasmid Description Source 
pBS – CaURA3 pBlueScript CaURA3 A. J. P. Brown 
pBS – CaHIS1 pBlueScript CaHIS1 C. Bachewich 
pFA – TAP- CaARG4 pFA-TAP-CaARG4 (153) 
pFA – GFP – CaARG4 pFA-GFP-CaARG4 (153) 
pFA – HA – CaHIS1 pFA-HA-CaHIS1 (153) 
pFA – MET3p-CaHIS1 pFA – MET3p-CaHIS1 (153) 





Table 4: Length by width ratios 1 of the sfp1/sfp1 strain compared to the control strain 
in rich and minimal media. 
Strain Medium Incubation 
Time (h) 
Mean LxW2 
(m2) ± S.E.M. 
W value3 P value4 




14218 p < 0.0001 
HHCa28 (n= 104) 11.08 ±0.20 
HHCa1 (n= 100) 
24 
14.18 ±0.34 
12856 p < 0.0001 
HHCa28 (n= 102) 10.95 ±0.25 




13371.5 p = 0.0001 
HHCa28 (n= 117) 11.11 ±0.23 
HHCa1 (n= 125) 
24 
13.21 ±0.28 
19024.5 p < 0.0001 
HHCa28 (n= 106) 9.33 ±0.23 
1 Strains HHCa1 (SFP1/SFP1, URA3, HIS1) and HHCa28 (sfp1::URA3/sfp1::HIS1) were 
incubated in media for 7 or 24 h at 30C, after which they were fixed in 70% EtOH, and 
length and width measurements were recorded.  
2 A minimum of 100 cells were measured, and values represent mean length by width 
ratios. 
3 Mann-Whitney test W value for statistical analysis of non-normally distributed samples 




Table 5: Length by width ratios of the sfp1/sfp1 strain and the control strain in media 






(m2) ± S.E. M. 
W value3 P value4 
HHCa1 (n= 113) Glucose 
10 
15.49 ±0.23 Reference 
HHCa1 (n= 118) Galactose 13.41 ±0.27 9715.0 p < 0.001 
HHCa1 (n= 114) Raffinose 11.30 ±0.31 10785.5 p < 0.001 
HHCa1 (n= 114) Glycerol 11.83 ±0.28 10605.0 p < 0.001 
HHCa1 (n= 101) Glucose 
24 
16.81 ±0.34 Reference 
HHCa1 (n= 109) Galactose 15.30 ±0.31 7009.0 p < 0.001 
HHCa1 (n= 111) Raffinose 9.47 ±0.33 10383.5 p < 0.001 
HHCa1 (n= 105) Glycerol 11.58 ±0.28 9305.5 p < 0.001 
HHCa28 (n= 114) Glucose 
10 
13.57 ±0.24 Reference 
HHCa28 (n= 116) Galactose 12.31 ±0.19 8684.0 p < 0.001 
HHCa28 (n= 113) Raffinose 11.24 ±0.21 9780.5 p < 0.001 
HHCa28 (n= 102) Glycerol 11.85 ±0.34 7705.0 p < 0.001 
HHCa28 (n= 105) Glucose 
24 
13.97 ±0.24 Reference 
HHCa28 (n= 112) Galactose 11.94 ±0.27 8415.0 p < 0.001 
HHCa28 (n= 110) Raffinose 9.58 ±0.25 10292.5 p < 0.001 
HHCa28 (n= 104) Glycerol 9.56 ±0.26 9718.0 p < 0.001 
1 Strains HHCa1 (SFP1/SFP1, URA3, HIS1) and HHCa28 (sfp1::URA3/sfp1::HIS1) were 
incubated in MM medium containing either 2% glucose, galactose, raffinose or glycerol, 
incubated for 10 or 24 h at 30C, fixed in 70% EtOH, and length and width 
measurements were recorded from images. Results represent two separate trials.  
2 A minimum of 100 cells were measured, and values represent mean length by width 
ratios. 
3 Mann-Whitney test W value for statistical analysis of non-normally distributed samples 
4 Mann-Whitney test P value for difference between control and knock-out samples. 
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Table 6: Length and width measurements of hyphae formed in the presence or 
absence of Sfp1p1. 
Strain Mean Length2 
(m) ± S.E. M. 
Mean Width3 
(m) ± S.E. M. 
HHCa1 (n= 50) 15.17 ±1.23 1.74 ±0.05 
HHCa28 (n= 52) 9.27 ±0.45 1.41 ±0.05 
1 Strains HHCa1 (SFP1/SFP1, URA3, HIS1) and HHCa28 (sfp1::URA3/sfp1::HIS1) were 
incubated in YPD medium overnight, diluted to an O.D.6oonm of 0.1 into fresh YPD 
supplemented with 10% fetal bovine serum (FBS), and incubated for 1.5 hours at 37C. 
Cells were fixed and widths and lengths were recorded from images. 
2 Statistical analysis of length measurements (non-normally distributed) was performed 
using the Mann-Whitney test and the values were W = 2420.0 and p = 0.0001 
3 Statistical analysis of width measurements (non-normally distributed) was performed 




Table 7: GO Slim Mapper term analysis of genes modulated in cells lacking 
Sfp1p in comparison to the complete list of C. albicans genes1. 
GO Slim Mapper Process 
Category2 
P value3 
GO genes in set4 
(Total 744) 
GO genes in genome5 
(Total 6810) 
Transport 1.54E-02 1011 136 
Response to chemical 
stimulus 
1.45E--3 645 99 
Response to drug 1.39E-02 360 56 
Ribosome biogenesis 1.39E-03 283 14 
Cell wall organization 1.07E-02 168 31 
Cytokinesis 3.77E-02 110 20 
Nucleus organization 4.34E-02 48 11 
Other 3.57E-03 472 74 
Not yet annotated 9.29E-06 594 32 
1 Genes significantly modulated by the absence of Sfp1p were obtained by microarray 
expression analysis of the sfp1::URA3/sfp1::HIS1 strain (HHCa28) and the SFP1/SFP1, 
URA3, HIS1 strain (HHCa1). GO Term classifications were carried out using the tool at 
http://www.candidagenomedatabase.org 
 2 GO Terms with significant differences between the two samples. 
3 Fisher exact test p value with a cut-off set at p <0.05 
4 Number of genes modulated by the absence of Sfp1p and associated with a GO Term 
category. 
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Table S1: Length by width ratios of the sfp1∆/sfp1∆ strain compared to the control 






(m2) ± S.E. M. 
W value3 P value4 




15501.5 p < 0.001 
HHCa28 (n= 114) 13.57 ±0.24 
HHCa1 (n= 101) 
24 
16.81 ±0.34 
13004.5 p < 0.001 
HHCa28 (n= 105) 13.97 ±0.24 




15021 p = 0.0256 
HHCa28 (n= 116) 12.31 ±0.19 
HHCa1 (n= 109) 
24 
15.30 ±0.31 
15500 p < 0.001 
HHCa28 (n= 112) 11.94 ±0.27 




12988 p = 0.9879 
HHCa28 (n= 113) 11.24 ±0.21 
HHCa1 (n= 111) 24 9.47 ±0.33 12013 p = 0.5176 
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HHCa28 (n= 110) 9.58 ±0.25 




12426.5 p = 0.9011 
HHCa28 (n= 102) 11.85 ±0.34 
HHCa1 (n= 105) 
24 
11.58 ±0.28 
13311 p < 0.001 
HHCa28 (n= 104) 9.56 ±0.26 
1 Strains HHCa1 (SFP1/SFP1, URA3, HIS1) and HHCa28 (sfp1::URA3/sfp1::HIS1) were 
incubated in MM medium containing either 2% glucose, galactose, raffinose or glycerol, 
incubated for 10 or 24 h at 30C, fixed in 70% EtOH, and length and width measurements 
were recorded from images. Results represent two separate trials.  
2 A minimum of 100 cells were measured, and values represent mean length by width ratios. 
3 Mann-Whitney test W value for statistical analysis of non-normally distributed samples 













 t-test              
p value6 
orf19.255 ZCF1 
Predicted zinc-cluster protein; possibly transcriptionally regulated upon hyphal 
formation; late-stage biofilm-induced; intron in 5'-UTR; mutants display decreased 
colonization of mouse kidneys 
-0.01 no replicates 
orf19.3145.4  ORF Predicted by Annotation Working Group; removed from Assembly 20 -0.0125 0.000147 
orf19.6116 GLK4 Putative glucokinase; decreased expression in hyphae compared to yeast-form cells -0.0153 7.89E-05 
orf19.3182 GIS2 
Putative transcription factor; expression is increased in high iron and reduced upon 
yeast-hyphal switch; null mutant exhibits sensitivity to sorbitol, 5-fluorocytosine, and 
cold temperatures 
-0.0163 2.81E-07 
orf19.3521 ARH2 Putative adrenodoxin-NADPH oxidoreductase; role in heme biosynthesis -0.017 0.001528 
orf19.1860 LSC2 
Putative succinate-CoA ligase beta subunit; transcription regulated by Mig1p and 
Tup1p; transcriptionally regulated by iron; expression greater in high iron; filament; 
protein present in exponential and stationary growth phase yeast cells 
-0.0176 0.000293 
orf19.7278  
Similar to a region of the Tca2 (pCal) retrotransposon, which is present in strain 
hOG1042 as 50 to 100 copies of a linear dsDNA 
-0.0205 0.001656 
orf19.2374  Predicted ORF from Assembly 19; removed from Assembly 20 -0.0216 0.000341 
orf19.1152  




Zinc cluster transcription factor; negative regulator of fluconazole, ketoconazole, 
brefeldin A resistance; transposon mutation increases filamentous growth; partially 




orf19.45  Predicted ORF from Assembly 19; merged with orf19.5742 in Assembly 20 -0.0327 0.159485 
orf19.675  
Putative cell wall protein; induced in core stress response and core caspofungin response; 
iron-regulated; amphotericin B, ketoconazole, and hypoxia induced; regulated by Cyr1p, 
Ssn6p; induced in oralpharyngeal candidasis  
-0.0339 5.90E-07 
orf19.5861 KRE9 
Protein of beta-1,6-glucan biosynthesis; required for serum-induced hyphal growth; 
required for efficient utilization of galactose and for growth on glucose; similar to S. 
cerevisiae Kre9p and Knh1p; O-glycosylated by Pmt1p  
-0.0353 0.00013 
orf19.2551 MET6 
Essential 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 
(cobalamin-independent methionine synthase); antigenic during murine or human 
systemic infection; heat shock, estrogen, possibly biofilm, and GCN-induced 
-0.0376 0.000219 
orf19.1716 URA3 
Orotidine-5'-phosphate decarboxylase, enzyme of pyrimidine biosynthesis; gene used as 
a molecular genetic marker, but decreased expression when integrated at ectopic 
chromosomal locations can cause defects in hyphal growth and virulence  
-0.0391 0.000304 
orf19.3775 SSK2 
MAP kinase kinase kinase (MAPKKK) that regulates Hog1p activation and signaling; 
transcription is downregulated in response to treatment with ciclopirox olamine  
-0.0397 0.00125 
orf19.5383 PMA1 
Plasma membrane H(+)-ATPase; highly expressed, comprising 20-40% of total plasma 
membrane protein; abundance increases at stationary phase transition; fluconazole 
induced; caspofungin repressed; upregulated in RHE model 
-0.0416 0.001297 
orf19.2866  Has domain(s) with predicted DNA binding activity  -0.0476 0.002343 
orf19.6078 POL93 
Predicted ORF in retrotransposon Tca8 with similarity to the Pol region of 
retrotransposons encoding reverse transcriptase, protease and integrase; downregulated 
in response to ciclopirox olamine; induced upon biofilm formation  
-0.0479 0.002905 
orf19.7265  Hap43p-repressed gene  -0.0485 0.001241 
orf19.1164 GAR1 
Putative H/ACA snoRNP pseudouridylase complex protein; mutation confers 
hypersensitivity to tubercidin (7-deazaadenosine); macrophage/pseudohyphal-induced  
-0.0517 6.20E-06 
orf19.3712  
Predicted ORF in Assemblies 19, 20 and 21; transcriptionally activated by Mnl1p under 





Adhesin-like cell wall protein; putative GPI-anchor; fluconazole-induced; regulated by 
iron; expression greater in high iron; induced during cell wall regeneration; Cyr1p or 
Ras1p downregulated; positively regulated by Tbf1p  
-0.0541 0.003068 
orf19.1105.2 PGA56 
Regulator of sorbose utilization; putative GPI-anchor; predicted helix-loop helix 
domain; hyphal induced; induced during cell wall regeneration; colony morphology-
related gene regulation by Ssn6p; transcription activated by Tbf1p, Hap43p  
-0.0544 0.00535 
orf19.7350 RCT1 
Fluconazole-induced protein; elevated mRNA levels in a cyr1 or ras1 null mutant and 
decreased mRNA abundance in efg1 null mutant; regulated by Nrg1p, Tup1p, Tbf1p, 
Ssn6p; induced in oralpharyngeal candidasis 
-0.0574 0.000912 
orf19.3038 TPS2 
Trehalose-6-phosphate (Tre6P) phosphatase; mutant heat sensitive, has Tre6P 
accumulation, decreased mouse virulence; possible drug target; two conserved 




Similar to co-chaperones; transcriptionally regulated by iron; expression greater in high 
iron; farnesol-, heavy metal (cadmium) stress-induced; protein level decreases in 
stationary phase cultures; Hap43p-repressed gene  
-0.0578 5.08E-06 
orf19.5591 ADO1 
Adenosine kinase; heterozygous null mutant exhibits resistance to cordycepin in the C. 
albicans fitness test; ketoconazole-induced; protein level decreased in stationary phase 
cultures; sumoylation target  
-0.0624 0.000634 
orf19.7219 FTR1 
High-affinity iron permease; required for mouse virulence, low-iron growth; iron, 
amphotericin B, caspofungin, ciclopirox, Hog1p, Sef1p, Sfu1p, and Hap43p regulated; 
complements S. cerevisiae ftr1 iron transport; Hap43p-repressed 
-0.0673 0.001295 
orf19.6187  Predicted ORF in Assemblies 19, 20 and 21; overlaps orf19.6185 and orf19.6188  -0.0681 0.003652 
orf19.1889  
Putative phosphoglycerate mutase family protein; stationary phase enriched protein; 
early-stage biofilm-induced  
-0.0689 0.000253 
orf19.3334 RPS21 
Predicted ribosomal protein; genes encoding cytoplasmic ribosomal subunits, translation 
factors, and tRNA synthetases are downregulated upon phagocytosis by murine 
macrophage; transcription is positively regulated by Tbf1p  
-0.0695 0.001073 
orf19.3911 SAH1 
Putative S-adenosyl-L-homocysteine hydrolase; predicted enzyme of sulfur amino acid 
metabolism; antigenic in human; biofilm-, alkaline-, fluconazole-induced expression; 
Gcn4p-regulated; amino acid starvation (3-AT) repressed 
-0.0722 8.57E-08 
orf19.710  
Putative beta subunit of succinate-CoA ligase; transcription regulated by Mig1p and 
Tup1p; transcriptionally regulated by iron; expression greater in high iron; merged with 




orf19.1407  Predicted ORF from Assembly 19; merged with orf19.6117 in Assembly 20 -0.0774 0.000814 
orf19.5445 GLO3 
Ortholog(s) have ARF GTPase activator activity and role in COPI coating of Golgi 
vesicle, ER to Golgi vesicle-mediated transport, retrograde vesicle-mediated transport, 
Golgi to ER  
-0.0816 0.000233 
orf19.5451  
Ortholog of Candida guilliermondii ATCC 6260 : PGUG_05321, Candida lusitaniae 
ATCC 42720 : CLUG_00887 and Candida albicans WO-1 : CAWG_02354 
-0.0837 0.000769 
orf19.5459  
Putative mRNA polyadenylation regulating protein; Hap43p-repressed gene, 
transcription is upregulated in an RHE model of oral candidiasis and in clinical isolates 
from HIV+ patients with oral candidiasis  
-0.0837 0.002607 
orf19.47  Predicted ORF from Assembly 19; removed from Assembly 20 -0.0962 4.36E-07 
orf19.84 CAN3 Hap43p-repressed gene; expression is regulated upon white-opaque switching  -0.098 1.36E-05 
orf19.338  
Putative protein of unknown function; stationary phase enriched protein; Hog1p-
downregulated; shows colony morphology-related gene regulation by Ssn6p  
-0.0992 3.15E-07 
orf19.6190 SRB1 
Essential GDP-mannose pyrophosphorylase; synthesizes GDP-mannose for protein 
glycosylation; functional homolog of S. cerevisiae Psa1p; on yeast-form cell surface, not 
hyphal cells; alkaline upregulated; induced on adherence to polystyrene  
-0.0996 1.97E-05 
orf19.4055  
Protein similar to S. cerevisiae Ybr075wp; transposon mutation affects filamentous 
growth; clade-associated gene expression  
-0.1021 7.35E-07 
orf19.5636 RBT5 
GPI-anchored cell wall protein involved in hemoglobin utilization; regulated by Rfg1p, 
Rim101p, Tbf1p, iron; repressed by Sfu1p, Hog1p, Tup1p; induced by serum, alkaline 
pH, ketoconazole, ciclopirox olamine, geldamycin, Hap43p, biofilm  
-0.108 0.004829 
orf19.968 PGA14 




Predicted ORF in Assemblies 19, 20 and 21; increased transcription is observed upon 





Putative GPI-anchored protein; hyphal induced; Hog1p-downregulated; induced in a 
cyr1 or efg1 homozygous null mutant; shows colony morphology-related gene 
regulation by Ssn6p; upregulated in an RHE model; mRNA binds to She3p  
-0.1143 0.000923 
orf19.316 SEC13 
Putative protein transport factor; antigenic during murine systemic infection; 
macrophage-downregulated protein abundance; protein level decreases in stationary 
phase cultures  
-0.1162 4.85E-06 
orf19.5809  Putative arylformamidase, enzyme of the NAD biosynthesis pathway; Gcn4p-regulated  -0.1196 0.000774 
orf19.3713  
Late-stage biofilm-induced gene; transcriptionally activated by Mnl1p under weak acid 
stress; transcription detected in high-resolution tiling array experiments 
-0.1253 0.00048 
orf19.7398.1 TSA1B 
Putative peroxidase; orf19.7398.1 is contig-truncated fragment of gene identical to 
TSA1; Tsa1p and Tsa1Bp role under oxidative/reductive stress, hyphal cell wall 
formation; in hyphal nucleus, cell wall; yeast-form nucleus, cytoplasm  
-0.1256 0.00087 
orf19.5989  
Ortholog(s) have mRNA binding activity, role in mRNA cleavage, mRNA 




Has domain(s) with predicted role in peptidyl-diphthamide biosynthetic process from 
peptidyl-histidine and cytoplasm localization  
-0.1267 no replicates 
orf19.4540 UBC8 
Protein similar to S. cerevisiae Ubc8p; transcription is induced in response to alpha 
pheromone in SpiderM medium  
-0.1275 0.002011 
orf19.1180  




Predicted ORF in Assemblies 19, 20 and 21; transcriptionally activated by Mnl1p under 
weak acid stress  
-0.1287 0.000884 
orf19.7635 DRS1 
Putative nucleolar DEAD-box protein; Hap43p-induced gene; mutation confers 
hypersensitivity to 5-fluorouracil (5-FU), tubercidin (7-deazaadenosine); transcription is 
positively regulated by Tbf1p; downregulated during core stress response 
-0.1338 0.002283 




Biofilm-induced gene; expression regulated during planktonic growth; similarity to 
mutator-like element (MULE) transposase  
-0.1384 0.001432 
orf19.2371  
Putative Gag protein of retrotransposon Tca2; separated by a stop codon from Pol protein 
orf19.2372; both likely translated as single polyprotein that includes nucleocapsid-like 
protein (Gag), reverse transcriptase, protease, and integrase  
-0.1385 8.45E-05 
orf19.4263  Ortholog of Candida albicans WO-1 : CAWG_04633  -0.139 0.000306 
orf19.7446 OPI3 
Phosphatidylethanolamine N-methyltransferase of phosphatidylcholine biosynthesis; 
downregulation correlates with clinical development of fluconazole resistance; 
amphotericin B repressed; caspofungin repressed; Hap43p-induced gene  
-0.1394 2.67E-05 
orf19.535 RBR1 
Glycosylphosphatidylinositol (GPI)-anchored cell wall protein required for filamentous 
growth at acidic pH; expression is repressed by Rim101p and activated by Nrg1p; 
Hap43p-induced gene  
-0.1402 0.000609 
orf19.2163  Ortholog(s) have cytosol localization  -0.1405 0.000407 
orf19.1154 EGD1 
Putative GAL4 DNA-binding enhancer protein; soluble protein in hyphae; biofilm 
induced; macrophage/pseudohyphal-induced; the same level of protein present in 
exponential and stationary growth phase yeast cultures  
-0.1436 9.92E-05 
orf19.1857  Protein not essential for viability  -0.1471 0.00324 
orf19.7308 TUB1 
Alpha-tubulin; gene has intron; complements cold-sensitivity of S. cerevisiae tub1 
mutant; C. albicans has single alpha-tubulin gene, whereas S. cerevisiae has two (TUB1, 
TUB3); farnesol-upregulated in biofilm; sumoylation target  
-0.1481 0.000217 
orf19.4040 ILV3 
Putative dihydroxyacid dehydratase; upregulated in biofilm; repressed by nitric oxide; 
macrophage-induced protein; farnesol-downregulated; protein present in exponential 
and stationary growth phase; Sef1p-, Sfu1p-, and Hap43p-regulated  
-0.1494 2.65E-05 
orf19.5710  Putative protein of unknown function; mRNA binds to She3p  -0.1501 6.09E-06 
orf19.3822 SCS7 
Putative ceramide hydroxylase; transcription is regulated by Nrg1p; transcriptionally 






Predicted ORF from Assembly 19; orf19.5372 and orf19.5373 are similar to the Tca2 
(pCal) retrotransposon, which is present in strain hOG1042 as 50 to 100 copies of a 
linear dsDNA; removed from Assembly 20; transcription is Tbf1p-activated  
-0.1561 0.000737 
orf19.1591 ERG10 
Acetyl-CoA acetyltransferase; role in ergosterol biosynthesis; soluble in hyphae; 
changes in protein abundance associated with azole resistance; fluconazole or 
ketoconazole induced; macrophage-downregulated protein; GlcNAc-induced protein  
-0.1593 4.76E-08 
orf19.2451 PGA45 
Cell wall protein; putative GPI-anchor; downregulated in core caspofungin response; 




Conserved acidic ribosomal protein, likely to be involved in regulation of translation 
elongation; interacts with Rpp2Ap; one of four similar C. albicans ribosomal proteins 
(Rpp1Ap, Rpp1Bp, Rpp2Ap, Rpp2Bp); transcription activated by Tbf1p  
-0.1622 4.95E-07 
orf19.3400 COQ3 
Protein with a predicted role in coenzyme Q biosynthesis; transcriptionally induced by 
interaction with macrophages; possibly an essential gene, disruptants not obtained by 
UAU1 method  
-0.1632 7.47E-05 
orf19.1631 ERG6 
Delta(24)-sterol C-methyltransferase, converts zymosterol to fecosterol, ergosterol 
biosynthesis; mutation confers nystatin resistance; Hap43, GlcNAc-, fluconazole-
induced; upregulated in azole-resistant strain 
-0.1634 0.002597 
orf19.1536  
Putative vacuolar transporter; Hap43p-induced gene, required for normal filamentous 
growth; mRNA binds to She3p and is localized to hyphal tips  
-0.1657 0.004456 
orf19.993  
Ortholog of C. parapsilosis CDC317 : CPAR2_502110, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_105930, Candida dubliniensis CD36 : CD36_09890 and Pichia 
stipitis Pignal : PICST_30848  
-0.1681 0.000188 
orf19.7076 GBP2 
Putative single-strand telomeric DNA-binding protein; protein level decreases in 
stationary phase cultures  
-0.1684 0.001537 
orf19.7005  Predicted ORF from Assembly 19; removed from Assembly 20 -0.1701 0.003206 
orf19.327 HTA3 
Putative histone H2A; amphotericin B repressed; flucytosine induced; RNA abundance 
regulated by tyrosol and cell density  
-0.1725 3.45E-05 
orf19.1082.1  
Ortholog(s) have cytochrome-c oxidase activity, role in mitochondrial respiratory chain 






Ortholog(s) have phosphatidylglycerophosphatase activity, role in cardiolipin 
biosynthetic process, phosphorylated carbohydrate dephosphorylation and 
mitochondrial matrix localization  
-0.1794 0.00017 
orf19.1785  Hap43p-repressed gene; biofilm-induced  -0.1818 0.001 
orf19.6160  
Ortholog(s) have role in eisosome assembly and eisosome, membrane raft, 
mitochondrion localization  
-0.1822 9.79E-08 
orf19.2116 NAT2 
Putative N-terminal acetyltransferase; Hap43p-repressed gene; mutation confers 
hypersensitivity to toxic ergosterol analog  
-0.187 1.40E-05 
orf19.339 NDE1 
Putative NADH dehydrogenase that could act alternatively to complex I in respiration; 
caspofungin repressed; fungal-specific (no human or murine homolog); transcription is 
upregulated in both intermediate and mature biofilms 
-0.1889 0.002443 
orf19.1357 FCY21 
High affinity, high capacity, hypoxanthine-adenine-guanine-cytosine/ H+ symporter; 
purine-cytosine permease of pyrimidine salvage; similar to S. cerevisiae Fcy2p; 
mutation confers resistance to 5-fluorocytosine (5-FC); biofilm-induced gene 
-0.1907 0.001654 
orf19.2864.1 RPL28 
Putative ribosomal protein; Plc1p-regulated; genes encoding cytoplasmic ribosomal 
subunits, translation factors, and tRNA synthetases are downregulated upon 
phagocytosis by murine macrophage 
-0.1947 0.002595 
orf19.2775 IDI1 
Ortholog(s) have isopentenyl-diphosphate delta-isomerase activity, role in farnesyl 
diphosphate biosynthetic process and cytosol, nucleus localization  
-0.1949 0.004145 
orf19.5684  
Ortholog(s) have structural constituent of ribosome activity and mitochondrial large 
ribosomal subunit localization  
-0.1982 0.002809 
orf19.3076  
Ortholog(s) have role in vesicle-mediated transport and COPI-coated vesicle, integral to 
Golgi membrane localization  
-0.1991 0.00634 
orf19.2346  Putative protein of unknown function, transcription is positively regulated by Tbf1p  -0.1993 8.72E-05 








Putative tRNA-His synthetase; genes encoding ribosomal subunits, translation factors, 
tRNA synthetases are downregulated upon phagocytosis by murine macrophage; 
stationary phase enriched protein  
-0.2083 0.003186 
orf19.6529 CDC34 
Putative ubiquitin-protein ligase; transcription is regulated by Nrg1p and Tup1p, and by 
Gcn2p and Gcn4p; planktonic growth-induced gene  
-0.2099 0.001073 
orf19.2953 TOM20 Putative mitochondrial primary import receptor  -0.2132 0.000711 
orf19.7613 HCR1 
Putative translation initiation factor; genes encoding ribosomal subunits, translation 




Ortholog of C. parapsilosis CDC317 : CPAR2_702310, Lodderomyces elongisporus 
NRLL YB-4239 : LELG_04029, Candida dubliniensis CD36 : CD36_73730 and 
Candida orthopsilosis Co 90-125 : CORT0G02490  
-0.2165 0.000171 
orf19.1144  Early-stage biofilm-induced gene  -0.2165 0.000461 
orf19.4438 RME1 
Protein similar to S. cerevisiae meiotic regulator Rme1p; white-specific transcription; 
upregulation correlates with clinical development of fluconazole resistance; biofilm and 
planktonic growth-induced gene; Upc2p-regulated in hypoxia  
-0.2211 0.001999 
orf19.4311 YNK1 
Nucleoside diphosphate kinase (NDP kinase); homo-hexameric; soluble protein in 
hyphae; flucytosine induced; biofilm induced; macrophage-induced protein; stationary 
phase enriched protein  
-0.2227 0.002824 
orf19.6105 MVD 
Mevalonate diphosphate decarboxylase; functional homolog of S. cerevisiae Erg19p; 
possible drug target; transcriptionally regulated by carbon source, yeast-hyphal switch, 
growth phase, antifungals; gene has intron  
-0.2264 0.004583 
orf19.7643  
Ortholog(s) have 4-hydroxybenzoate octaprenyltransferase activity, antioxidant activity 
and role in polyprenol biosynthetic process, ubiquinone biosynthetic process  
-0.2335 2.92E-09 
orf19.5305 RHD3 
GPI-anchored cell wall protein; yeast-associated protein; transcriptionally regulated by 
iron; expression greater in high iron; clade-associated gene expression; not essential for 





Pry family protein; required for virulence in mouse systemic/rabbit corneal infections; 
not required for filamentation; mRNA binds She3 and is localized to hyphal tips; Hap43-
induced; detected in both yeast and hyphal culture supernatants 
-0.2369 5.74E-05 
orf19.5112 TKL1 
Putative transketolase; localizes to surface of yeast-form cells, but not hyphae; soluble 
protein in hyphae; transcription regulated by Nrg1p, Mig1p, and Tup1p; antigenic in 
human or murine infection; possibly essential (by UAU1 method)  
-0.2371 0.00017 
orf19.7097  
Putative cytoplasmic RNA-binding protein; heterozygous null mutant exhibits 
hypersensitivity to parnafungin and cordycepin in the C. albicans fitness test  
-0.2383 0.002479 
orf19.1030  Putative peptidyl-prolyl cis-trans isomerase  -0.2392 0.001135 
orf19.5463 SEC6 
Predicted subunit of the exocyst complex, involved in exocytosis; localizes to a crescent 




1,3-beta-glucan-linked structural cell wall protein; N-mannosylated, O-glycosylated by 
Pmt1p; tandem repeats; cell wall defect in heterozygous mutant; hyphal repressed; 
Hog1p, fluconazole, hypoxia induced; iron, Efg1p, Plc1p, temp regulated 
-0.2435 0.000399 
orf19.5437 RHR2 
Glycerol 3-phosphatase; roles in osmotic tolerance, glycerol accumulation in response 
to salt; required for biofilm formation; biofilm-induced; regulated by macrophage, stress 
response, yeast-hyphal switch, pheromone, GCN4, HOG1, NRG1, TUP1  
-0.2444 0.001051 
orf19.3302  
Putative type-1 protein phosphatase targeting subunit; late-stage biofilm-induced gene; 
transcription downregulated upon yeast-hyphal switch; transcriptionally activated by 
Mnl1p under weak acid stress  
-0.2491 0.00046 
orf19.6081 PHR2 
Glycosidase; role in cell wall structure; may act on beta-1,3-glucan prior to beta-1,6-
glucan linkage; role in vaginal not systemic virulence (low pH not neutral); low pH, high 
iron, fluconazole, Hap43p-induced; Rim101p-downregulated at Ph8 
-0.2493 0.000445 
orf19.4980 HSP70 
Putative hsp70 chaperone; role in entry into host cells; heat-shock, amphotericin B, 
cadmium, ketoconazole-induced; farnesol-downregulated in biofilm; surface localized 
in yeast-form and hyphal cells; antigenic in host  
-0.25 0.000818 
orf19.4523  
Ortholog(s) have 5-formyltetrahydrofolate cyclo-ligase activity, role in folic acid-
containing compound biosynthetic process and mitochondrion localization  
-0.2504 3.06E-05 
orf19.6676  
Has domain(s) with predicted diphthine synthase activity and role in peptidyl-





Putative translation initiation factor eIF3, p39 subunit; mutation confers hypersensitivity 
to roridin A and verrucarin A; ribosomal subunits, translation factors, tRNA synthetases 
are downregulated upon phagocytosis by murine macrophages 
-0.2505 0.003255 
orf19.7399 - ORF Predicted by Annotation Working Group; removed from Assembly 21 -0.2508 0.000277 
orf19.5157  
Predicted ORF in Assemblies 19, 20 and 21; six putative membrane-spanning regions; 
similar to S. cerevisiae Yjl097p, which is required for growth  
-0.2532 1.31E-06 
orf19.698  
Ortholog(s) have role in endoplasmic reticulum inheritance and integral to endoplasmic 
reticulum membrane localization  
-0.2536 0.000276 
orf19.2954  Hap43p-repressed gene; repressed by nitric oxide  -0.2538 1.98E-05 
orf19.3470  Putative flavodoxin; similar to S. cerevisiae Ypl207p; predicted Kex2p substrate  -0.2549 0.000356 
orf19.1234 FGR6-10 
Protein lacking an ortholog in S. cerevisiae; member of a family encoded by FGR6-




Ortholog(s) have role in inositol metabolic process and cytosol, nuclear envelope 
localization  
-0.2619 1.10E-05 
orf19.6041 RPO41 Putative mitochondrial RNA polymerase; downregulated during core stress response  -0.2626 6.82E-05 
orf19.5117 OLE1 
Fatty acid desaturase, essential protein involved in oleic acid synthesis; required for 
aerobic hyphal growth and chlamydospore formation; subject to hypoxic regulation; 
fluconazole-induced; caspofungin repressed; Hap43p-induced  
-0.264 4.48E-05 
orf19.2392  Protein not essential for viability  -0.2643 0.000547 
orf19.3459  
Putative serine/threonine/tyrosine (dual-specificity) kinase; disruptants not obtained by 





Ribosomal protein S5; macrophage/pseudohyphal-induced after 16 h; genes encoding 
cytoplasmic ribosomal subunits, translation factors, tRNA synthetases are 
downregulated upon phagocytosis by murine macrophage; Hap43p-induced gene  
-0.2671 0.005503 
orf19.4565 BGL2 
Cell wall 1,3-beta-glucosyltransferase; one of many 1,3-beta-glucosyltransferases; 
mutant has cell-wall and growth defects, but wild-type 1,3- or 1,6-beta-glucan content; 
antigenic; virulence role in mouse systemic infection  
-0.2675 0.000566 
orf19.5443 BNA4 
Putative kynurenine 3-monooxygenase, involved in NAD biosynthesis; transposon 
mutation affects filamentous growth; Hap43p-repressed gene; oral infection 
upregulated; mutants have reduced capacity to damage oral epithelial cells  
-0.268 0.001598 
orf19.1085  
Ortholog(s) have ubiquitin-protein ligase activity and role in ER-associated protein 
catabolic process, protein ubiquitination involved in ubiquitin-dependent protein 
catabolic process, vesicle organization  
-0.2716 3.02E-05 
orf19.6146 CLG1 Putative cyclin-like protein; transcription is regulated upon yeast-hyphal switch  -0.2766 0.000376 
orf19.5191 FGR6-1 
Protein lacking an ortholog in S. cerevisiae; member of a family encoded by FGR6-




Putative DNA-binding transcription factor; putative TFIID subunit; flucytosine 
repressed; merged with orf19.6193 in Assembly 20  
-0.2791 2.53E-06 
orf19.2372  
Putative Pol protein of retrotransposon Tca2; separated by a stop codon from Gag protein 
orf19.2371; both likely translated as single polyprotein that includes nucleocapsid-like 
protein (Gag), reverse transcriptase, protease, and integrase  
-0.2799 0.000475 
orf19.6113  
Predicted ORF in Assemblies 19, 20 and 21; transcription detected in high-resolution 
tiling array experiments  
-0.2808 0.002013 
orf19.2208  Ortholog(s) have role in response to salt stress and cytoplasm localization  -0.2842 5.25E-05 
orf19.1392  
Ortholog(s) have chaperone binding, protein disulfide isomerase activity, unfolded 
protein binding activity, role in ER-associated protein catabolic process, protein 
retention in ER lumen and endoplasmic reticulum membrane localization  
-0.285 0.003188 




Predicted ORF from Assembly 19; orf19.5372 and orf19.5373 are similar to the Tca2 
(pCal) retrotransposon, which is present in strain hOG1042 as 50 to 100 copies of a 
linear dsDNA; clade-associated gene expression; removed from Assembly 20  
-0.2869 0.001824 
orf19.5027 LCB2 








Small GTPase of Rab family; role in post-Golgi secretion; possible C-terminal 
palmitoylation; downregulated on adherence to polystyrene; localizes to the 
Spitzenkorper during hyphal growth; functional homolog of S. cerevisiae Sec4p  
-0.2884 5.71E-05 
orf19.3895 CHT2 
GPI-linked chitinase required for normal filamentous growth; downregulated in core 
caspofungin response; fluconazole, Cyr1p-, Efg1p-, pH-regulated; mRNA binds She3p, 
is localized to yeast-form buds and hyphal tips  
-0.2926 0.006682 
orf19.7625 PGA1 
Putative GPI-anchored protein; induced during cell wall regeneration; required for 
normal adhesion to host cells and for adherence during biofilm formation 
-0.296 0.004391 
orf19.1560 POB3 
Protein similar to S. cerevisiae Pob3p, which is involved in chromatin assembly and 
disassembly; transposon mutation affects filamentous growth  
-0.297 6.72E-08 
orf19.561  Predicted ORF from Assembly 19; removed from Assembly 20 -0.2979 0.00461 
orf19.5101 CCR4 
Component of the Ccr4-Pop2 mRNA deadenylase; transposon mutation affects 
filamentous growth  
-0.3036 0.00094 
orf19.6459 DPP3 
Protein similar to S. cerevisiae pyrophosphate phosphatase Dpp1p; required for farnesol 
biosynthesis; downregulated in response to 17-beta-estradiol, ethynyl estradiol  
-0.3056 0.006126 
orf19.783  
Ortholog(s) have role in endocytosis, retrograde vesicle-mediated transport, Golgi to ER, 
vacuole organization and COPI-coated vesicle, Golgi membrane, endosome localization  
-0.3082 0.000227 




Putative heteropentameric replication factor C subunit; flucytosine induced; periodic 
mRNA expression, peak at cell-cycle G1/S phase  
-0.3095 0.005541 
orf19.6716 ABD1 
RNA (guanine-N7-)-methyltransferase, SAM-dependent; methylates mRNA 5' cap; 
binds phosphorylated RNA Pol II C-terminal domain peptide; does not bind mRNA 
TPase and mRNA GTase (Cet1p and Cgt1p); functional homolog of S. cerevisiae Abd1p  
-0.3118 0.004228 
orf19.4907  
Putative protein of unknown function; Hap43p-repressed gene; increased transcription 
is observed upon fluphenazine treatment; possibly transcriptionally regulated by Tac1p; 
induced by nitric oxide; fungal-specific (no human/murine homolog  
-0.3159 0.005417 
orf19.7673  
Ortholog(s) have mRNA binding activity, role in mRNA splicing, via spliceosome and 
U1 snRNP, U2-type prespliceosome, U4/U6 x U5 tri-snRNP complex, U5 snRNP, 
commitment complex localization  
-0.3182 3.65E-06 
orf19.1378 SUP35 
Translation factor eRF3; shows prion-like aggregation in some, not all, studies; partially 
complements S. cerevisiae sup35 mutant translation defect; species barrier with S. 
cerevisiae Sup35p prion; gene not regulated by yeast-hyphal switch  
-0.3182 0.003662 
orf19.568 SPE2 




Septin; essential for viability; forms ring at sites of cell division and also forms filaments 
in mature chlamydospore; filamentous growth induced; regulated by Nrg1p, Tup1p, 
tyrosol and cell density  
-0.3217 0.000135 
orf19.1401 EAP1 
GPI-anchored cell wall adhesin; cell-cell adhesion, biofilm formation; Efg1p-regulated; 
mutant suppresses polystyrene or cell adhesion, filamentation, invasive growth defects 
of S. cerevisiae flo8 or flo11 mutant; biofilm-induced  
-0.3225 0.002204 
orf19.3292  
Ortholog(s) have peptide-methionine (R)-S-oxide reductase activity, role in cellular 
response to oxidative stress and cytosol, mitochondrion, nucleus localization  
-0.3231 0.001751 
orf19.4732 SEC24 
Protein with a possible role in ER to Golgi transport; induced upon yeast-hyphal switch; 
sumoylation target  
-0.3246 0.000447 
orf19.6287 AAT21 




HSP70 family chaperone; found in cell wall fractions; antigenic; role in import of beta-
defensin peptides; ATPase domain binds histatin 5; at surface of hyphae, not yeast-form 





Zn2-Cys6 transcriptional regulator of ergosterol biosynthetic genes and sterol uptake; 
binds ERG2 promoter; induced upon ergosterol depletion, by azoles, anaerobicity, in 
biofilms; macrophage/pseudohyphal-repressed  
-0.3307 0.002808 
orf19.2396 IFR2 
Zinc-binding dehydrogenase; upregulated by benomyl, ciclopirox olamine or alpha 
pheromone; regulated by oxidative stress (via Cap1p) and osmotic stress (via Hog1p); 
protein present in exponential and stationary phase; Hap43p-induced gene  
-0.3327 6.92E-05 
orf19.340  
Ortholog(s) have role in protein targeting to membrane, protein targeting to vacuole and 
ESCRT I complex localization  
-0.3355 7.45E-05 
orf19.6229 CAT1 
Catalase; resistance to oxidative stress, neutrophils, peroxide; role in virulence; regulated 
by iron, ciclopirox, fluconazole, carbon source, pH, Rim101p, Ssn6p, Hog1p, Hap43p, 
Sfu1p, Sef1p, farnesol, core stress response  
-0.3371 0.000504 
orf19.2926  
Ortholog(s) have 5'-3' exonuclease activity, damaged DNA binding activity, role in DNA 
repair and nucleus localization  
-0.3385 0.002795 
orf19.3051  
Predicted ORF in Assemblies 19, 20 and 21; shows colony morphology-related gene 
regulation by Ssn6p  
-0.3406 0.004975 
orf19.3152 AMO2 
Protein similar to A. niger predicted peroxisomal copper amino oxidase; mutation 
confers hypersensitivity to toxic ergosterol analog; induced upon biofilm formation  
-0.3425 0.002618 
orf19.7231 FTR2 
High-affinity iron permease; probably interacts with ferrous oxidase; regulated by iron 
level, ciclopirox olamine, amphotericin B, caspofungin; complements S. cerevisiae ftr1 
iron transport defect; Hap43p-repressed  
-0.3444 0.002716 
orf19.4959  
Ortholog of C. parapsilosis CDC317 : CPAR2_202690, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_112521, Debaryomyces hansenii CBS767 : DEHA2E16434g and 
Candida dubliniensis CD36 : CD36_12360  
-0.3454 0.002093 
orf19.6538 VMA11 
Predicted ortholog of S. cerevisiae Tfp3p, which is the c' subunit of the V0 subcomplex 
of the vacuolar ATPase; required for hemoglobin-iron utilization  
-0.3471 3.75E-05 
orf19.1661 DBP5 
Ortholog(s) have RNA helicase activity, RNA-dependent ATPase activity, inositol 




Putative mitotic exit network component; periodic mRNA expression, peak at cell-cycle 





Ortholog of S. cerevisiae : YMR087W, C. glabrata CBS138 : CAGL0J01397g, C. 
parapsilosis CDC317 : CPAR2_107150, Candida dubliniensis CD36 : CD36_03920 and 
Pichia stipitis Pignal : PICST_61741  
-0.3505 0.000108 
orf19.3965  
Ortholog(s) have role in double-strand break repair via homologous recombination, 
meiotic gene conversion, reciprocal meiotic recombination, replication fork protection 
and Smc5-Smc6 complex, cytosol, nucleus localization  
-0.3568 0.006917 
orf19.7329  Ortholog(s) have ubiquitin-protein ligase activity  -0.3584 0.001917 
orf19.7080 LEU2 
Isopropyl malate dehydrogenase; enzyme of leucine biosynthesis; upregulated in the 
presence of human whole blood or polymorphonuclear (PMN) cells; protein level 
decreases in stationary phase; GlcNAc-induced protein  
-0.3598 0.000152 
orf19.7128 SYS1 Putative Golgi integral membrane protein; transcription is regulated by Mig1p  -0.3603 5.29E-07 
orf19.7270  
Ortholog of C. parapsilosis CDC317 : CPAR2_808740, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_95761, Debaryomyces hansenii CBS767 : DEHA2G11946g and 
Candida dubliniensis CD36 : CD36_70220  
-0.3614 0.003452 
orf19.4853 HCM1 Protein with forkhead domain; similar to S. cerevisiae Hcm1p; Hap43p-induced gene -0.3615 0.001803 
orf19.1227 ZCF4 Putative transcription factor with zinc cluster DNA-binding motif  -0.3622 0.004788 
orf19.916  
Ortholog(s) have role in apoptotic process, calcium-mediated signaling, endoplasmic 
reticulum unfolded protein response and Golgi apparatus, endoplasmic reticulum, 
fungal-type vacuole membrane, mitochondrion localization  
-0.3636 3.81E-06 
orf19.1613 ILV2 
Putative acetolactate synthase; regulated by Gcn4p; induced by amino acid starvation 
(3-AT treatment); stationary phase enriched protein  
-0.3637 0.00138 
orf19.1193 GNP1 
Protein similar to asparagine and glutamine permease; fluconazole or caspofungin 
induced; transcription is regulated by Nrg1p, Mig1p, Tup1p, Gcn2p, Gcn4p, and alkaline 
regulated by Rim101p; biofilm-induced; fungal-specific  
-0.3659 0.003187 




Component of actomyosin ring at bud neck; cell-cycle regulated serine phosphorylation 
at CDK sites regulates association with formins Bni1p and Bnr1p, Iqg1p degradation, 
and ring disassembly; mutation causes severe cytokinetic defects  
-0.3692 0.003408 
orf19.6078.1 RFC52 
Putative replication factor C complex protein; periodic mRNA expression, peak at cell-
cycle G1/S phase; overlaps orf19.6079  
-0.3704 0.000116 
orf19.797 BAT21 
Putative branched chain amino acid aminotransferase; regulated by Gcn4p, Gcn2p; 




Small RAN G-protein; essential; prenylation not predicted; overproduction rescues S. 
cerevisiae gsp1 viability; macrophage/pseudohyphal-induced; not transcriptionally 
regulated by white-opaque or yeast-hyphal switching; GlcNAc-induced  
-0.3733 0.003743 
orf19.5217 TES1 Putative acyl-CoA thioesterase -0.3734 0.002023 
orf19.820 SDS22 Putative protein serine-threonine phosphatase; macrophage/pseudohyphal-repressed  -0.3744 0.001677 
orf19.953.1 COF1 
Putative cofilin; macrophage-induced protein; protein present in exponential and 
stationary-phase yeast cells, but higher amounts in stationary phase  
-0.3749 0.000785 
orf19.6927 PEP8 
Protein similar to S. cerevisiae Pep8p, which is involved in retrograde transport; 
transposon mutation affects filamentous growth  
-0.3761 0.000136 
orf19.1397  Has domain(s) with predicted heme binding activity  -0.3787 0.001213 
orf19.5400  ORF Predicted by Annotation Working Group; merged with orf19.5399 in Assembly 20 -0.3808 no replicates 
orf19.837 GNA1 
Glucosamine-6-phosphate acetyltransferase; enzyme of UDP-GlcNAc biosynthesis; 
required for viability in absence of GlcNAc supplementation; required for persistent 
infection and wild-type virulence in mouse systemic infection  
-0.3824 5.75E-05 




Cytosolic leucyl tRNA synthetase; conserved amino acid and ATP binding class I 
signature, tRNA binding, proofreading motifs; likely essential for growth; interacts with 
benzoxaborole antifungals; present in exponential and stationary phase  
-0.383 0.000443 
orf19.5788 EFT2 
Elongation Factor 2 (eEF2); GTPase; essential; highly expressed; target of sordarin 
antifungals; antigenic in human/mouse; lacks site for regulatory phosphorylation by 
eEF2 kinase; GCN-regulated; higher protein amount in stationary phase  
-0.3866 0.005191 
orf19.4262  
Ortholog(s) have mRNA binding activity and role in cellular protein complex 
localization, establishment of mitochondrion localization, nuclear-transcribed mRNA 
catabolic process, deadenylation-dependent decay  
-0.3888 0.000435 
orf19.5779 RNR1 
Ribonucleotide reductase large subunit; expression greater in low iron; transposon 
mutation affects filamentous growth; farnesol upregulated in biofilm; regulated by cell 
cycle, tyrosol, cell density; regulated by Sef1p, Sfu1p, and Hap43p  
-0.3895 0.001137 
orf19.4485  Predicted ORF from Assembly 19; removed from Assembly 20 -0.3896 0.001184 
orf19.6756  
Ortholog(s) have Rab GTPase binding activity and Golgi apparatus, endoplasmic 
reticulum localization 
-0.39 0.000107 
orf19.1883 YCS4 Putative condensin complex subunit; cell-cycle regulated periodic mRNA expression  -0.3905 2.12E-05 
orf19.3010.1 ECM33 
GPI-anchored cell wall protein; mutants show cell-wall defects and reduced adhesion, 
host cell damage, and endocytosis; mutant infection is immunoprotective in murine 
model; fluconazole-induced; caspofungin repressed  
-0.391 0.002401 
orf19.6399 ATS1 
Putative protein required for modification of wobble nucleosides in tRNA; induced upon 
adherence to polystyrene; regulated by Sef1p-, Sfu1p-, and Hap43p  
-0.3916 0.007043 
orf19.4633  
Ortholog(s) have carbonyl reductase (NADPH) activity, oxidoreductase activity, acting 
on the aldehyde or oxo group of donors, NAD or NADP as acceptor activity and cytosol, 
nucleus, ribosome localization  
-0.3934 2.47E-06 
orf19.3043  
Ortholog(s) have triglyceride lipase activity, role in triglyceride catabolic process and 
mitochondrion localization  
-0.3934 7.69E-05 
orf19.4651 PGA53 
GPI-anchored cell surface protein of unknown function; greater mRNA abundance 





Has domain(s) with predicted nucleotide binding, oxidoreductase activity, transferase 
activity, transferring acyl groups other than amino-acyl groups, zinc ion binding activity 
and role in oxidation-reduction process  
-0.3978 0.001363 
orf19.3518  
Ortholog(s) have dicarboxylic acid transmembrane transporter activity, role in 
mitochondrial transport and mitochondrial inner membrane localization  
-0.3981 0.004887 
orf19.951  




Ortholog(s) have poly(A) RNA binding activity, role in mRNA polyadenylation, 
poly(A)+ mRNA export from nucleus, regulation of mRNA stability and cytoplasm, 
nucleus localization  
-0.3995 0.001181 
orf19.7079  Ortholog(s) have role in cytokinesis and cellular bud neck localization  -0.4022 0.000306 
orf19.1054  Ortholog(s) have structural constituent of nuclear pore activity  -0.4026 0.000991 
orf19.4026 HIS1 
ATP phosphoribosyl transferase; enzyme of histidine biosynthesis; fungal-specific (no 
human, murine homolog); upregulated in biofilm; acid upregulated/alkaline 
downregulated by Rim101p; regulated by Gcn2p, Gcn4p; strain CA9 is a his1 mutant  
-0.4028 0.003814 
orf19.3259  
Ortholog(s) have peptidase activity, role in protein targeting to ER, signal peptide 
processing and signal peptidase complex localization  
-0.403 9.53E-05 
orf19.1814 STT4 Putative phosphatidylinositol-4-kinase  -0.4045 0.003051 
orf19.1414  
Protein of unknown function, transcription is upregulated in an RHE model of oral 
candidiasis; Hap43p-repressed gene  
-0.4064 7.52E-07 
orf19.1195  
Ortholog(s) have metalloendopeptidase activity, role in cellular iron ion homeostasis, 




Putative protein of unknown function, transcription is upregulated in clinical isolates 





Ortholog(s) have GTPase activity, ribosome binding activity, role in nonfunctional 
rRNA decay, nuclear-transcribed mRNA catabolic process, no-go decay, ribosome 
disassembly and cytosol localization  
-0.4111 0.002507 
orf19.2222  Putative casein kinase; plasma membrane-localized  -0.4112 0.000585 
orf19.532 RBR2 
Cell wall protein; expression is repressed by Rim101p; expression is regulated upon 
white-opaque switching; transcription is repressed in response to alpha pheromone in 
SpiderM medium; macrophage-induced gene  
-0.4123 0.002007 
orf19.5741 ALS1 
Adhesin; ALS family of cell-surface glycoproteins; adhesion, virulence roles; 
immunoprotective; band at hyphal base; amyloid domain; biofilm-induced; Rfg1p, 
Ssk1p; strain background affects expression; N-term binds fucose-containing glycans  
-0.4136 0.013313 
orf19.511  
Ortholog(s) have ribosylnicotinamide kinase activity, role in NAD biosynthesis via 
nicotinamide riboside salvage pathway, nicotinamide riboside metabolic process and 
cytosol, nucleus localization  
-0.4147 5.69E-06 
orf19.5083 DRG1 
Member of the DRG family of GTP-binding proteins; involved in regulation of invasive 
filamentous growth  
-0.4173 0.001403 
orf19.301 PGA18 Putative GPI-anchored protein; regulated by Nrg1p, Tup1p  -0.4176 0.00176 
orf19.6034 TUB2 
Beta-tubulin; functional homolog of ScTub2p; overproduction causes S. cerevisiae 
inviability; has two introns; hyphal-induced; fluconazole-induced; slow growth, ectopic 
expression causes increased white-to opaque switching; GlcNAc-induced  
-0.4279 0.006582 
orf19.749  
Protein likely to be essential for growth, based on an insertional mutagenesis strategy; 
merged with orf19.48 in Assembly 20  
-0.4332 0.004128 
orf19.4437  
Ortholog(s) have ATPase activity, DNA binding, nucleosome binding, rDNA binding 
activity  
-0.4371 0.001938 
orf19.6524 TOM40 Protein involved in mitochondrial protein import  -0.4375 0.00483 
orf19.3479  Predicted ORF in Assemblies 19, 20 and 21; merged with orf19.3477 -0.4384 0.00089 
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orf19.7522  Hap43p-repressed gene; mutation confers hypersensitivity to amphotericin B -0.4426 0.002038 
orf19.6086 LEU4 
Putative 2-isopropylmalate synthase; regulated by Nrg1p, Mig1p, Tup1p, Gcn4p; 
upregulated in the presence of human whole blood or polymorphonuclear (PMN) cells; 
macrophage/pseudohyphal-repressed after 16h; fungal-specific  
-0.4427 0.002821 
orf19.3031 SEC62 Putative endoplasmic reticulum (ER) protein-translocation complex subunit  -0.4477 8.45E-05 
orf19.2093 RFA1 
Putative DNA replication factor A; RNA abundance regulated by cell cycle, tyrosol and 
cell density  
-0.4481 0.000147 
orf19.2601 HEM1 
Putative 5-aminolevulinate synthase; transcriptionally regulated by iron; caspofungin 




Putative protein of unknown function, transcription is upregulated in clinical isolates 
from HIV+ patients with oral candidiasis  
-0.45 0.00019 
orf19.7215.3  
Ortholog(s) have chaperone binding, unfolded protein binding activity, role in protein 
refolding and mitochondrial matrix localization  
-0.4509 0.002562 
orf19.5734 POP2 
Component of the Ccr4-Pop2 mRNA deadenylase; heterozygous null mutant exhibits 
resistance to parnafungin and cordycepin in the C. albicans fitness test  
-0.4509 0.003309 
orf19.1684  
Ortholog of C. parapsilosis CDC317 : CPAR2_503620, Debaryomyces hansenii 
CBS767 : DEHA2D15268g, Candida dubliniensis CD36 : CD36_81500 and Pichia 
stipitis Pignal : PICST_66925  
-0.4513 0.003022 
orf19.7519  
Ortholog of C. parapsilosis CDC317 : CPAR2_800030, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_125790, Debaryomyces hansenii CBS767 : DEHA2E18260g and 
Candida dubliniensis CD36 : CD36_25180  
-0.452 0.001341 
orf19.5873 POL1 
Putative DNA directed DNA polymerase alpha; RNA abundance regulated by cell cycle, 
tyrosol and cell density  
-0.4535 0.007533 
orf19.7298 CHS2 
Chitin synthase; nonessential; required for wild-type chitin deposition in hyphae; 
transcription is regulated during dimorphic transition; Chs1p and Chs2p, but not Chs3p, 





Putative subunit of the Hat1p-Hat2p histone acetyltransferase complex, involved in 
DNA damage repair and morphogenesis; mutations cause constitutive pseudohyphal 
growth, caspofungin sensitivity  
-0.4549 0.00123 
orf19.1597 ABG1 
Vacuolar membrane protein of yeast and hyphae; depletion causes abnormal vacuolar 
morphology, cell separation defect, sensitivity to cell wall perturbation, increased hyphal 
branching; essential gene, no mammalian homolog; Cyr1p-regulated  
-0.4558 1.81E-05 
orf19.390 CDC42 
Rho-type GTPase; required for budding and maintenance of hyphal growth; GGTase I 
geranylgeranylated; misexpression blocks hyphal growth, causes avirulence in mouse 
IV infection; shows actin-dependent localization to hyphal tip  
-0.457 0.001021 
orf19.3312  Ortholog(s) have mitochondrion localization  -0.4621 0.005706 
orf19.5775  
Predicted ORF in Assemblies 19, 20 and 21; member of a family encoded by FGR6-
related genes in the RB2 repeat sequence 
-0.4623 0.007642 
orf19.1116  Planktonic growth-induced gene  -0.4627 0.000176 
orf19.4309 GRP2 
Methylglyoxal reductase; regulation associated with azole resistance; induced in core 
stress response or by oxidative stress (via Cap1p), fluphenazine, benomyl, or with long 
term fluconazole treatment; Hap43p-induced; antigenic in humans  
-0.4628 0.00116 
orf19.5893 RIP1 
Putative ubiquinol cytochrome c-reductase; transcriptionally regulated by iron; 




Similar to chaperones of Hsp70p family; role in translocation of proteins into the ER; 
transcriptionally regulated by iron; expression greater in high iron; protein present in 
exponential and stationary growth phase yeast cultures  
-0.4641 2.82E-05 
orf19.2065  Ortholog(s) have role in allantoin catabolic process and cytosol, nucleus localization  -0.4645 0.00035 
orf19.7108  D-ribulose-5-phosphate 3-epimerase; stationary phase enriched protein  -0.4659 0.000164 
orf19.5246  Hap43p-repressed gene  -0.4669 0.001645 
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orf19.429  Putative non-canonical poly(A) polymerase; repressed by nitric oxide  -0.4687 0.000213 
orf19.317  
Ortholog(s) have inosine nucleosidase activity, nicotinamide riboside hydrolase activity, 
purine-nucleoside phosphorylase activity  
-0.4714 3.61E-05 
orf19.6219  
Ortholog of C. parapsilosis CDC317 : CPAR2_208960, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_114040, Candida dubliniensis CD36 : CD36_06470 and Pichia 
stipitis Pignal : PICST_51125  
-0.4726 0.064153 
orf19.3921  Ortholog(s) have cell division site, cell tip, cytosol, nucleus localization  -0.4751 0.000564 
orf19.2761  
Putative glycosylphosphatidylinositol (GPI) anchor assembly protein; transposon 
insertion causes decreased colony wrinkling but does not block true hyphal growth; 
induced by nitric oxide independent of Yhb1p  
-0.4757 0.000216 
orf19.956  Ortholog(s) have role in fermentation and mitochondrion localization  -0.4761 0.003261 
orf19.3873 ARC40 
Protein similar to S. cerevisiae Arc40p, which is involved in actin filament organization 
in S. cerevisiae; transposon mutation affects filamentous growth  
-0.4765 1.19E-05 
orf19.6702 DED81 
Putative tRNA-Asn synthetase; genes encoding ribosomal subunits, translation factors, 
tRNA synthetases are downregulated upon phagocytosis by murine macrophage; protein 
enriched in stationary phase yeast cultures  
-0.4772 0.002796 
orf19.1634  Has domain(s) with predicted fatty-acyl-CoA binding activity  -0.4797 0.002212 
orf19.3947  Ortholog(s) have rDNA binding activity  -0.4813 0.00546 
orf19.7056  
Putative protein of unknown function, transcription is upregulated in clinical isolates 
from HIV+ patients with oral candidiasis; regulated by Sef1p-, Sfu1p-, and Hap43p  
-0.483 0.008001 
orf19.6944 PHB1 
Putative prohibitin; identified in detergent-resistant membrane fraction (possible lipid 





Ortholog of C. parapsilosis CDC317 : CPAR2_211990, Debaryomyces hansenii 
CBS767 : DEHA2G03036g, Candida dubliniensis CD36 : CD36_16850 and Pichia 
stipitis Pignal : psti_CGOB_00069  
-0.4868 0.000285 
orf19.374  
Ortholog(s) have role in protein targeting to vacuole involved in ubiquitin-dependent 
protein catabolic process via the multivesicular body sorting pathway  
-0.4876 6.83E-06 
orf19.6923  
Ortholog(s) have chromatin binding activity, role in RNA polymerase II transcriptional 
preinitiation complex assembly and transcription factor TFIID complex localization  
-0.4938 7.33E-06 
orf19.2730  Has domain(s) with predicted zinc ion binding activity  -0.4942 0.001757 
orf19.5589  
Predicted ORF in Assemblies 19, 20 and 21; transcription detected in high-resolution 
tiling array experiments  
-0.4943 0.000355 
orf19.267  Protein required for normal filamentous growth; mRNA binds to She3p  -0.4983 0.001 
orf19.3045  Predicted ORF in Assemblies 19, 20 and 21; virulence-group-correlated expression  -0.4983 0.001966 
orf19.6063 UBP6 
Putative ubiquitin-specific protease of the 26S proteasome; oxidative stress-induced via 
Cap1p  
-0.4996 1.47E-05 
orf19.6856  Predicted ORF from Assembly 19; merged with orf19.748 in Assembly 20 -0.4996 0.002649 
orf19.3794 CSR1 
Zinc-finger transcription factor involved in zinc homeostasis and in regulation of biofilm 




Ribosome-associated protein; antigenic in mice; complements S. cerevisiae yst1 yst2 
mutant; similar to laminin-binding proteins, does not bind laminin; predicted S/T 
phosphorylation, N-glycosylation, myristoylation, Hap43p-, Gcn4p-regulated  
-0.5031 0.002671 
orf19.1833  
Ortholog(s) have pseudouridine synthase activity, role in box H/ACA snoRNA 3'-end 
processing, rRNA pseudouridine synthesis, snRNA pseudouridine synthesis and 90S 





Putative nucleolar protein with a predicted role in pre-rRNA processing and ribosome 
biogenesis; required for biofilm formation; repressed by nitric oxide 
-0.5082 0.000272 
orf19.5685 THS1 
Putative threonyl-tRNA synthetase; transcription regulated by Mig1p and Tup1p; 




Putative adenylate kinase; decreased expression in hyphae compared to yeast; 
macrophage-induced protein; adenylate kinase release used as a marker for cell lysis; 
possibly an essential gene (UAU1 method); biofilm-induced gene  
-0.5096 0.007393 
orf19.2960 FRS2 
Putative tRNA-Phe synthetase; genes encoding ribosomal subunits, translation factors, 
tRNA synthetases are downregulated upon phagocytosis by murine macrophage; protein 
present in exponential and stationary growth phase yeast cultures  
-0.5097 0.000136 
orf19.3944 GRR1 
Protein involved in the negative control of pseudohyphal growth; ortholog of S. 
cerevisiae Grr1p, which is an F-box protein component of the SCF ubiquitin-ligase 
complex required for cell cycle progression  
-0.5136 0.001778 
orf19.5360 RPC11 Putative RNA polymerase III subunit C11; downregulated in core caspofungin response  -0.5144 0.003941 
orf19.5321  
Ortholog(s) have methylenetetrahydrofolate reductase (NADPH) activity and role in 
methionine biosynthetic process, oxidation-reduction process  
-0.5146 0.000148 
orf19.5849 CWT1 
Zn2Cys6 transcription factor involved in negative regulation of nitrosative stress 
response; mutant has cell wall defects; transcription increased at stationary phase; has 
predicted PAS domain; similar to S. cerevisiae Rds2p  
-0.5151 0.00017 
orf19.441 RPT1 
Putative 26S proteasome regulatory subunit 7; Hap43p-repressed gene; regulated by 
Gcn2p and Gcn4p; overlaps orf19.442  
-0.519 0.001255 
orf19.1723  
Ortholog(s) have role in response to purine-containing compound and cytoplasm, 
nucleus localization  
-0.5199 0.001287 
orf19.7057  Putative glutamine-tRNA ligase; stationary phase enriched protein  -0.5211 0.000527 
orf19.3050 AGE1 






Putative peptidyl-prolyl cis-trans isomerase; macrophage/pseudohyphal-repressed; 




Putative pyridoxamine 5'-phosphate oxidase; early-stage biofilm- and planktonic 
growth-induced gene  
-0.5297 0.006077 
orf19.5844  
Ortholog(s) have role in meiotic DNA recombinase assembly, reciprocal meiotic 
recombination and condensed nuclear chromosome localization 
-0.5309 0.022685 
orf19.2289 ARP3 
Protein with Myo5p-dependent localization to cortical actin patches at hyphal tip; 
mutation confers hypersensitivity to cytochalasin D 
-0.5311 0.001073 
orf19.5871 SNF5 
SWI/SNF chromatin remodeling complex subunit involved in transcriptional regulation; 
mutants have defects in silicone adherence, biofilm formation, hyphal morphogenesis, 
cell wall defects; increased cell aggregation during yeast form growth  
-0.5408 0.001928 
orf19.2573 FRS1 
Phenylalanyl-tRNA synthetase; possible role in early cell wall biosynthesis; 
downregulated by phagocytosis by macrophages; possibly essential gene, disruptants not 
obtained by UAU1 method; protein present in exponential and stationary phase  
-0.5409 0.002139 
orf19.3919  Early-stage biofilm-induced gene  -0.5415 0.005751 
orf19.7232 IRR1 Putative cohesin complex subunit; cell-cycle regulated periodic mRNA expression  -0.5423 0.004511 
orf19.3268 TMA19 Cell wall protein, ortholog of S. cerevisiae Tma19p (Ykl065cp)  -0.5432 1.33E-05 
orf19.1652 POx1-3 Predicted acyl-CoA oxidase; farnesol regulated; stationary phase enriched protein  -0.5443 0.003325 
orf19.5776 TOM1 Putative E3 ubiquitin ligase; transcription is regulated by Nrg1p and Mig1p  -0.5479 0.001585 
orf19.6628  
Ortholog of C. parapsilosis CDC317 : CPAR2_206070, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_100837, Debaryomyces hansenii CBS767 : DEHA2E20262g and 




orf19.1952  Protein not essential for viability; merged with orf19.1953 in Assembly 21  -0.5564 0.004271 
orf19.3803 MNN22 
Putative Golgi alpha-1,2-mannosyltransferase; regulated by Tsa1p, Tsa1Bp in minimal 
media at 37 deg; Hog1p-induced; induced by nitric oxide; downregulated in core stress 
response; planktonic growth-induced gene  
-0.5615 8.41E-05 
orf19.5641 CAR2 
Ornithine aminotransferase; role in arginine metabolism; alkaline upregulated; mutation 
confers hypersensitivity to toxic ergosterol analog and to amphotericin B; present in 
exponential and stationary phase yeast cultures; biofilm-induced  
-0.565 0.00015 
orf19.2151 NAG6 
Protein required for wild-type mouse virulence and wild-type cycloheximide resistance; 
putative GTP-binding motif; similar to S. cerevisiae Yor165Wp; in gene cluster that 
encodes enzymes of GlcNAc catabolism; no human or murine homolog  
-0.5665 0.000408 
orf19.151 TPO5 
Putative polyamine transporter; mutation confers hypersensitivity to toxic ergosterol 
analog; hyphal induced; macrophage induced  
-0.567 0.005276 
orf19.4831 MTS1 
Sphingolipid C9-methyltransferase, catalyzes methylation of the 9th carbon in the long 
chain base component of glucosylceramides; glucosylceramide biosynthesis is important 
for virulence  
-0.5691 0.003156 
orf19.109  Probable mitochondrial tyrosyl-tRNA synthetase, based on conservation in other fungi  -0.5701 0.018821 
orf19.240 PAM17 
Predicted component of the presequence translocase-associated import motor (PAM 
complex) involved in protein import into mitochondrial matrix 
-0.5702 6.63E-05 
orf19.5897  
Ortholog(s) have Seh1-associated complex, cytosol, extrinsic to fungal-type vacuolar 
membrane localization  
-0.5758 0.000347 
orf19.4211 FET3 
Multicopper oxidase; required for growth in low iron, for prostaglandin E2 production; 
ketoconazole, caspofungin, amphotericin B repressed; regulated by Sef1p, Sfu1p, and 
Hap43p; reports differ if functional homolog of S. cerevisiae Fet3  
-0.5759 0.006034 
orf19.6170  
Ortholog(s) have microtubule binding, protein heterodimerization activity, protein 
homodimerization activity  
-0.577 0.006115 
orf19.3573 PEx6 
Ortholog(s) have ATPase activity, protein heterodimerization activity, role in protein 
import into peroxisome matrix, receptor recycling, replicative cell aging and cytosol, 





Putative nicotinamidase, involved in NAD salvage pathway; decreased transcription is 
observed in an azole-resistant strain that overexpresses MDR1  
-0.5793 0.002564 
orf19.967  
Ortholog(s) have endodeoxyribonuclease activity, exodeoxyribonuclease activity, 
ribonuclease activity and role in DNA catabolic process, DNA recombination, RNA 
catabolic process, apoptotic process, cellular response to nitrogen starvation  
-0.5816 1.70E-05 
orf19.6967 USO6 Putative vesicular transport protein; transcription is induced upon filamentous growth  -0.5844 6.17E-06 
orf19.5858 EGD2 
Putative nascent polypeptide associated complex protein alpha subunit; soluble protein 
in hyphae; macrophage/pseudohyphal-induced; protein level decrease in stationary 
phase cultures; GlcNAc-induced protein  
-0.5846 0.000842 
orf19.1007  Putative transcription factor with bZIP DNA-binding motif  -0.5851 0.002275 
orf19.7506  
Ortholog(s) have ATPase activity, DNA binding, nucleosome binding activity, role in 
chromatin remodeling and ISW1 complex localization  
-0.5897 0.000773 
orf19.5076 PFY1 
Profilin, functional homolog of S. cerevisiae Pfy1p; hyphal-induced; 
macrophage/pseudohyphal-induced; regulated by Nrg1p, Tup1p; gene lacks intron 




Putative adhesin-like protein involved in cell wall maintenance, redundant with Sun41p; 
possibly secreted; macrophage-downregulated gene; transcription is negatively 
regulated by Rim101p, Cyr1p, Ras1p  
-0.5913 0.001765 
orf19.1637  Ortholog(s) have cytosol, nucleus localization  -0.5915 1.30E-06 
orf19.586 ERV46 
Putative ER-derived vesicle protein, COPII-coated vesicle complex subunit; 
transcription is induced upon filamentous growth  
-0.592 0.006967 
orf19.3169  
Ortholog(s) have role in establishment of mitotic sister chromatid cohesion and cytosol, 
nucleus localization  
-0.5937 0.004061 
orf19.7312 ERG13 
3-hydroxy-3-methylglutaryl coenzyme A synthase; ergosterol biosynthesis protein; 
sumoylation target; transposon mutation affects filamentous growth; amphotericin B, 





Putative porphobilinogen synthase; transcriptionally regulated by iron; expression 
greater in high iron; protein level decrease in stationary phase cultures  
-0.5947 0.001364 
orf19.1843 ALG6 
Putative glucosyltransferase involved in cell wall mannan biosynthesis; transcription is 
elevated in chk1, nik1, and sln1 homozygous null mutants; repressed by nitric oxide; 
possibly essential gene, disruptants not obtained by UAU1 method  
-0.5975 0.003575 
orf19.589 VPS21 
Late endosomal Rab small monomeric GTPase involved in transport of endocytosed 
proteins to the vacuole; involved in filamentous growth and virulence  
-0.5977 6.84E-05 
orf19.287  
Putative NADH-ubiquinone oxidoreductase subunit; Hap43p-repressed gene; repressed 




Ortholog(s) have D-arabinose 1-dehydrogenase [NAD(P)+] activity and role in dehydro-
D-arabinono-1,4-lactone biosynthetic process  
-0.6016 0.002818 
orf19.5689  
Ortholog(s) have role in ER to Golgi vesicle-mediated transport, late endosome to 
vacuole transport via multivesicular body sorting pathway, vesicle coating and COPI 
vesicle coat, endosome localization  
-0.6048 0.001849 
orf19.3681  




Protein similar to S. cerevisiae Nrg2p transcription factor, which regulates invasive 
growth in S. cerevisiae; transposon mutation affects filamentous growth  
-0.614 0.001106 
orf19.3294 MBF1 Putative transcriptional coactivator; caspofungin repressed  -0.6145 0.00025 
orf19.426  
Ortholog of C. parapsilosis CDC317 : CPAR2_107740, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_136277, Debaryomyces hansenii CBS767 : DEHA2A02266g and 
Candida dubliniensis CD36 : CD36_05120  
-0.6177 1.21E-05 
orf19.3702  Predicted ORF from Assembly 19; merged with orf19.6452 in Assembly 20 -0.6187 0.000348 
orf19.4901  Has domain(s) with predicted methyltransferase activity and role in metabolic process  -0.6275 0.004792 
121 
 
orf19.5996.1 RPS19A Putative ribosomal protein S19; protein level decreases in stationary phase cultures -0.6283 2.44E-05 
orf19.2426  Ortholog(s) have cytosol, nucleus localization  -0.629 0.005993 
orf19.4865  
Ortholog(s) have phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity, 
phosphatidylinositol-3-phosphatase activity, phosphatidylinositol-4-phosphate 
phosphatase activity and role in phosphatidylinositol dephosphorylation  
-0.6296 0.00581 
orf19.1999  
Predicted ORF in Assemblies 19, 20 and 21; transcription detected in high-resolution 
tiling array experiments  
-0.6314 0.001306 
orf19.7030 SSR1 
Beta-glucan associated ser/thr rich cell-wall protein with a role in cell wall structure; 
GPI anchor; similar mRNA abundance in yeast-form and germ tubes; detected at germ 
tube plasma membrane; repressed in cells treated with Congo Red 
-0.6342 0.001212 
orf19.3324 TIF 
Translation initiation factor; upregulated in highly virulent strain compared to less 
virulent strain; antigenic in human; flucytosine induced; translation-related genes are 
downregulated upon phagocytosis 
-0.6348 0.004267 
orf19.3399  
Ortholog(s) have histone binding activity, role in histone exchange and Swr1 complex, 
cytoplasm localization  
-0.6357 0.00363 
orf19.7114 CSA1 
Surface antigen on elongating hyphae and buds; no obvious hyphal defects in mutant; 
strain variation in repeat domain number; upregulated in filaments; alkaline upregulated 
by Rim101p; ciclopirox induced; Efg1p-, Cph1p, Hap43p-regulated  
-0.6368 0.000341 
orf19.1095  
Putative nuclear pore complex; possibly an essential gene, disruptants not obtained by 
UAU1 method  
-0.638 8.14E-05 
orf19.5806 ALD5 
NAD-aldehyde dehydrogenase; decreased expression in fluconazole-resistant isolate, or 
in hyphae; biofilm induced; fluconazole-downregulated; protein abundance is affected 
by URA3 expression in the CAI-4 strain; stationary phase enriched  
-0.6403 0.000146 
orf19.3735  
Predicted ORF in Assemblies 19, 20 and 21; transcription is induced in response to alpha 
pheromone in SpiderM medium 
-0.6416 0.002907 




Ortholog(s) have RNA polymerase II core binding, RNA polymerase II transcription 
factor binding transcription factor activity, triplex DNA binding activity  
-0.646 0.005788 
orf19.3466  
Predicted ORF in Assemblies 19, 20 and 21; decreased transcription is observed upon 
fluphenazine treatment or in an azole-resistant strain that overexpresses CDR1 and 
CDR2  
-0.6511 0.000912 
orf19.6293 EMP24 COPII-coated vesicle component  -0.6518 0.005227 
orf19.2016  
Ortholog(s) have protein binding, bridging activity, role in ergosterol biosynthetic 
process and endoplasmic reticulum membrane localization  
-0.6555 0.002855 
orf19.2077 ZCF9 
Putative transcription factor with zinc cluster DNA-binding motif; hypersensitive to 
toxic ergosterol analog ECC69 and/or ECC1384  
-0.6562 0.001278 
orf19.2974 YKT6 Putative protein of the vacuolar SNARE complex with a predicted role in vacuolar fusion  -0.657 4.00E-05 
orf19.6057  
Ortholog(s) have 3-methyl-2-oxobutanoate hydroxymethyltransferase activity, role in 
pantothenate biosynthetic process and mitochondrion localization  
-0.6616 0.000548 
orf19.412 SSH1 Protein with a role in protein translocation across membranes  -0.6618 0.000121 
orf19.6376 PTC5 
Mitochondrial protein phosphatase of the Type 2C-related family (serine/threonine-
specific), involved in drug response and cadmium tolerance  
-0.6649 0.004598 
orf19.2618 MET2 
Homoserine acetyltransferase; Hap43p-, Gcn4p-regulated; macrophage/pseudohyphal-
repressed; not highly biofilm induced, in contrast to many sulfur amino acid metabolic 
genes; no human or murine homolog; virulence-group-correlated expression 
-0.6649 0.00604 
orf19.6046 APC1 
Putative Anaphase-Promoting Complex/Cyclosome subunit; essential for growth; 
periodic mRNA expression, peak at cell-cycle S/G2 phase  
-0.6678 0.000172 
orf19.458  
Ortholog(s) have protein transmembrane transporter activity and role in chaperone-
mediated protein complex assembly, mitochondrial respiratory chain complex III 




orf19.6526  Ortholog(s) have COPI-coated vesicle, Golgi apparatus localization  1.44028 0.000496 
orf19.3057  
Ortholog(s) have role in mitochondrial genome maintenance and endoplasmic reticulum 
localization  
1.50105 0.000368 
orf19.2315  Putative transcription factor with bZIP DNA-binding motif  1.50168 0.000859 
orf19.2895 VMA8 
Protein similar to the S. cerevisiae Vma8p subunit of vacuolar H+-ATPase; transcription 
is regulated by Nrg1p and Mig1p; transcription is increased in populations of cells 
exposed to fluconazole over multiple generations  
1.50247 1.70E-05 
orf19.1681  
Ortholog of C. parapsilosis CDC317 : CPAR2_503590, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_115755, Debaryomyces hansenii CBS767 : DEHA2D15334g and 
Candida dubliniensis CD36 : CD36_81530  
1.50447 0.000112 
orf19.6893  Ortholog(s) have role in ER to Golgi vesicle-mediated transport  1.50707 0.007554 
orf19.2733  
Putative subunit of phosphatidylinositol 3-kinase complexes I and II; transcription is 
activated in the presence of elevated CO2  
1.50794 0.003168 
orf19.5177  Ortholog of Candida albicans WO-1 : CAWG_05627  1.50832 0.00152 
orf19.1764  
Ortholog of C. parapsilosis CDC317 : CPAR2_407390, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_95056, Debaryomyces hansenii CBS767 : DEHA2F09504g and 
Candida dubliniensis CD36 : CD36_24220  
1.50936 0.00733 
orf19.3736 KAR4 
Protein similar to S. cerevisiae Kar4p, which has a role in karyogamy; transcription is 
opaque-specific, a-specific, and induced by alpha factor 
1.51383 0.000878 
orf19.138 FIG1 
Probable ortholog of S. cerevisiae Fig1p, which is an integral membrane protein required 
for mating; role in thigmotropism; transcription is opaque-specific, a-specific, and 
activated by Cph1p or alpha pheromone  
1.51396 0.004938 
orf19.2915  
Ortholog(s) have nucleoside-diphosphatase activity, nucleoside-triphosphatase activity, 
nucleoside-triphosphate diphosphatase activity, role in protein mannosylation and 




orf19.335  Sef1p-, Sfu1p-, and Hap43p-regulated gene ( 1.51486 0.001752 
orf19.3955 MES1 
Cytoplasmic methionyl-tRNA synthetase; zinc-binding motif; ribosomal subunits, 
translation factors, tRNA synthetases are downregulated upon phagocytosis by murine 
macrophage; protein present in exponential and stationary phase yeast  
1.51587 0.000741 
orf19.5666  Ortholog(s) have transcription coactivator activity  1.51773 4.23E-05 
orf19.5440 RPT2 
Putative ATPase of the 19S regulatory particle of the 26S proteasome; oxidative stress-
induced via Cap1p  
1.51859 0.002285 
orf19.5727  
Ortholog of C. parapsilosis CDC317 : CPAR2_601230, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_115908, Debaryomyces hansenii CBS767 : DEHA2E12540g and 
Candida dubliniensis CD36 : CD36_64130  
1.51926 0.000926 
orf19.5855 MBP1 
Putative component of the MBF transcription complex involved in G1/S cell-cycle 
progression; non-periodic mRNA expression; predicted, conserved MBF binding sites 
upstream of G1/S-regulated genes  
1.52234 0.003568 
orf19.5680  
Predicted ORF in Assemblies 19, 20 and 21; possibly an essential gene, disruptants not 
obtained by UAU1 method  
1.52412 0.000413 
orf19.4620 TIM12 
Predicted component of the TIM22 complex, involved in protein import into 
mitochondrial inner membrane  
1.52486 0.000587 
orf19.6667  Ortholog(s) have histone deacetylase activity  1.52525 0.005099 
orf19.2742  
Ortholog of C. parapsilosis CDC317 : CPAR2_400095, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_113280, Lodderomyces elongisporus NRLL YB-4239 : 
LELG_04166 and Candida dubliniensis CD36 : CD36_42560  
1.52787 0.000979 
orf19.729 SHE3 
Protein similar to S. cerevisiae She3p, an adaptor protein required for specific mRNA 
transport; transposon mutation affects filamentous growth  
1.52861 0.004997 
orf19.6875 VPS35 





orf19.5029 MODF Ortholog(s) have mitochondrion localization  1.53592 0.007607 
orf19.261  
Ortholog(s) have dolichol kinase activity, role in protein glycosylation and endoplasmic 
reticulum membrane localization  
1.53785 0.002624 
orf19.4225 LEU3 
Zinc-finger protein; putative role in regulating branched-chain amino acid biosynthesis 
genes; alkaline upregulated; transcriptionally activated by Mnl1p under weak acid stress; 
required for yeast cell adherence to silicone substrate  
1.53798 4.22E-05 
orf19.981  Predicted ORF from Assembly 19; merged with orf19.4911 in Assembly 20 1.53883 0.000796 
orf19.542.2 MIM1 Predicted mitochondrial protein involved in outer membrane protein import  1.54033 6.27E-06 
orf19.1606  Predicted ORF in Assemblies 19, 20 and 21; Plc1p-regulated  1.54041 0.004848 
orf19.5850 NOC2 
Putative nucleolar complex protein; Hap43p-induced gene; transposon mutation affects 
filamentous growth; mutation confers hypersensitivity to 5-fluorouracil (5-FU), 
tubercidin (7-deazaadenosine); downregulated during core stress response  
1.5405 0.002972 
orf19.5901 PKC1 
Protein kinase C; functional homolog of S. cerevisiae Pkc1p; mutant has abnormal yeast-
form cell morphology and increased cell lysis; activated by phosphatidylserine; target of 
antifungal, cercosporamide; R400P mutant is activated  
1.5435 0.000354 
orf19.5035  Ortholog(s) have DNA binding, nucleosome binding activity  1.54561 0.006531 
orf19.4163  
Ortholog(s) have role in protein targeting to vacuole, receptor-mediated endocytosis, 
response to pheromone and actin cortical patch, cytosol, endosome, plasma membrane, 
ribosome localization  
1.54701 4.40E-05 
orf19.5572  
Ortholog of C. parapsilosis CDC317 : CPAR2_600660, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_104804, Debaryomyces hansenii CBS767 : DEHA2C11902g and 
Candida dubliniensis CD36 : CD36_63110  
1.54994 6.87E-06 
orf19.4057  






Putative serine/threonine protein kinase; possibly an essential gene, disruptants not 
obtained by UAU1 method  
1.55229 0.001229 
orf19.3956  
Ortholog(s) have glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity and role 




Putative nuclear pore-associated protein; Hap43p-induced gene; induced upon low-level 
peroxide stress; possibly an essential gene, disruptants not obtained by UAU1 method  
1.55472 0.004273 
orf19.1464 BMT5 
Putative beta-mannosyltransferase involved in beta-1,2-mannosylation of 
phospholipomannan; member of a 9-member family that includes Bmt1p, Bmt2p, 
Bmt3p, and Bmt4p with roles in mannosylation of cell wall phosphopeptidomannan  
1.55577 3.09E-05 
orf19.5605  
Ortholog(s) have protein binding, bridging, ubiquitin protein ligase binding activity and 




Putative enzyme of arginine biosynthesis; transcription of genes of arginine biosynthesis 
pathway, except for ARG2, is induced upon phagocytosis by macrophage 
1.56069 0.000303 
orf19.4874 MNN3 
Predicted Golgi alpha-1,2-mannosyltransferase; mutation confers hypersensitivity to 
toxic ergosterol analog, and to amphotericin B; late-stage biofilm-induced gene  
1.56173 0.000242 
orf19.1185  
Ortholog(s) have ubiquitin-protein ligase activity and role in establishment of mitotic 
spindle orientation, mitotic cell cycle spindle assembly checkpoint, protein 
autoubiquitination, septin ring assembly  
1.56256 0.000496 
orf19.2799 GPI8 
Protein similar to S. cerevisiae Gpi8p, which is a subunit of the GPI transamidase 
complex that adds GPI anchors to proteins; likely to be essential for growth, based on an 
insertional mutagenesis strategy  
1.56441 1.68E-05 
orf19.621  Predicted ORF from Assembly 19; removed from Assembly 20 1.56683 0.004212 
orf19.1750 SLR1 
Protein similar to mammalian SR-like RNA splicing factor, involved in filamentous 
growth and virulence; gene has intron  
1.56914 0.000409 
orf19.2190 VRP1 
Verprolin-related protein involved in actin cytoskeleton organization and polarized 






Transcriptional regulator of iron-responsive genes; represses iron utilization genes if iron 
is present; Hap43p-repressed; promotes gastrointestinal commensalism in mice 
1.57436 0.000222 
orf19.6780 MET8 
Putative bifunctional dehydrogenase and ferrochelatase with a predicted role in siroheme 
biosynthesis; regulated by Gcn2p and Gcn4p  
1.57838 0.00596 
orf19.3237  Ortholog(s) have cytosol, mitochondrion, nucleus localization  1.57992 0.00023 
orf19.157  Predicted ORF from Assembly 19; merged with orf19.156 in Assembly 20 1.58138 0.000214 
orf19.2400  
Ortholog(s) have role in mRNA splicing, via spliceosome, maturation of SSU-rRNA, 
positive regulation of ATPase activity, positive regulation of helicase activity  
1.5832 0.000299 
orf19.6991 PRE3 
Putative beta-1 proteasome subunit; macrophage-induced protein; regulated by Gcn2p 
and Gcn4p; GlcNAc-induced protein  
1.58413 4.62E-05 
orf19.4812  
Ortholog(s) have holo-[acyl-carrier-protein] synthase activity, role in protein-cofactor 
linkage and mitochondrion localization  
1.58671 0.004891 
orf19.2507 ARP9 
Protein similar to S. cerevisiae Arp3p, a component of the Arp2/3 complex involved in 
actin-dependent processes; likely to be essential for growth, based on an insertional 
mutagenesis strategy  
1.58798 0.000255 
orf19.6639  Hap43p-repressed gene  1.58988 0.002243 
orf19.882 HSP78 
Putative heat-shock protein; transcriptionally regulated by macrophage response; 
transcription is regulated by Nrg1p, Mig1p, Gcn2p, Gcn4p, Mnl1p; heavy metal 
(cadmium) stress-induced; stationary phase enriched protein  
1.60091 0.002241 
orf19.3445 HOC1 
Protein with similarity to mannosyltransferases; similar to S. cerevisiae Hoc1p and C. 
albicans Och1p  
1.60092 0.000798 
orf19.6284  
Ortholog(s) have GTP binding, signal recognition particle binding activity, role in 




orf19.486 NIP100 p150 subunit of dynactin; required for normal spindle formation and position  1.60107 0.066069 
orf19.3768  Predicted ORF from Assembly 19; merged with orf19.736 in Assembly 20 1.60315 0.000321 
orf19.5777  Predicted ORF in Assemblies 19, 20 and 21; induced upon biofilm formation  1.60512 0.000126 
orf19.2269  
Putative 3-phosphoserine phosphatase; fungal-specific (no human or murine homolog); 
increased transcription observed upon benomyl treatment or in an azole-resistant strain 
that overexpresses MDR1; early-stage biofilm-induced  
1.60538 0.000917 
orf19.1848.1  
Ortholog of S. cerevisiae : KSH1, C. parapsilosis CDC317 : CPAR2_203260, Candida 




Dynamin-family GTPase-related protein; induced upon adherence to polystyrene; 
regulated by Gcn2p and Gcn4p  
1.60762 0.000972 
orf19.609  Predicted ORF in Assemblies 19, 20 and 21; transcription is specific to white cell type  1.60874 0.001478 
orf19.5841  
Ortholog of C. parapsilosis CDC317 : CPAR2_212340, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_101113, Debaryomyces hansenii CBS767 : DEHA2G03784g and 
Candida dubliniensis CD36 : CD36_17700  
1.61256 0.004665 
orf19.2637  Ortholog(s) have Golgi apparatus, fungal-type vacuole membrane localization  1.61418 0.001504 
orf19.1531  
Ortholog(s) have RNA binding, protein heterodimerization activity, role in mRNA 




Ortholog(s) have phosphatidylinositol-3-phosphate binding, ubiquitin-protein ligase 
activity, role in protein ubiquitination and cytosol, fungal-type vacuole membrane, late 
endosome, nucleus localization  
1.61747 0.000746 
orf19.3884 FGR50 






Subunit of the RNA polymerase II mediator complex; transposon mutation affects 
filamentous growth; suppresses S. cerevisiae diploid filamentous (flo8, ste7, ste12, tec1) 
or haploid invasive (flo8) mutant growth defects  
1.61854 0.006181 
orf19.2972 PDE2 
Cyclic nucleotide phosphodiesterase, high affinity; role in moderating signaling via 
cAMP; required for wild-type virulence, hyphal growth, switching, and cell wall, but not 
for pseudohyphal growth; expressed shortly after hyphal induction  
1.61877 0.007419 
orf19.7089 PMR1 
Putative secretory pathway P-type Ca2+/Mn2+-ATPase; required for protein 
glycosylation and cell wall maintenance; required for hyphal tip oscillation in semisolid 
substrate; putative ortholog of S. cerevisiae PMR1  
1.62062 0.000229 
orf19.6712  Ortholog(s) have COPI-coated vesicle, Golgi apparatus localization  1.62069 0.002819 
orf19.1465  Has domain(s) with predicted N-acetyltransferase activity and role in metabolic process 1.62133 0.002837 
orf19.6416  
Ortholog(s) have role in cellular response to oxidative stress, protein N-linked 
glycosylation and endoplasmic reticulum membrane localization 
1.62545 0.000133 
orf19.1636 STE50 
Protein with sterile alpha motif (SAM) and Ras-associated domain (RAD); similar to S. 
cerevisiae Rad50p, which is involved in signal transduction via interaction with and 
regulation of MAPKKK  
1.62671 7.35E-05 
orf19.5213.2 COx9 Putative subunit VIIa of cytochrome c oxidase; flucytosine induced  1.62889 5.66E-05 
orf19.6338  Ortholog of Candida albicans WO-1 : CAWG_05352  1.63025 0.001952 
orf19.1604  Protein with a Gal4p-like DNA-binding domain  1.63027 0.003226 
orf19.4134  Ortholog(s) have plasma membrane localization  1.63047 0.003651 
orf19.6706 GYP7 






Ortholog of S. cerevisiae : YML002W, C. glabrata CBS138 : CAGL0L07634g, C. 




Putative alanine glyoxylate aminotransferase; regulated by Gcn4p and hemoglobin; 
stationary phase enriched protein  
1.63503 0.001018 
orf19.3132  Predicted ORF in Assemblies 19, 20 and 21; induced by nitric oxide  1.64053 0.002169 
orf19.7317 UGA33 
Zinc-finger transcription factor; similar to S. cerevisiae Uga3p which regulates gamma-




Putative MRP/CFTR-subfamily ABC transporter; member of multidrug resistance-
associated protein (MRP) subfamily of ABC family; similar to S. cerevisiae Bpt1p  
1.64313 0.002555 
orf19.4172  Has domain(s) with predicted hydrolase activity and role in metabolic process  1.6436 0.005859 
orf19.1821  
Predicted ORF in Assemblies 19, 20 and 21; transcription is repressed in response to 
alpha pheromone in SpiderM medium  
1.64455 0.006538 
orf19.1360  








Putative GTPase activating protein (GAP) for RHO1; downregulated upon adherence to 
polystyrene; macrophage/pseudohyphal-repressed; transcription is upregulated in RHE 
model of oral candidiasis and in clinical oral candidiasis  
1.65229 0.000561 
orf19.7581  
Ortholog(s) have role in spliceosomal complex assembly and U2 snRNP, U2-type 
prespliceosome localization  
1.65292 0.001354 




G-protein alpha subunit; regulates filamentous growth, copper resistance; involved in 
cAMP-mediated glucose signaling; reports differ on role in cAMP-PKA pathway, MAP 
kinase cascade; Gpr1p C terminus binds Gpa2p; regulates HWP1 and ECE1  
1.65676 0.001159 
orf19.4757 NAR1 
Putative cytosolic iron-sulfur (FeS) protein assembly machinery protein; induced by 
nitric oxide; oxidative stress-induced via Cap1p  
1.6579 0.002459 
orf19.3767  
Ortholog(s) have signal sequence binding activity, role in protein targeting to vacuole 
and Golgi apparatus localization  
1.65844 0.006934 
orf19.7244  
Putative fumarylacetoacetate hydrolase; biofilm-induced gene; induced by nitric oxide 
independent of Yhb1p; regulated by Sef1p-, Sfu1p-, and Hap43p  
1.66561 0.000406 
orf19.28  Putative thiamine transmembrane transporter; biofilm-induced 1.66691 0.084545 
orf19.5614  
Putative ribonuclease H1; biofilm-induced gene; possibly an essential gene, disruptants 
not obtained by UAU1 method  
1.66792 0.000325 
orf19.2896 SOU1 
Enzyme involved in utilization of L-sorbose; has sorbitol dehydrogenase, fructose 
reductase, and sorbose reductase activities; NAD-binding site motif; transcriptional 
regulation affected by chromosome 5 copy number; Hap43p-induced gene  
1.66812 3.87E-06 
orf19.4294  
Ortholog(s) have oxidoreductase activity, role in cytochrome c-heme linkage, 




Putative phosphoadenosine-5'-phosphate (PAP) or 3'-phosphoadenosine 5'-
phosphosulfate (PAPS) phosphatase; possible role in sulfur recycling; induced upon 
biofilm formation; Hap43p-repressed gene  
1.67035 0.001214 
orf19.6464  
Predicted ORF in Assemblies 19, 20 and 21; induced upon adherence to polystyrene; 
oxidative stress-induced via Cap1p 
1.67258 0.004459 
orf19.5174 TAF19 Putative TFIID subunit; mutation confers hypersensitivity to amphotericin B 1.67349 0.004794 
orf19.6606  
Ortholog of C. parapsilosis CDC317 : CPAR2_201040, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_112677, Debaryomyces hansenii CBS767 : DEHA2E02420g and 





Ortholog(s) have mRNA binding activity, role in spliceosomal complex assembly and 
U2 snRNP, U2-type prespliceosome localization  
1.67498 0.003687 
orf19.7678 ATP16 
Subunit of the mitochondrial F1F0 ATP synthase; sumoylation target; protein newly 
produced during adaptation to the serum  
1.67542 0.002419 
orf19.4567  Catechol 1,2-dioxygenase (1,2-CTD), involved in degradation of aromatic compounds  1.67578 0.004963 
orf19.4761 HST1 Putative histone deacetylase, involved in regulation of white-opaque switching  1.67649 0.005219 
orf19.4307  
Ortholog(s) have role in late endosome to vacuole transport via multivesicular body 
sorting pathway, protein targeting to vacuole and late endosome localization  
1.68283 0.002341 
orf19.6525  
Predicted ORF in Assemblies 19, 20 and 21; transcriptionally activated by Mnl1p under 
weak acid stress  
1.68397 3.99E-05 
orf19.3674 GAL102 
UDP-glucose 4,6-dehydratase with role in mannosylation of cell wall proteins; mutation 
confers hypersensitivity to toxic ergosterol analog; overlaps orf19.3673  
1.68485 0.000151 
orf19.1294  Predicted ORF from Assembly 19; merged with orf19.2629 in Assembly 20 1.68994 0.001625 
orf19.1278  Predicted ORF from Assembly 19; merged with orf19.4403 in Assembly 20 1.69286 0.006664 
orf19.274 TFC4 
Putative RNA polymerase III transcription initiation factor complex (TFIIIC) subunit; 
transcriptionally activated by Mnl1p under weak acid stress; possibly an essential gene, 
disruptants not obtained by UAU1 method  
1.69701 0.000129 
orf19.7183  
Ortholog(s) have role in protein folding in endoplasmic reticulum and ER membrane 
protein complex localization 
1.70006 0.001198 
orf19.3340 SOD2 
Mitochondrial Mn-containing superoxide dismutase; protection against oxidative stress; 
homotetramer active; N-terminal 34 amino acids removed on mitochondrial import; 




orf19.5194.1  Putative protein of unknown function; clade-associated gene expression  1.70152 0.007156 
orf19.2180  
Ortholog(s) have calcium ion binding, zinc ion binding activity, role in axial cellular bud 
site selection, bipolar cellular bud site selection, regulation of COPII vesicle coating and 
cellular bud neck, cytosol, nucleus localization  
1.70406 0.001504 
orf19.6864  
Has domain(s) with predicted ubiquitin-protein ligase activity, role in protein 
ubiquitination and ubiquitin ligase complex localization  
1.70496 0.006062 
orf19.5302 PGA31 
Cell wall protein; putative GPI anchor; expression is regulated upon white-opaque 
switching; induced by Congo Red and by cell wall regeneration  
1.70521 0.001583 
orf19.337  
Ortholog(s) have SNAP receptor activity and role in Golgi to vacuole transport, intra-
Golgi vesicle-mediated transport, vacuole fusion, non-autophagic, vesicle fusion  
1.70564 0.001205 
orf19.1655.3  
Ortholog(s) have role in cation transport, regulation of membrane potential and plasma 
membrane localization  
1.7081 1.67E-05 
orf19.551  
Ortholog of C. parapsilosis CDC317 : CPAR2_204170, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_110235, Debaryomyces hansenii CBS767 : DEHA2F17072g and 
Candida dubliniensis CD36 : CD36_29980  
1.70971 0.001508 
orf19.2785 ATP7 
Putative subunit of the F1F0-ATPase complex; shows colony morphology-related gene 
regulation by Ssn6p; farnesol-, macrophage-downregulated protein abundance; protein 
present in exponential and stationary yeast growth phases; Hap43p-induced  
1.71654 0.001234 
orf19.7187 MAM33 
Putative mitochondrial acidic matrix protein; regulated by Ssn6p; protein present in 
exponential and stationary growth phase yeast cultures  
1.7198 0.005241 
orf19.804  Ortholog(s) have mitochondrion localization  1.72247 0.005723 
orf19.1659 ALG8 
Putative glucosyltransferase involved in cell wall mannan biosynthesis; transcription is 
elevated in nik1 and sln1 homozygous null mutants, but not in the chk1 null mutant; 
possibly an essential gene, disruptants not obtained by UAU1 method  
1.72364 0.000133 




Ortholog(s) have ubiquitin-protein ligase activity and role in anaphase-promoting 
complex-dependent proteasomal ubiquitin-dependent protein catabolic process, 
chromatin assembly, protein ubiquitination  
1.7248 0.003192 
orf19.7276.1 TLO4 
Member of a family of telomere-proximal genes of unknown function; transcription is 
upregulated in an RHE model of oral candidiasis; Hap43p-repressed gene  
1.72508 0.006475 
orf19.1856  Ortholog(s) have histone deacetylase activity  1.7254 0.001915 
orf19.6470 AHP2 Putative thiol-specific peroxiredoxin; macrophage-downregulated gene  1.72667 0.000839 
orf19.3806  
Ortholog(s) have role in negative regulation of gluconeogenesis, proteasomal ubiquitin-
dependent protein catabolic process, traversing start control point of mitotic cell cycle 
and GID complex, cytoplasm, nucleus localization  
1.72853 3.82E-06 
orf19.6964  Predicted ORF from Assembly 19; removed from Assembly 20 1.73214 0.005635 
orf19.3542 LEM3 
Putative membrane protein; early-stage biofilm-induced gene; mutation causes 
increased resistance to miltefosine  
1.73402 0.003359 
orf19.6662  
Putative coenzyme Q (ubiquinone) binding protein; transcription is upregulated in 
clinical isolates from HIV+ patients with oral candidiasis  
1.73426 0.000101 
orf19.2215 GLE1 Putative nucleoporin; moderately induced at 42 degrees C 1.7351 5.61E-05 
orf19.844 STE11 
Protein similar to S. cerevisiae Ste11p; mutants are sensitive to growth on H2O2 medium 
( 
1.7366 0.000293 
orf19.3544  Putative protein of unknown function; Hap43p-repressed gene  1.73697 0.000575 
orf19.639  
Predicted ORF in Assemblies 19, 20 and 21; decreased transcription is observed upon 






RecQ-related DNA helicase; Bloom's syndrome-related gene; haploinsufficient for wild-
type lifespan; upregulated in farnesol treated biofilm  
1.74815 0.00191 
orf19.2252  
Ortholog of C. parapsilosis CDC317 : CPAR2_406690, Lodderomyces elongisporus 
NRLL YB-4239 : LELG_02433, Candida dubliniensis CD36 : CD36_21270 and Pichia 
stipitis Pignal : PICST_33114  
1.75062 3.50E-06 
orf19.1756 GPD1 
Putative glycerol-3-phosphate dehydrogenase; role in glycerol biosynthesis; biofilm-




Ortholog of C. parapsilosis CDC317 : CPAR2_403360, Debaryomyces hansenii 
CBS767 : DEHA2D00814g, Candida dubliniensis CD36 : CD36_43140 and Pichia 
stipitis Pignal : PICST_32156 
1.75777 0.002545 
orf19.5213  
Putative protein of unknown function, transcription is upregulated in clinical isolates 
from HIV+ patients with oral candidiasis  
1.75852 0.003926 
orf19.7038  
Ortholog(s) have phosphatidylinositol-3-phosphate binding activity, role in protein 
targeting to vacuole and cytoplasm, nucleus localization  
1.76292 0.001813 
orf19.3453  Ortholog(s) have cytoplasm localization  1.76639 0.006791 
orf19.5311  
Ortholog of C. parapsilosis CDC317 : CPAR2_402060, Candida dubliniensis CD36 : 
CD36_43850, Pichia stipitis Pignal : PICST_68242 and Candida tropicalis MYA-3404 
: CTRG_00303  
1.76694 0.003797 
orf19.7444  Ortholog(s) have cytoplasm, holo TFIIH complex localization  1.77107 0.000377 
orf19.5503  
Putative protein of unknown function, transcription is upregulated in clinical isolates 
from HIV+ patients with oral candidiasis  
1.77822 0.002464 
orf19.1500  
Ortholog of C. parapsilosis CDC317 : CPAR2_210210, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_128446, Debaryomyces hansenii CBS767 : DEHA2B04092g and 
Candida dubliniensis CD36 : CD36_16720 
1.77859 0.006796 
orf19.4242 CST20 
Protein kinase of Ste20p/p65PAK family, required for wild-type mating efficiency and 
virulence in a mouse model; Cst20p-Hst7p-Cek1p-Cph1p MAPK pathway regulates 





Ortholog of C. parapsilosis CDC317 : CPAR2_808260, Candida dubliniensis CD36 : 
CD36_87460, Candida tropicalis MYA-3404 : CTRG_05596 and Candida albicans 
WO-1 : CAWG_03064  
1.78124 0.001574 
orf19.1159  
Protein similar to A. nidulans CYSA serine O-trans-acetylase, suggesting that C. 
albicans uses an O-acetyl-serine (OAS) pathway of sulfur assimilation; induced upon 
biofilm formation  
1.78245 0.001336 
orf19.4375.1 RPS30 
Putative 40S ribosomal protein S30; shows colony morphology-related gene regulation 
by Ssn6p  
1.78291 0.003283 
orf19.2191  
Ortholog(s) have role in endocytic recycling, peptidyl-diphthamide biosynthetic process 
from peptidyl-histidine and cytosol, endosome, nucleus localization  
1.78614 0.007039 
orf19.1035 WAR1 
Zinc cluster transcription factor; plays a role in resistance to weak organic acids; required 
for yeast cell adherence to silicone substrate  
1.78921 0.007313 
orf19.1975  
Ortholog(s) have role in mRNA splicing, via spliceosome, mitotic cell cycle G2/M 
transition checkpoint, regulation of mitotic metaphase/anaphase transition and U4/U6 x 
U5 tri-snRNP complex, U5 snRNP localization  
1.79069 0.000136 
orf19.4439.1  
Ortholog(s) have role in nucleotide-excision repair, phosphorylation of RNA polymerase 
II C-terminal domain, transcription from RNA polymerase II promoter and core TFIIH 
complex, cytosol, holo TFIIH complex localization  
1.79199 0.000151 
orf19.1083  Putative protein of unknown function; macrophage-induced gene 1.79299 2.60E-05 
orf19.2104  
Ortholog(s) have chaperone binding activity, role in aerobic respiration, iron-sulfur 
cluster assembly and mitochondrion localization  
1.79338 0.006465 
orf19.2166  Putative vacuolar H(+)-ATPase; plasma membrane localized  1.79441 0.001861 
orf19.876 PGA33 Putative GPI-anchored protein  1.79534 0.001525 
orf19.2758 PGA38 
Putative GPI-anchored protein; adhesin-like protein; repressed during cell wall 





Outwardly rectifying, noisily gated potassium channel; modulates sensitivity to human 
salivary histatin (Hst5); very similar to S. cerevisiae Tok1p  
1.80288 5.28E-05 
orf19.867  Ortholog(s) have ribosome localization 1.80635 0.000182 
orf19.3146  Predicted ORF from Assembly 19; merged with orf19.2227 in Assembly 20 1.8075 0.010086 
orf19.1548  
Ortholog(s) have role in mRNA splicing, via spliceosome and U4/U6 x U5 tri-snRNP 
complex localization  
1.80783 0.000246 
orf19.4626  
Ortholog(s) have role in TOR signaling cascade, positive regulation of transcription from 
RNA polymerase I promoter and cytosol, extrinsic to membrane, nucleus localization  
1.80901 0.005561 
orf19.3483  




Phosphatidylinositol-4-phosphate 5-kinase; activity induced by phosphatidic acid (Pld1p 
product); macrophage/pseudohyphal-repressed; mRNA binds to She3p and is localized 
to yeast cell buds and hyphal tips; Hap43p-induced gene  
1.81425 0.003362 
orf19.1417  
Ortholog of C. parapsilosis CDC317 : CPAR2_401720, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_102588, Debaryomyces hansenii CBS767 : DEHA2G16698g and 
Candida dubliniensis CD36 : CD36_43970  
1.81566 0.001323 
orf19.3290  Plasma membrane-localized protein; repressed by nitric oxide; Hap43p-repressed gene  1.816 1.81E-05 
orf19.3922  
Possible pyrimidine 5' nucleotidase; protein present in exponential and stationary growth 
phase yeast cultures; Hap43p-repressed gene 
1.81737 4.81E-05 
orf19.1911 PGA52 
GPI-anchored cell surface protein of unknown function; Hap43p-repressed gene; 




Ortholog(s) have role in mitochondrial genome maintenance, phospholipid transport, 
protein import into mitochondrial outer membrane and ERMES complex, integral to 





Putative UBx-domain (ubiquitin-regulatory domain) protein; macrophage-
downregulated gene  
1.83254 6.23E-05 
orf19.2612  
Putative zinc finger DNA-binding transcription factor; expression downregulated in an 
ssr1 null mutant; late-stage biofilm-induced gene  
1.83855 0.064755 
orf19.5751 ORM1 
Putative endoplasmic reticulum membrane protein; Hap43p-repressed gene; mutation 
confers hypersensitivity to aureobasidin A 
1.84394 0.001056 
orf19.7127.1  
Putative protein of unknown function, transcription is upregulated in an RHE model of 
oral candidiasis  
1.84424 2.13E-07 
orf19.3535  Ortholog(s) have cellular bud neck, fungal-type vacuole localization  1.84649 0.000258 
orf19.4250  
Ortholog of C. parapsilosis CDC317 : CPAR2_502480, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_115972, Debaryomyces hansenii CBS767 : DEHA2G19976g and 
Candida dubliniensis CD36 : CD36_52200  
1.84665 0.000359 
orf19.7044 RIM15 
Ortholog(s) have protein kinase activity, role in age-dependent response to oxidative 
stress involved in chronological cell aging, protein phosphorylation, regulation of 
meiosis and cytosol, nucleus localization  
1.85386 0.001158 
orf19.4590 RFx2 
Transcriptional repressor; regulator of filamentation, response to DNA damage, 
adhesion, virulence in murine mucosal, systemic infections; RFx domain; regulated by 
Nrg1p, UV-induced; partially complements S. cerevisiae rfx1 mutant defects  
1.86068 0.001299 
orf19.6308  Ortholog of Candida albicans WO-1 : CAWG_01818  1.86456 0.003177 
orf19.3135  
Ortholog(s) have protein binding, bridging activity and role in ER-associated protein 
catabolic process, lipid particle organization  
1.86604 0.000192 
orf19.7507  
Has domain(s) with predicted oxidoreductase activity, role in antibiotic biosynthetic 
process and cytoplasm localization  
1.86683 0.000115 




Aspartate aminotransferase; soluble protein in hyphae; macrophage-induced protein; 
alkaline upregulated; amphotericin B repressed; gene used for strain identification by 
multilocus sequence typing; farnesol-, Hap43p-induced; GlcNAc-induced  
1.87091 0.001238 
orf19.2988  Biofilm-induced gene 1.87247 0.003849 
orf19.3122.2  
Ortholog(s) have role in exocytosis, filamentous growth, mRNA export from nucleus, 
proteasomal ubiquitin-dependent protein catabolic process, proteasome assembly, 
regulation of cell cycle 
1.87584 0.000268 
orf19.1301  Ortholog(s) have cytoplasm, nucleus, ribosome localization  1.87813 0.005488 
orf19.4349.6  ORF Predicted by Annotation Working Group; removed from Assembly 20 1.88423 0.005192 
orf19.6625  
Ortholog(s) have acetyltransferase activator activity, histone binding activity and role in 
double-strand break repair via nonhomologous end joining, nucleosome assembly, 
positive regulation of histone acetylation  
1.88548 0.005798 
orf19.1861  Late-stage biofilm-induced  1.88587 5.39E-06 
orf19.642  
Ortholog of C. parapsilosis CDC317 : CPAR2_203380, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_117493, Debaryomyces hansenii CBS767 : DEHA2G19228g and 
Candida dubliniensis CD36 : CD36_30470  
1.88628 0.00058 
orf19.203 STB3 




Ortholog(s) have role in SCF-dependent proteasomal ubiquitin-dependent protein 
catabolic process, cellular response to methylmercury and SCF ubiquitin ligase complex, 
cytosol localization  
1.89233 0.003494 
orf19.2863.1 ERV1 
Predicted component of the mitochondrial intermembrane space (IMS), involved in 
protein import into mitochondrial intermembrane space  
1.89935 0.00128 
orf19.3421.1 MED19 RNA polymerase II mediator complex subunit  1.90558 0.00161 
140 
 
orf19.2061  Protein not essential for viability  1.90584 0.002252 
orf19.6889 MKK2 
Protein similar to S. cerevisiae Mkk2p, a MAP kinase kinase involved in signal 
transduction; macrophage-downregulated gene; mutant is hypersensitive to caspofungin; 
not essential for viability  
1.90672 1.93E-05 
orf19.2810 AAP1 
Putative amino acid permease; fungal-specific (no human or murine homolog); possibly 
an essential gene, disruptants not obtained by UAU1 method  
1.9082 0.006982 
orf19.212 VPS28 
ESCRT I protein sorting complex subunit involved in Rim8p processing and proteolytic 




Putative negative regulator of RNA polymerase III; decreased expression in hyphae 
compared to yeast-form cells; caspofungin repressed  
1.91531 0.000425 
orf19.6753  
Predicted ORF in Assemblies 19, 20 and 21; possibly an essential gene, disruptants not 
obtained by UAU1 method 
1.91737 0.000634 
orf19.6056  




Protein similar to S. cerevisiae Ymr171cp; transcriptionally regulated by iron; induced 
in a ssr1 null mutant; fungal-specific (no human or murine homolog) 
1.92133 0.000364 
orf19.5814  
Ortholog of C. parapsilosis CDC317 : CPAR2_303800, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_110078, Debaryomyces hansenii CBS767 : DEHA2E21362g and 
Candida dubliniensis CD36 : CD36_17470  
1.92845 0.000123 
orf19.7517 CHT1 
Chitinase; putative N-terminal catalytic domain; has secretory signal sequence; lacks 
S/T region and N-glycosylation motifs of Chs2p and Chs3p; alkaline downregulated; 
expression not detected in yeast-form or hyphal cells  
1.93029 6.69E-07 
orf19.1872  Plasma membrane protein; repressed by nitric oxide  1.9305 5.96E-05 
orf19.5021 PDx1 
Pyruvate dehydrogenase complex protein x, an essential component of the mitochondrial 
pyruvate dehydrogenase complex which is involved in the respiratory pathway; protein 





Ortholog(s) have role in mitochondrial genome maintenance, plasmid maintenance and 
cytosol, mitochondrion localization  
1.93805 0.00013 
orf19.2411  Ortholog(s) have SNAP receptor activity, role in transport and endosome localization  1.93891 0.000486 
orf19.4913  
Ortholog(s) have ubiquitin binding activity, role in cellular protein localization, positive 
regulation of ubiquitin-specific protease activity and cell cortex of cell tip, cell division 
site, cytosol localization  
1.94119 0.001751 
orf19.1107  Ortholog(s) have cytoplasm localization 1.94165 0.000191 
orf19.191 KIC1 
Member of the GCK-III subfamily of eukaryotic Ste20p kinases; in RAM cell wall 
integrity signaling network; role in cell separation, azole sensitivity; required for hyphal 
growth; constitutive expression is MTL, white-opaque independent  
1.94261 0.001239 
orf19.7112 FRP2 
Putative ferric reductase; alkaline upregulated by Rim101p; fluconazole-downregulated; 
upregulated in the presence of human neutrophils; possibly adherence-induced; 
regulated by Sef1p, Sfu1p, and Hap43p  
1.94288 0.005902 
orf19.2990 xOG1 
Exo-1,3-beta-glucanase; 5 glycosyl hydrolase family member; affects sensitivity to 
chitin and glucan synthesis inhibitors; not required for yeast-to-hyphal transition or for 
virulence in mouse systemic infection; Hap43p-induced gene  
1.95631 0.002205 
orf19.5178 ERG5 
Putative C-22 sterol desaturase; fungal C-22 sterol desaturases are cytochrome P450 
enzymes of ergosterol biosynthesis, catalyze formation of the C-22(23) double bond in 
the sterol side chain; transposon mutation affects filamentous growth  
1.95848 4.59E-05 
orf19.6583  
Predicted ORF in Assemblies 19, 20 and 21; transcription is induced in response to alpha 
pheromone in SpiderM medium  
1.95996 0.001209 
orf19.6013  Ortholog(s) have cytosol, nucleolus localization  1.96096 0.000708 
orf19.6636  
Ortholog of S. cerevisiae : YPR084W, C. glabrata CBS138 : CAGL0K07898g, C. 
parapsilosis CDC317 : CPAR2_702430, Candida tenuis NRRL Y-1498 : 
CANTEDRAFT_112957 and Candida dubliniensis CD36 : CD36_31160  
1.96849 0.005704 
orf19.4323  






Putative pre-ribosomal factor; decreased mRNA abundance observed in cyr1 
homozygous mutant hyphae; induced by heavy metal (cadmium) stress; Hog1p regulated  
1.97072 0.002568 
orf19.2842 GZF3 
Putative transcription factor; oxidative stress-induced via Cap1p; null mutant exhibits 
abnormal colony morphology and altered sensitivity to fluconazole, LiCl, and copper  
1.97753 0.000568 
orf19.3263 ATO10 Putative fungal-specific transmembrane protein  1.97952 0.000348 
orf19.2711.1 MED20 
Subunit of the RNA polymerase II mediator complex; involved in control of filamentous 
growth and biofilm formation  
1.98056 0.004164 
orf19.2245 YPT72 
Vacuolar Rab small monomeric GTPase involved in vacuolar biogenesis; involved in 
filamentous growth and virulence  
1.98525 0.000507 
orf19.1936 SNF1 
Essential protein; functional homolog of S. cerevisiae Snf1p regulator of sugar 
metabolism; constitutively expressed; Thr208 phosphorylation may have regulatory 
role; up-regulation associated with azole resistance; has polyhistidine tract  
1.98544 0.000296 
orf19.193  
Ortholog of C. parapsilosis CDC317 : CPAR2_209710, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_113479, Debaryomyces hansenii CBS767 : DEHA2C15114g and 
Candida dubliniensis CD36 : CD36_19310  
1.98701 0.032247 
orf19.4284 BUR2 
Protein with similarity to S. cerevisiae Bur2p, contains a cyclin domain; not required for 
wild-type hyphal growth, adherence to buccal epithelial cells, or virulence in mouse 
systemic infection  
1.99593 0.007553 
orf19.2378  
Ortholog(s) have role in vacuolar proton-transporting V-type ATPase complex assembly 
and integral to endoplasmic reticulum membrane localization  
1.99874 0.001054 
orf19.2393  Putative transcription factor with zinc finger DNA-binding motif  1.99916 0.000194 
orf19.4508  Ortholog of Candida albicans WO-1 : CAWG_04200  1.99933 0.000858 
orf19.3936  
Putative glycerophosphocholine phosphodiesterase; mutation confers hypersensitivity to 





Putative enzyme of lysine biosynthesis; soluble protein in hyphae; amphotericin B 
repressed; Gcn4p-regulated; shows colony morphology-related gene regulation by 
Ssn6p; protein present in exponential and stationary growth phase yeast cells  
2.00505 0.000461 
orf19.5474  
Predicted ORF in Assemblies 19, 20 and 21; transcriptionally activated by Mnl1p under 
weak acid stress; transcription detected in high-resolution tiling array experiments  
2.00778 0.003833 
orf19.2026  
Ortholog of S. cerevisiae UBP13, a putative ubiquitin carboxyl-terminal hydrolase; late-
stage biofilm-induced gene  
2.01061 0.000651 
orf19.6132  
Ortholog of C. parapsilosis CDC317 : CPAR2_701740, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_93887, Debaryomyces hansenii CBS767 : DEHA2E04554g and 
Candida dubliniensis CD36 : CD36_33000  
2.01378 0.001583 
orf19.852 SAP98 
Glycosyl-phosphatidylinositol-anchored aspartic endopeptidase; regulated by Gcn2p 
and Gcn4p; expressed only in opaque MTLa/MTLa cells  
2.02198 0.00071 
orf19.6313 MNT4 
Putative mannosyltransferase; transcriptionally regulated by iron; expression greater in 
low iron  
2.02487 1.38E-05 
orf19.3360  Hap43p-repressed gene; late-stage biofilm-induced  2.02492 8.58E-05 
orf19.1121  
Ortholog of Candida dubliniensis CD36 : CD36_53470, Spathaspora passalidarum 
NRRL Y-27907 : SPAPADRAFT_55715, Candida tropicalis MYA-3404 : 
CTRG_05538 and Candida albicans WO-1 : CAWG_04746  
2.02556 2.86E-06 
orf19.4006  Ortholog(s) have cytosol, nucleus localization  2.03708 3.02E-06 
orf19.6795  Ortholog(s) have enzyme activator activity 2.0421 0.002929 
orf19.3986 PPR1 
Putative transcription factor with zinc cluster DNA-binding motif; has similarity to S. 
cerevisiae Ppr1p, which is a transcription factor involved in the regulation of uracil 
biosynthesis genes  
2.05533 0.004412 




Plasma membrane pH-sensor involved in the Rim101p pH response pathway; required 
for processins and activation of Rim101p and for alkaline pH-induced hyphal growth  
2.05721 0.004479 
orf19.5906 ADE2 
Phosphoribosylaminoimadazole carboxylase; role in adenine biosynthesis; required for 
normal growth and virulence in immunosuppressed mouse infection; not induced in 
GCN response, in contrast to S. cerevisiae ADE2; stationary phase-enriched 
2.06508 0.001493 
orf19.2005 REG1 
Putative protein phosphatase regulatory subunit; Hap43p-repressed gene; 
macrophage/pseudohyphal-induced; possibly transcriptionally regulated upon hyphal 
formation; late-stage biofilm-induced  
2.0699 0.000173 
orf19.3711  Biofilm-induced gene  2.07743 2.11E-05 
orf19.6552  
Ortholog(s) have thiol oxidase activity, role in protein thiol-disulfide exchange and 
integral to endoplasmic reticulum membrane localization  
2.07882 1.47E-05 
orf19.1444  
Ortholog(s) have phosphatidylinositol-4,5-bisphosphate binding activity, role in actin 
cortical patch assembly, actin filament organization, endocytosis and actin cortical 
patch, mating projection tip localization  
2.08306 7.21E-05 
orf19.4292  
Ortholog(s) have SNAP receptor activity, role in Golgi to vacuole transport, vacuole 
inheritance and Golgi apparatus, endosome localization  
2.09533 2.93E-05 
orf19.194  
Ortholog of C. parapsilosis CDC317 : CPAR2_209720, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_114035, Debaryomyces hansenii CBS767 : DEHA2E10494g and 
Candida dubliniensis CD36 : CD36_19300  
2.09824 0.000175 
orf19.4033 PRP22 
Putative RNA-dependent ATPase; induced upon adherence to polystyrene; 
transcriptionally activated by Mnl1p under weak acid stress  
2.11775 0.004089 
orf19.6884 GWT1 
Inositol acyltransferase with role in early steps of GPI anchor biosynthetic process; 
antifungal drug target  
2.11867 0.00432 
orf19.3971  Early-stage biofilm-induced gene  2.13346 4.12E-05 
orf19.5467 TLO7 
Member of a family of telomere-proximal genes of unknown function; may be spliced 





Putative esterase; possibly transcriptionally regulated by Tac1p; transcriptionally 
activated by Mnl1p under weak acid stress; protein present in exponential and stationary 
growth phase yeast cultures  
2.14775 0.001232 
orf19.4950 AKR1 Ankyrin-repeat protein; increased transcription is observed upon fluphenazine treatment  2.15312 0.005519 
orf19.7492 SWC4 Subunit of the NuA4 histone acetyltransferase complex  2.15378 5.78E-06 
orf19.792  
Ortholog(s) have protein serine/threonine kinase activity, protein 
serine/threonine/tyrosine kinase activity  
2.15696 0.003323 
orf19.5620  
Stationary phase enriched protein; Gcn4p-regulated; induced by amino acid starvation 
(3-AT); increased transcription by benomyl treatment or in an azole-resistant strain that 
overexpresses MDR1; biofilm-induced; overlaps orf19.5621  
2.15701 0.005449 
orf19.618  Predicted ORF from Assembly 19; removed from Assembly 20 2.15864 0.001507 
orf19.979 FAS1 
Beta subunit of fatty-acid synthase; multifunctional enzyme; fluconazole-induced; 
Hap43p-induced; amphotericin B, caspofungin repressed; macrophage/pseudohyphal-
induced; fungal-specific (no human or murine homolog) 
2.1639 0.004702 
orf19.4492  
Ortholog(s) have role in nuclear division, rRNA processing and nuclear periphery, 
nucleolus, preribosome, large subunit precursor, spindle pole body localization  
2.16453 0.00705 
orf19.6811  
Ortholog(s) have iron ion binding activity, role in biotin biosynthetic process, iron-sulfur 
cluster assembly and mitochondrial intermembrane space localization  
2.18273 0.00905 
orf19.5094 BUL1 
Protein not essential for viability; macrophage/pseudohyphal-induced; similar to S. 
cerevisiae Bul1p, which may be involved in selection of substrates for ubiquitination  
2.18615 0.006736 
orf19.4199  
Ortholog(s) have role in ER to Golgi vesicle-mediated transport and endoplasmic 
reticulum localization  
2.20422 2.26E-06 
orf19.2317  
Predicted ORF in Assemblies 19, 20 and 21; transcription is induced in response to alpha 




orf19.5286 YCP4 Putative flavodoxin; fungal-specific (no human or murine homolog) 2.22434 0.003845 
orf19.1108 HAM1 
Putative deoxyribonucleoside triphosphate pyrophosphohydrolase; caspofungin 
repressed; regulated by Gcn2p and Gcn4p  
2.22927 0.003477 
orf19.1272  Ortholog(s) have role in regulation of cell size and cytoplasm, nucleus localization  2.23682 0.000938 
orf19.5170 ENA21 
Predicted ORF similar to S. cerevisiae sodium transporters Ena1p and Ena5p; Gcn4p-
regulated; flucytosine, amphotericin B, or ketoconazole-induced; osmotic stress-
induced; overlaps orf19.5170.1, which is annotated as a blocked reading frame  
2.25231 0.0012 
orf19.980  
Ortholog(s) have inositol heptakisphosphate kinase activity, inositol hexakisphosphate 
1-kinase activity, inositol hexakisphosphate 3-kinase activity, inositol hexakisphosphate 
4-kinase activity, inositol hexakisphosphate 6-kinase activity  
2.25443 0.000132 
orf19.4566  
Protein similar to S. cerevisiae Rot1p, which has roles in cytoskeletal dynamics and cell 
wall biosynthesis; predicted Kex2p substrate  
2.25657 0.002783 
orf19.3234.1 SFT1 Putative Golgi v-SNARE; Plc1p-regulated  2.25835 0.001316 
orf19.637 SDH2 
Succinate dehydrogenase, Fe-S subunit; localizes to surface of yeast cells, but not 
hyphae; transcriptionally regulated by iron; expression greater in high iron; repressed by 
nitric oxide, Hap43p; induced during log phase aerobic growth  
2.26059 0.000639 
orf19.7500 PxA1 
Putative peroxisomal, half-size adrenoleukodystrophy protein (ALD or ALDp) 
subfamily ABC family transporter  
2.27978 0.002357 
orf19.117  
Ortholog(s) have SNAP receptor activity, role in vesicle fusion and SNARE complex, 
extrinsic to plasma membrane localization  
2.28877 0.000233 
orf19.5022  
Ortholog(s) have inorganic cation transmembrane transporter activity and role in cellular 
cobalt ion homeostasis, cellular manganese ion homeostasis, cobalt ion transport, 
manganese ion transport  
2.28914 2.85E-09 
orf19.6246  
Ortholog(s) have peptide alpha-N-acetyltransferase activity, role in N-terminal peptidyl-
methionine acetylation, cytoskeleton organization, mitochondrion inheritance and NatB 





Putative permease; amphotericin B induced; flucytosine repressed; possibly an essential 
gene, disruptants not obtained by UAU1 method  
2.29589 0.005741 
orf19.4653  
Transcriptionally regulated by iron; expression greater in low iron; similar to GPI-linked 
cell-wall proteins  
2.30628 0.001428 
orf19.2111.2 RPL38 
60S ribosomal ribosomal protein subunit; genes encoding cytoplasmic ribosomal 
subunits, translation factors, tRNA synthetases are downregulated upon phagocytosis by 
murine macrophage 
2.30822 0.001791 
orf19.6316.4  Putative nuclear protein; Hap43p-induced gene; ortholog of S. cerevisiae YLR363W-A 2.31031 0.005076 
orf19.4445  
Protein of unknown function; Plc1p-regulated; expression is upregulated early upon 
infection of reconstituted human epithelium (RHE), while expression of the C. 
dubliniensis ortholog is not upregulated; not required for viability  
2.31048 7.55E-05 
orf19.5639 HIS4 
Multifunctional enzyme that catalyzes three steps of histidine biosynthesis, with 
phosphoribosyl-AMP cyclohydrolase, phosphoribosyl-ATP diphosphatase, and 
histidinol dehydrogenase activities; required for wild-type adhesion to human calls  
2.33559 9.84E-05 
orf19.7255 RPC10 
Putative RNA polymerase subunit ABC10-alpha of RNA polymerase complexes I, II, 
and III; flucytosine induced  
2.34217 8.80E-06 
orf19.6544 LPI9 
Ortholog(s) have protein phosphatase 1 binding, protein phosphatase type 1 regulator 




Ortholog of C. parapsilosis CDC317 : CPAR2_205340, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_133521, Debaryomyces hansenii CBS767 : DEHA2E21868g and 
Candida dubliniensis CD36 : CD36_31170  
2.34981 0.006022 
orf19.7033  Putative dual specificity protein phosphatase, similar to S. cerevisiae Pps1p  2.36 no replicates 
orf19.1766  Secreted protein; fluconazole-induced  2.37457 0.006406 




Similar to oxysterol binding protein; non-sex gene located within the MTLa mating-
type-like locus; Plc1p-regulated  
2.37675 0.000438 
orf19.6881 YTH1 
Putative mRNA cleavage and polyadenylation specificity factor; transcription is 
regulated upon yeast-hyphal switch; decreased expression in hyphae compared to yeast-
form cells; fluconazole or flucytosine induced  
2.37867 0.005781 
orf19.1477  
Putative protein of unknown function; Hap43p-repressed gene; S. cerevisiae ortholog 
YGL010W localizes to the endoplasmic reticulum  
2.409 4.52E-07 
orf19.278  Protein required for adhesion to abiotic substrate; biofilm-induced  2.42431 0.005689 
orf19.1842 BUD5 Predicted GTP/GDP exchange factor for Rsr1p  2.43978 2.87E-06 
orf19.6802  
Ortholog(s) have palmitoyltransferase activity, role in protein palmitoylation, vacuole 
fusion, non-autophagic and Golgi apparatus, endoplasmic reticulum, fungal-type 
vacuole membrane localization  
2.44542 0.000484 
orf19.5519 GCV1 
Putative T subunit of glycine decarboxylase; transcription is negatively regulated by 
Sfu1p  
2.45233 0.000495 
orf19.6869  Ortholog(s) have role in protein targeting to membrane and cytoplasm localization  2.46 0.000543 
orf19.3742  
Predicted ORF in Assemblies 19, 20 and 21; expression regulated during planktonic 
growth; greater mRNA abundance observed in a cyr1 homozygous null mutant than in 
wild type  
2.46949 0.030241 
orf19.6782 BMT1 
Beta-mannosyltransferase, required for addition of the 1st beta-mannose residue to acid-
stable fraction of cell wall phosphopeptidomannan; 9-gene family member; mutants 
induce higher levels of inflammatory cytokines in mouse dendritic cells  
2.47604 0.001793 
orf19.2168.3  
Ortholog(s) have role in cellular protein localization, endoplasmic reticulum inheritance, 
endoplasmic reticulum tubular network organization and nuclear pore complex assembly 
2.47715 1.10E-05 
orf19.6455  
Putative protein of unknown function, transcription is upregulated in clinical isolates 




orf19.72  Predicted ORF from Assembly 19; merged with orf19.4720 in Assembly 20 2.49896 5.58E-05 
orf19.847 YIM1 
Protein similar to protease of mitochondrial inner membrane; increased transcription is 
observed upon benomyl treatment; macrophage-downregulated gene  
2.50751 0.00099 
orf19.6594 PLB3 
GPI-anchored cell surface phospholipase B; possibly secreted; fungal-specific (no 
mammalian homolog); transcription positively regulated by Tbf1p; possible essential 
gene (UAU1 method); late-stage biofilm-induced gene; fluconazole-induced  
2.51507 0.001805 
orf19.85 GPx2 
Similar to glutathione peroxidase; expression greater in high iron; alkaline upregulated 
by Rim101p; transcriptionally induced by alpha factor or interaction with macrophage; 
regulated by Efg1p; caspofungin repressed 
2.52121 0.000746 
orf19.1562  
Late-stage biofilm-induced gene; transcription is repressed in response to alpha 
pheromone in SpiderM medium  
2.53551 7.40E-05 
orf19.2050  
Ortholog(s) have sterol esterase activity, role in cellular lipid metabolic process, sterol 




Predicted membrane transporter; member of the proton coupled folate transporter/heme 
carrier protein (PCFT/HCP) family, major facilitator superfamily (MFS); virulence-
group-correlated expression  
2.55065 6.98E-06 
orf19.4720 CTR2 
Putative low-affinity copper transporter of the vacuolar membrane; late-stage biofilm-
induced gene; induced by nitric oxide; clade-associated gene expression  
2.55668 1.77E-05 
orf19.3826  Predicted ORF in Assemblies 19, 20 and 21; Plc1p-regulated  2.56852 0.000832 
orf19.4369  Protein not essential for viability  2.58834 0.00023 
orf19.2881 MNN4 
Regulator of mannosylphosphorylation of N-linked mannans to cell wall proteins; not 
required for virulence/kidney burden in mice or normal interaction with macrophages; 
mutants induce high levels of inflammatory cytokines in dendritic cells  
2.58953 0.004101 
orf19.7374 CTA4 
Zinc cluster transcription factor; involved in response to nitric oxide; induced by nitric 
oxide; transcriptionally activated by Mnl1p under weak acid stress; downregulated upon 





Putative protein of unknown function; transcription is positively regulated by Tbf1p; 
overlaps orf19.7015  
2.62791 0.001187 
orf19.3893 SCW11 
Cell wall protein; transcription decreased in mutant lacking ACE2; downregulated in 
core caspofungin response; expression greater in high iron; possibly an essential gene, 
disruptants not obtained by UAU1 method; planktonic growth-induced  
2.64787 0.002442 
orf19.4166 ZCF21 
Predicted Zn2-Cys6 zinc-finger protein; mutants display increased colonization of 
mouse kidneys  
2.66852 4.27E-06 
orf19.2607  
Ortholog of C. parapsilosis CDC317 : CPAR2_800670, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_112575, Debaryomyces hansenii CBS767 : DEHA2C16940g and 
Candida dubliniensis CD36 : CD36_26980  
2.67118 0.004909 
orf19.2474 PRC3 
Putative carboxypeptidase Y precursor; transcription is regulated by Nrg1p and Mig1p; 
regulated by Gcn2p and Gcn4p  
2.68186 7.41E-05 
orf19.1480  
Putative succinate dehydrogenase, enzyme of citric acid cycle; downregulated by Efg1p; 
repressed by nitric oxide; Hap43p-repressed gene  
2.68592 0.00111 
orf19.449  
Putative phosphatidyl synthase; stationary phase enriched protein; transcription reduced 
upon yeast-hyphal switch; Hap43p-repressed gene; biofilm-induced  
2.6864 0.000496 
orf19.7670  
Putative Ca2+/H+ antiporter; oral infection upregulated gene; mutants have reduced 
capacity to damage oral epithelial cells  
2.69841 0.001464 
orf19.3222  
Ortholog(s) have Golgi apparatus, endoplasmic reticulum, fungal-type vacuole 
membrane localization  
2.7068 0.001099 
orf19.697  Ortholog(s) have mitochondrial outer membrane localization  2.73118 0.001983 
orf19.3448  Predicted ORF in Assemblies 19, 20 and 21; ketoconazole-repressed  2.73598 0.00015 
orf19.2706 CRH11 
GPI-anchored cell wall transglycosylase, putative ortholog of S. cerevisiae Crh1p; 
predicted glycosyl hydrolase domain; similar to Csf4p and to antigenic A. fumigatus 





Putative transporter; slightly similar to the Sit1p siderophore transporter; Gcn4p-
regulated; fungal-specific (no human or murine homolog); transcriptionally activated by 
Mnl1p under weak acid stress  
2.75867 0.001205 
orf19.5848  
Late-stage biofilm-induced gene; oral infection upregulated gene; mutants have reduced 
capacity to damage oral epithelial cells  
2.75912 0.007263 
orf19.3568 RxT3 Putative transcriptional repressor  2.78897 2.69E-05 
orf19.1356  
Ortholog(s) have thiosulfate sulfurtransferase activity, role in tRNA wobble position 
uridine thiolation and mitochondrion localization  
2.80903 7.57E-05 
orf19.1509 ROD1 
Protein not essential for viability; similar to S. cerevisiae Rod1p, which is a membrane 
protein with a role in drug tolerance; repressed by Rgt1p 
2.82571 1.98E-06 
orf19.2748 ARG83 
Zinc-finger protein; clade-associated gene expression; null mutant shows abnormal 
regulation of invasive colony growth and is unable to utilize proline as a nitrogen source; 
late-stage biofilm-induced  
2.84648 0.00039 
orf19.5285 PST3 
Putative flavodoxin; biofilm induced; fungal-specific (no human or murine homolog); 
stationary phase enriched protein  
2.85231 0.006739 
orf19.94  
Ortholog of C. parapsilosis CDC317 : CPAR2_603030, Candida tenuis NRRL Y-1498 
: CANTEDRAFT_113701, Debaryomyces hansenii CBS767 : DEHA2F10054g and 
Candida dubliniensis CD36 : CD36_60970  
2.8783 3.52E-05 
orf19.4372  




Predicted membrane transporter, member of the drug:proton antiporter (14 spanner) 
(DHA2) family, major facilitator superfamily (MFS) 
2.91155 2.29E-05 
orf19.3567 BIO32 
Putative class III aminotransferase with a predicted role in biotin biosynthesis; induced 
during planktonic growth  
2.9605 0.000667 
orf19.1996 CHA1 
Similar to catabolic serine/threonine dehydratases; negatively regulated by Rim101p; 
expression greater in low iron; regulated on white-opaque switching; filament induced; 





Centromere-associated protein; similar to CENP-C proteins; Cse4p and Mif2p 
colocalize at C. albicans centromeres  
2.98228 7.72E-09 
orf19.2808 ZCF16 Predicted zinc-finger protein; not essential for viability  2.98848 0.006395 
orf19.7198  
Ortholog(s) have role in negative regulation of induction of conjugation with cellular 
fusion and negative regulation of transcription from RNA polymerase II promoter 
3.06124 0.000197 
orf19.4248  
Predicted ORF in Assemblies 19, 20 and 21; regulated by Gcn4p; repressed in response 
to amino acid starvation (3-aminotriazole treatment) 
3.07897 0.004934 
orf19.2948 SNO1 
Protein with a predicted role in pyridoxine metabolism; expressed during stationary 
phase; transcription is regulated by Tup1p, Efg1p; 
3.10085 0.000673 
orf19.1313 CDR3 
Transporter of the Pdrp/Cdrp family of the ATP-binding cassette (ABC) superfamily; 
transports phospholipids in an out-to-in direction; expressed in opaque-phase cells; 
induced by macrophage interaction; fluconazole-downregulated  
3.15883 0.00098 
orf19.3190 HAL9 
Protein with Zn(2)-Cys(6) binuclear cluster; gene in zinc cluster region of Chr. 5; 
transcriptionally activated by Mnl1p in weak acid; similar to S. cerevisiae Hal9p, which 
is a putative transcription factor involved in salt tolerance  
3.16476 7.02E-05 
orf19.4749  Hap43p-induced gene; hyphal-induced expression, regulated by Cyr1p, Ras1p, Efg1p  3.27669 0.001548 
orf19.7106 VPS70 




Enzyme of sulfur amino acid biosynthesis; putative role in regulation of cell wall 
biogenesis; upregulated in biofilm; possibly adherence-induced; regulated by 
Tsa1p/Tsa1Bp in H2O2 stress; Gcn4p-regulated; Tbf1p-activated; Hap43p-repressed  
3.46353 0.001074 
orf19.3352  
Has domain(s) with predicted nucleotide binding, oxidoreductase activity and role in 
oxidation-reduction process  
3.50041 2.53E-05 
orf19.4024 RIB5 
Putative riboflavin synthase; fungal-specific (no human or murine homolog); farnesol-




orf19.3577.1  Ortholog(s) have mitochondrial intermembrane space localization  3.60791 0.000212 
orf19.7436.1 ECM15 
Protein with a predicted role in cell wall organization; Hap43p-repressed gene; 
caspofungin repressed  
3.62313 0.000147 
orf19.4593 RGA2 
Putative GTPase-activating protein (GAP) for Rho-type GTPase Cdc42p; involved in 
cell signaling pathways controlling cell polarity; similar to S. cerevisiae Rga2p; induced 
upon low-level peroxide stress; late-stage biofilm-induced  
3.7318 0.005128 
orf19.5342  Ortholog(s) have cytosol, fungal-type vacuole, nucleus localization  4.09653 0.000434 
orf19.3870 ADE13 
Adenylosuccinate lyase; enzyme of adenine biosynthesis; soluble protein in hyphae; not 
induced during GCN response, in contrast to the S. cerevisiae ortholog; repressed by 
nitric oxide  
4.10905 0.003707 
orf19.7098  Putative protein of unknown function; Hap43p-repressed gene; repressed by nitric oxide  4.44856 0.002434 
orf19.1641  Ortholog(s) have cytosol, nucleus localization  4.76057 0.00012 
orf19.1855  
Predicted membrane transporter, member of the anion:cation symporter (ACS) family, 
major facilitator superfamily (MFS); Gcn4p-regulated; flucytosine induced; 
ketoconazole-repressed; oxidative stress-induced via Cap1p 
4.84589 0.00157 
orf19.7514 PCK1 
Phosphoenolpyruvate carboxykinase; regulated by hyphal switch, carbon source, 
Hap43p; repressed on glucose; induced by fluconazole, phagocytosis, H2O2, biofilm 
formation; induced in oralpharyngeal candidasis  
5.0044 0.005654 
orf19.2738 SUL2 
Putative sulfate transporter; transcription is negatively regulated by Sfu1p; induced upon 
biofilm formation; amphotericin B induced  
5.73615 0.00022 
orf19.670.2  
Hap43p-repressed gene; hypoxia downregulated, ketoconazole induced; late-stage 
biofilm-induced; induced in oralpharyngeal candidasis  
6.0384 0.00158 
orf19.2192 GDH2 
Putative NAD-specific glutamate dehydrogenase; fungal-specific (no human or murine 
homolog); transcription is regulated by Nrg1p, Mig1p, Tup1p, and Gcn4p; stationary 





Putative MFS transporter; transcription regulated by Nrg1p; macrophage/pseudohyphal-
repressed; transcription induced by alpha pheromone in SpiderM medium; possibly an 
essential gene, disruptants not obtained by UAU1 method  
7.60748 0.002538 
orf19.944 IFG3 Putative D-amino acid oxidase 7.82894 0.000759 
1 List of genes modulated differently in the sfp1∆/sfp1∆ (HHCa28) and SFP1/SFP1 (HHCa1) after incubation in minimal 
medium to an OD600nm of 0.8. Modulated genes were selected from four independent microarray experiments with an 
expression cutoff at 1.5 folds and t-test with p < 0.05. 
2 Name assigned to open reading frame (orf) from assembly 19 of the Candida albicans genome. 
3 Common name assigned to orf obtained from the Candida Genome Database (http://www.candidagenome.org/). 
4 Description of orf function obtained from the Candida Genome Database (http://www.candidagenome.org/). 
5 Normalized expression levels of orf obtained from the four microarray experiments using GeneSpring v.9.0. 
6 t-test p value from four microarray experiments performed in GeneSpring v.9.0. 
